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Abstract
Total joint arthroplasties (TJA) are commonly performed procedures for patients afflicted with hip and 
knee osteoarthritis (OA), and although successful, these surgeries can yield suboptimal results in a 
non-negligible proportion of patients. In order to improve surgical outcomes, patients at risk of poor 
results could be targeted with focused interventions. However, the evidence regarding the ability to 
identify which patients are at risk of poor outcomes is scarce. The objectives of this memoir were 1) to 
systematically review the literature of preoperative determinants of medium-term patient-reported pain 
and physical function after total hip arthroplasty (THA) and total knee arthroplasty (TKA) and 2) to 
develop clinical prediction models allowing the individual identification of patients at risk of poor 
outcomes following THA and TKA. 
Systematic literature searches targeting studies evaluating all studied determinants of pain and function 
following THA and TKA were performed in four important databases until April 2015 and October 
2014 respectively. Moreover, retrospective data from 265 patients having undergone THA at the 
Hôpital Maisonneuve-Rosemont from 2004 to 2010 was used to develop a preliminary prediction 
algorithm (PA) to identify patients at risk of poor surgical results. Finally, prospective data from 141 
patients recruited at their inclusion on a preoperative waitlist for TKA in three hospitals in Québec 
City, Canada and followed 6 months postoperatively was used to develop a clinical prediction rule 
(CPR) to identify patients at risk of poor outcomes
Twenty-two (22) studies evaluating determinants of poor pain and function after THA with moderate-
to-excellent methodological quality found that preoperative levels of pain and function, higher body 
mass index (BMI), greater medical comorbidities, worse general health, lower education level, lower 
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OA radiographic severity and contralateral hip OA were consistently associated with poor THA 
outcomes. Thirty-four (34) studies evaluating determinants of poor pain and function after TKA with 
moderate-to-excellent methodological quality identified preoperative levels of pain and function, 
greater medical comorbidity, lower general health, greater levels of depression and/or anxiety, 
presence of back pain, greater pain catastrophizing and greater socioeconomic deprivation as 
consistently associated with worse outcomes. 
A preliminary PA consisting of age, gender, BMI and three items of the preoperative Western Ontario 
and McMaster Universities Osteoarthritis Index (WOMAC) was able to identify patients at risk of 
suboptimal outcomes (worst quartile of the postoperative WOMAC score and perceiving their operated 
hip as artificial with minor or major limitations) on an average±standard deviation (SD) of 446±171 
days after THA with a sensitivity of 75.0% (95% CI: 59.8 – 85.8), a specificity of 77.8% (95% CI: 
71.9 – 82.7) and a positive likelihood ratio of 3.38 (98% CI: 2.49 – 4.57). A CPR consisting of five 
items of the preoperative WOMAC was able to predict the identity of patients awaiting TKA at the 
highest risk of poor outcomes (worst quintile of the postoperative WOMAC score) six months 
postoperatively with a sensitivity of 82.1 % (95% CI: 66.7 – 95.8), a specificity of 71.7% (95% CI: 
62.8 – 79.8) and a positive likelihood ratio of 2.9 (95% CI: 1.8 – 4.7). 
This memoir led to the identification of a list of determinants of pain and disability following TKA and 
THA with the highest level of evidence to date. Moreover, two clinical prediction models with good
predictive capabilities were developed in order to allow the identification of patients at risk of poor 
outcomes following TKA and THA. These findings could help target the patients most likely to benefit 
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from interventions aimed at diminishing their risk profile and improving surgical outcomes of hip or 
knee arthroplasties. External validation of these rules is warranted before clinical implementation.
Keywords: Total joint arthroplasty, Systematic review, Determinants, Prediction, Postoperative pain, 
Postoperative function
vRésumé
Les arthroplasties totales de la hanche (ATH) et du genou (ATG) sont souvent offertes aux patients 
atteints de dégénérescence articulaire sévère. Bien qu’efficace chez la majorité des patients, ces 
interventions mènent à des résultats sous-optimaux dans de nombreux cas. Il demeure difficile
d’identifier les patients à risque de résultats sous-optimaux à l’heure actuelle. L’identification de ces 
patients avant la chirurgie pourrait permettre d’optimiser la gamme de soins et de services offerts et de 
possiblement améliorer les résultats de leur chirurgie. Ce mémoire a comme objectifs : 1) de réaliser
une revue systématique des déterminants associés à la douleur et aux incapacités fonctionnelles
rapportées par les patients à moyen-terme suivant ces deux types d’arthroplastie et 2) de développer 
des modèles de prédiction clinique permettant l’identification des patients à risque de mauvais résultats 
en terme de douleur et d’incapacités fonctionnelles suivant l’ATH et l’ATG.
Une revue systématique de la littérature identifiant les déterminants de la douleur et de la fonction 
suivant l’ATH et l’ATG a été réalisée dans quatre bases de données jusqu’en avril 2015 et octobre 
2014, respectivement. Afin de développer un algorithme de prédiction pouvant identifier les patients à 
risque de résultats sous-optimaux, nous avons aussi utilisé des données rétrospectives provenant de
265 patients ayant subi une ATH à l’Hôpital Maisonneuve-Rosemont (HMR) de 2004 à 2010. 
Finalement, des données prospectives sur 141 patients recrutés au moment de leur inclusion sur une 
liste d’attente pour une ATG dans trois hôpitaux universitaires à Québec, Canada et suivis jusqu’à six 
mois après la chirurgie ont permis l’élaboration d’une règle de prédiction clinique permettant 
l’identification des patients à risque de mauvais résultats en terme de douleur et d’incapacités 
fonctionnelles.
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Vingt-deux (22) études d’une qualité méthodologique moyenne à excellente ont été incluses dans la 
revue. Les principaux déterminants de douleur et d’incapacités fonctionnelles après l’ATH incluaient: 
le niveau préopératoire de douleur et de fonction, un indice de la masse corporelle plus élevé, des
comorbidités médicales plus importantes, un état de santé générale diminué, une scolarité plus faible, 
une  arthrose radiographique moins sévère et la présence d’arthrose à la hanche controlatérale. Trente-
quatre (34) études évaluant les déterminants de douleur et d’incapacités fonctionnelles après l’ATG 
avec une qualité méthodologique moyenne à excellente ont été évaluées et les déterminants suivant ont 
été identifiés: le niveau préopératoire de douleur et de fonction, des comorbidités médicales plus 
importantes, un état de santé générale diminué, un plus grands niveau d’anxiété et/ou de symptômes 
dépressifs, la présence de douleur au dos, plus de pensées catastrophiques ou un faible niveau 
socioéconomique.
Pour la création d’une règle de prédiction clinique, un algorithme préliminaire composé de l’âge, du 
sexe, de l’indice de masse corporelle ainsi que de trois questions du WOMAC préopératoire a permis 
l’identification des patients à risque de résultats chirurgicaux sous-optimaux (pire quartile du 
WOMAC postopératoire et percevant leur hanche opérée comme  artificielle avec des limitations 
fonctionnelles mineures ou majeures) à une durée moyenne ±écart type de 446±171 jours après une 
ATH avec une sensibilité de 75.0% (95% IC: 59.8 – 85.8), une spécificité de 77.8% (95% IC: 71.9 –
82.7) et un rapport de vraisemblance positif de 3.38 (98% IC: 2.49 – 4.57).
Une règle de prédiction clinique formée de cinq items du questionnaire WOMAC préopratoire a 
permis l’identification des patients en attente d’une ATG à risque de mauvais résultats (pire quintile du 
WOMAC postopératoire) six mois après l’ATG avec une sensibilité de 82.1 % (95% IC: 66.7 – 95.8), 
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une spécificité de 71.7% (95% IC: 62.8 – 79.8) et un rapport de vraisemblance positif de 2.9 (95% IC: 
1.8 – 4.7). 
Les résultats de ce mémoire ont permis d’identifier, à partir de la littérature, une liste de déterminants 
de douleur et d’incapacités fonctionnelles après l’ATH et l’ATG avec le plus haut niveau d’évidence à 
ce jour. De plus, deux modèles de prédiction avec de très bonnes capacités prédictives ont été 
développés afin d’identifier les patients à risque de mauvais résultats chirurgicaux après l’ATH et 
l’ATG. L’identification de ces patients avant la chirurgie pourrait permettre d’optimiser leur prise en 
charge et de possiblement améliorer les résultats de leur chirurgie.
Mots-clés: Arthroplastie de la hanche, Arthroplastie totale du genou, Revue systématique, 
Déterminant, Prédicteur, Douleur postopératoire, Fonction postopératoire
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CHAPTER 1
INTRODUCTION
21. Introduction
OA is a progressive condition affecting a more than 10% of the Canadian population aged 15 or older 
and has a predilection for the elderly population [1, 2]. Patients afflicted by hip or knee OA can 
experience significant pain and functional limitations [3-5]. Recent recommendations suggest both 
pharmacological and non-pharmacological approaches to the management of hip and knee OA [6-8]. 
The gold standard treatment for both hip and knee OA when all conservative methods have been 
exhausted is the replacement of the respective joints with a prosthesis (THA and TKA respectively) 
[8]. These interventions are generally associated with successful outcomes, and in most cases, lead to a 
dramatic amelioration of pain levels as well as an improvement in functional status [9-13]. This has 
steered a tremendous upsurge in the popularity of these interventions, as evidenced by an approximate 
six-fold increase in the demand for TKA in the following decades [14]. These statistics invariably 
suggest the economic burden of TJAs; effectively, just the in-hospital costs associated with these 
procedures are estimated at almost 1 billion Canadian dollars ($CAD) per year [15].  Clearly, 
strategies targeted at ameliorating the management of these patients are required in order to avert the 
rising demand and efficiently allocate resources to this clientele.
Although generally considered successful, TJAs can lead to poor pain-related and functional outcomes 
in 7-23% in those undergoing THA and in 10-30 % of those undergoing TKA [4, 12, 13, 16]. 
Moreover, 7 % of patients undergoing THA and up to 23% of those undergoing TKA are dissatisfied 
with their surgical outcomes [4, 17]. Identifying such patients could help clinicians and patients 
themselves in making the decision of going forward with such an intervention or it may lead to the 
implementation of medical and rehabilitation interventions to help these patients before and after the 
surgery [18]. For example, patients identified as potentially at risk of a poorer outcome before their 
3surgery could be enrolled in a prehabilitation program during pre-surgery wait or intensive 
rehabilitation could be planned postoperatively [19]. Moreover, targeting of modifiable risk factors in 
those at risk of poor outcomes could ultimately improve their surgical outcome. Eventually, in terms of 
health service organization, identification of patients risking poorer outcomes following TJA may 
allow stakeholders and clinicians to better plan healthcare resources required by patients who are most 
likely to benefit from these interventions, as well as diverting efforts from patients who are likely to 
fare well on their own [19, 20].
The identification of factors affecting the outcomes of TJAs and of patients at risk of poorer outcomes 
remains a challenge. The surgical outcomes are clearly complex and investigations of possible 
determinants have been primarily directed toward perioperative surgical complications and prosthetic-
related factors [20]. Many personal, clinical, surgical or psychosocial factors have been associated with 
worse pain, function or poor satisfaction following TJA, however results have not been consistent 
across studies [20]. Several systematic reviews have attempted to summarize the determinants of pain 
and function following THA and TKA, however they included studies with low methodological 
quality and often only focused on one type of determinant [10, 18, 21, 22].  It thus remains a challenge 
to identify which TJA candidates will likely do well, or do poorly following surgery and may need 
targeted interventions [18, 20]. 
In light of the aforementioned shortcomings of TJA outcomes, identification of patients at risk of poor 
surgical results is paramount. Although prioritization tools have been developed to identify patients 
most in need of surgery [23], at the present time, no validated clinical prediction tools have been 
developed to identify patients at risk of suboptimal outcomes in terms of pain and disability. Such 
4tools could help manage more efficiently patients undergoing TJA and those waiting for their surgery. 
Development of new prediction tools are in line with the recommendations of the final report of the 
Canadian Federal Advisor on Wait Times, which suggested the implementation of new innovative 
models of care [24]. 
2. Literature review
2.1.  Osteoarthritis
2.1.1.    General principles and epidemiology
OA is a dynamic process characterized by a progressive loss of the articular cartilage in association 
with remodelling and sclerosis of the subchondral bone, resulting in a structural and functional 
deficiency of synovial joints [1, 25]. OA affects primarily the elderly, and as the population ages, the 
number of people expected to be afflicted with OA will increase, especially in the age group of 50 to 
80 years old [26]. The prevalence of OA in Canada is anticipated to increase from 3 million (14%) in 
2010 to 5.8 million (18%) in 2031 [1]. The total annual direct healthcare costs associated with OA in 
Canada are estimated to rise from 1.8 billion $CAD in 2010 to 8.1 billion $CAD in 2031 [1]. This rise 
can be attributed to an increase in the number of persons living with OA, to the increasing incidence of 
OA and greater longevity [1]. Other contributing factors are the increasing number of TJAs and greater 
use of services by patients treated surgically [1]. Disability attributed to OA in the population aged 15 
and over is projected to increase from a prevalence of 2.3% (595,000) in 1991 to 3.3% (1.13 million) 
in 2031 [27].
52.1.2.    Hip and knee OA
Hip and knee OA are important subgroups of articular degenerative diseases and represent the first 
cause of functional limitations when walking or in any other task involving the lower limb [28]. The 
natural history of knee and hip OA involve progressive degenerative changes of the articular surfaces, 
resulting in increased pain, loss of joint range of motion (ROM), and loss of function [29]. 
Recent guidelines suggest that an optimal management of hip and knee OA should rely on a
combination of pharmacological and non-pharmacological approaches [6]. These include 
biomechanical interventions, administration of intra-articular corticosteroids, land-based and water-
based exercise, self-management, education, strength and weight training and oral medication [6]. 
Whenever these interventions fail to alleviate joint OA-related symptomatology, it is almost 
universally recommended to proceed with a hip or knee replacement surgery, which are considered 
both effective and cost-effective [6].
2.2.  Joint arthroplasties
2.2.1.    Epidemiology
TJAs are commonly performed surgical interventions; for example, TKA ranks second among all 
orthopaedic procedures after fracture fixation [14]. In 2010-2011, it is estimated that more than 90,000 
THAs and TKAs were performed in Canada [30]. There is an increasing trend in the number of TJAs 
performed in Canada; the rate at which these procedures were completed doubled from 1996 to 2006 
[31]. It is estimated that these trends will continue to substantially evolve, with a 175% projected
increase in the demand for THA and 673% for TKA [14]. The economic impact of these interventions 
is considerable. The total in-hospital costs of knee and hip replacements in Canada in 2011 was 
6estimated at 963 million $CAD [15]. Increasing trends are equally observed for hip and knee 
replacement-related acute care hospitalizations, a surrogate of the number of performed TJAs; 2014 
data indicates a five-year increase of 16.5% for hip replacement and 19.2% for TKA [15]. A greater 
proportion of hip and knee replacements were performed on females based on data collected in 2014  
(60.2% and 58.1% respectively) [15]. Age trends for males and females undergoing knee replacement 
were similar, the average values being 67.4 and 67.2 years respectively [15]. However, males 
undergoing hip replacement were on average younger than females (67.3 vs. 72.4 years old) [15]. The 
great majority of patients undergoing hip and knee arthroplasty were overweight or obese (74.4% and 
86.7% respectively) [15]. The most important indication for primary hip arthroplasty is OA (76.5% in 
2013), with acute hip fracture a distant second (13.7%) [15]. An even greater proportion of primary 
TKAs were conducted for OA (97.1%) [15]. 
2.2.2.    Surgical techniques and types of prostheses
2.2.2.1.        TKA and other types of knee arthroplasty
The TKA procedure typically involves the replacement of the articular surfaces of the femur, the tibia 
and the patella by implants made of metal alloy and polyethylene. The vast majority of implants today 
are fixed with the use of cement. Two types of implants and procedures are used for the stabilization of 
the prosthesis: the postero-stabilized implant with ablation of the posterior cruciate ligament or the non 
postero-stabilized type where the knee ligaments are still competent. A meta-analysis has not 
demonstrated any differences in terms of durability, either in the short or the long term, between the 
two types of implants [32]. There is no consistent evidence as to whether one type of implant, 
stabilization or fixation produces better short or long term outcomes.
7Less invasive alternatives to TKA include unicompartmental knee arthroplasty (UKA) and 
bicompartmental knee arthroplasty (BKA). The most popular intervention, UKA, entails the 
replacement of the medial or the lateral articular surfaces of the tibiofemoral joint [33]. Traditionally, 
its indications are more strict when compared to TKA: a diagnosis of OA or osteonecrosis of the 
medial or the lateral compartment of the tibiofemoral joint, an age greater than 60, a low demand for 
activity, weight under 82 kg, minimal pain at rest suggesting a low possibility of an inflammatory 
component, a range of motion arc greater than 90° with less than 5° of flexion contracture and an 
angular deformity smaller than 15° that is passively corrected to neutral [34]. However, recently, 
indications have expanded in order to include younger and heavier patients [33]. When compared to 
TKA, UKAs tend to have higher revision rates, but possibly lead to a more normal feeling in the knee, 
smaller risk of infection and less extensive surgery [35]. Similar short-term and long-term clinical 
results are noted for UKA procedures when compared to TKAs [36, 37].
2.2.2.2 Hip arthroplasty
THA entails the replacement of the native femoral head and acetabulum with artificial materials. Four 
basic components are employed for THA: the acetabular component, the acetabular insert, the femoral 
head and the femoral component. 
Different bearing or articulating surfaces have been developed. The most commonly used bearing
surfaces in 2012 in Canada was metal-on-polyethylene (more than 80% of THAs) [38]. Because of the 
wear-related complications associated with the polyethylene components, alternative bearing couples 
have been developed. Ceramic components have the lowest wear rates among any bearing surface 
[38]. However, they are more brittle, and up to 17% of patients with ceramic-on-ceramic THAs 
8experience audible squeaking noise [38, 39]. Metal-on-metal bearings have low wear rates and are less 
brittle than ceramic components. They support the use of larger femoral head sizes, which are 
associated with improved stability and lower rates of dislocation. Nevertheless, metal-on-metal 
bearings raise a great concern due to local adverse reactions to metal debris, with host responses 
causing local inflammation and formation of pseudotumors, and occasionally, soft-tissue and bony 
destruction [40]. Although rates of complications and revisions differ between the types of bearings, 
recent meta-analyses reported no difference in terms of physical functioning and pain [40, 41]. 
Three different methods of fixation are employed by surgeons in order to secure the femoral stem and 
the acetabular components. Bone cement can be used to fix the implant to the patient’s natural 
remaining bone stock. Cementless implants are initially secured with bone screws or are press-fit into 
position to allow secondary fixation with bone integration on the implant surface. A hybrid approach 
combines cemented and cementless implant components. Cemented implants are associated with 
higher rates of implant loosening, osteolysis and femoral stem fracture and are occasionally employed 
in older and lower-demand patients [38]. Cementless implants were the most frequently used fixation 
method in Canada in 2010 (84%), followed by hybrid (15%) and cemented (1%) implants. A recent 
meta-analysis showed unclear results regarding whether cemented or cementless fixation are related to 
better patient-reported clinical results [42].
Hip resurfacing arthroplasty (HR) is an alternative to THA with a femoral stem in patients who are 
younger, more active, with normal kidney function and appropriate proximal femoral bone 
morphology and quality [43]. It involves the resurfacing of the native femoral head with a metal cap
and the implantation of an acetabular component with a polished inner cobalt-chrome metal surface 
9[38]. Theoretical advantages of HR include a greater potential of replicating physiological hip 
function, lower rates of dislocation, and improved levels of activity with minimal wear of the articular 
surfaces [40]. Multiple studies concluded that patient-reported outcomes in terms of pain and function 
are similar between THA with a femoral stem and HR [40]. 
2.3.  Defining outcome after joint arthroplasty
Evaluating the surgical results after a procedure entails establishing a definition of what represents a 
good and a bad outcome. Measuring surgical results following hip and knee arthroplasty is clearly 
complex, as evidenced by the different outcomes used to evaluate its effectiveness. For the greatest 
part, assessment of joint arthroplasty outcomes has focused on surgical and technical aspects [20]. 
However, recently, a shift towards patient-reported outcome measures (PROMs) has been advocated, 
and this is evidenced in the latest literature [20, 44]. Disease-specific measures for domains such as 
pain, function and stiffness have received notable attention. Despite the fact that such measures do not 
necessarily provide a holistic view of the patients’ health status on their own, they offer valuable 
information regarding aspects that are important from the patients’ perspective [45]. There have been 
several approaches at quantifying the results of joint arthroplasty in terms of PROMs. One method is 
the concept of “change” in health status following the intervention when compared to the status 
preoperatively, which can be viewed as a measure of effectiveness of TJA [46]. Recently, attempts at 
identifying a value for the change in health status that can be considered appropriate have been 
undertaken, as evidenced by the development of tools such as the OMERACT-OARSI set of responder 
criteria and the minimal clinically important difference or improvement (MCID or MCII) (see 
Appendices A and B) [47-51]. These approaches entail the use of an anchor item evaluating the 
patients’ own impression regarding the outcomes of the intervention, that is further employed to 
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identify a cut-off value for what represents an appropriate surgical results in terms of pain, stiffness 
and function (Appendices A and B). The other school of thought focuses on the concept of “patient 
state” following the intervention, regardless of the level of improvement through surgery [46]. This has 
led to the development of the concept of patient-acceptable symptom state (PASS) in order to quantify 
an appropriate level of symptoms following therapeutic interventions, including THA and TKA [48]. 
However, no consensus has been reached regarding which approach represents the most valid method 
of assessing the results of TJA. As can be seen Appendix B, the main difficulty resides in the different 
values obtained for each type of outcome assessment among different studies. This is probably due to 
different anchor items employed in each study, different methodologies of deriving these values, 
different follow-up time points as well as lack of validation of derived cut-off values in several studies. 
2.4.  Evolution of patients following a TJA
Both TKA and THA are generally considered effective and safe procedures and allow for adequate 
alleviation of pain and improvement of function as well as health-related quality of life (HRQoL) for 
the majority of patients undergoing the procedures [9, 11, 52-54]. These interventions are however 
associated with perioperative and immediate postoperative complications that can significantly 
jeopardize the well-being of the patients [52]. The most feared complication, infection of the joint, 
occurs in approximately 1% of TKA procedures and up to 2.5% of THA [39, 55, 56]. Up to 2% of 
patients can experience nerve injuries, most frequently peroneal nerve palsy for TKA and the peroneal 
division of the sciatic nerve in THAs [57, 58]. Despite adequate thromboprophylaxis, symptomatic 
thromboembolic events occur in 2-3% of patients, with up to 15% demonstrating evidence of deep 
vein thrombosis on venographic studies [59, 60]. Surgical revision of a failed implant occurs in only 
2% of TKA cases at 5 years and 5% at 10 years for THA [61, 62].
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A growing body of evidence indicates that a significant proportion of patients will experience poor 
outcomes; as many as 25% of THA patients and 30% of TKA patients will suffer from chronic pain 
and disability and up to 23% will experience dissatisfaction with the surgical outcomes [4, 12, 13, 16, 
17]. The reasons behind such poor outcomes remain unclear, rendering the identification of factors 
affecting the outcomes of knee and hip arthroplasty and of patients at risk of poorer outcomes a 
significant challenge. The outcomes of joint arthroplasties are clearly complex and investigations of 
possible determinants have been primarily directed toward perioperative surgical complications and 
prosthetic-related factors [20]. Many demographic, socioeconomic, clinical or psychosocial factors 
have been associated with worse pain, function and HRQoL following TKA and THA, however results 
have not been consistent across studies and the precise impact or strength of the association between 
these factors and the outcomes remain elusive. It thus remains a challenge to identify which join 
arthroplasty candidates will likely do well, or do poorly following their surgery.
2.5.  Determinants of TKA and THA outcomes in terms of pain and functional limitations
Several systematic reviews have attempted to summarize the determinants of pain and/or functional 
limitations after TKA and THA. Santaguida et al. (2008) concluded that older age and female gender 
are significant determinants of worse function following TKA [18]. Ethgen et al. (2004) suggested that 
female gender, presence of comorbidity and poor preoperative quality of life are all determinants of 
worse outcomes after surgery [10]. A systematic review by Vissers et al. (2012) identified pain 
catastrophizing and lower preoperative mental health as significant determinants of poor TKA 
outcomes [13]. The main limitations of the published reviews is their focus on solely one type of 
determinant, inclusion of studies with poor methodological quality, reporting of results based on 
conjoined TKA and THA cohorts and a large range of follow-up periods. Moreover, there has been an 
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increasing amount of novel evidence published recently on the topic, notably with the investigation of 
novel possible determinants, which can be generally classified as demographic, socioeconomic, 
psychosocial, clinical, surgical and healthcare-related. This motivates a comprehensive assessment of 
the literature of determinants of TJA in a structured manner.
2.6.  Identification of patients at risk of poor outcomes following joint arthroplasty
2.6.1.    General principles of prediction tools
By developing accurate and easy-to-use prediction tools, better case management of patients scheduled 
to undergo joint replacement may be achieved. A clinical prediction tool can be defined as “a tool that 
quantifies the individual contributions that various components of the history, physical examination, 
and basic laboratory results make toward the diagnosis, prognosis, or likely response to treatment in an 
individual patient” [63]. The prediction tools are intended to assist the clinician’s diagnostic or 
prognostic assessment, and tend to be used when decision-making is difficult or when achieving cost-
saving without compromising quality of patient care is possible [64].
Several phases are required in order to adequately implement a clinical prediction tool. Firstly, during 
the development phase, identification of predictors from an observational study is undertaken in order 
to choose a group with the best predictive capabilities [65]. Several statistical methods can be 
employed to develop a prediction tool, each presenting their own advantages and disadvantages. 
Scoring systems and predictive models derived from univariate or multivariate analyses allow the 
allocation of a “weight” to factors significantly associated with the desired outcome [65]. These 
models are easy to interpret, but are not fully reliable at eliminating the bias associated to the 
interaction between independent variables [65]. Nomograms are graphical calculating devices allowing 
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the graphical computation of complicated formulas [65]. Many nomograms are developed using 
regression analysis, and although their use may be more simplistic, they retain the disadvantages 
associated with their inherent methodology [65]. Artificial neural networks are computational models 
similar in structure and function to biological neural networks, where input flowing through the 
network generates an output, and subsequent inputted data sets lead to an adjustment of the 
relationship that predicts the outcome [65]. They can identify complex non-linear associations between 
variables, but can be difficult to use clinically due to their requirement of greater computational 
resources when compared to other types of prediction models [65]. Recursive partitioning analyses, of 
which the classification and regression tree (CART) approach is the most popular, is a non-parametric 
method allowing the development of a decision tree splitting the patient populations into progressively 
smaller samples based on risk factors [64]. The decision tree is generally easily understood by 
clinicians, and can be well translated into everyday practice. Moreover, this approach is more liberal 
regarding required assumptions as compared to more traditional methods such as logistic regression 
[66]. However, some authors suggest that the CART approach may be less accurate than other models, 
as the amount of data contained in the “leaves” may be insufficient to reliably predict the outcome 
[65]. Moreover, the developed trees suffer from instability, as small changes in the sample or different 
cutting points may significantly alter the entire structure [67]. 
The next phase of the establishment of a clinical decision tool is its validation in order to ensure its 
reliability.  This can be achieved in different ways. Several statistical methods can be employed in 
order to determine whether the associations between the given predictors and outcomes are due purely 
to chance, i.e. establishing the internal validity of the prediction algorithm. The most straightforward 
method, the split-sample approach, involves developing the prediction rule in a random half of the 
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sample, termed the “training sample”, and testing its validity in the other half of the sample, namely 
the “validation sample”. An extension of this is the cross-validation approach, which entails removing 
a certain number of patients from the sample, generating the rule using the remainder of patients, 
testing its performance on the subsample that was initially removed from the sample, and repeating the 
procedure several times such as data on all subjects is used to develop the model [68]. The most 
efficient approach of internal validation is however bootstrapping, which involves drawing samples 
with replacement from the original data set that have the same sample size as the original sample set 
followed by testing of the predictive model in those samples [68]. Typically, 1,000 bootstrap 
resamples are completed. In the case of the CART approach, the bootstrap estimates of the predictive 
qualities along with their 95% confidence intervals are calculated, and subsequently compared to the 
respective asymptotic values. If the confidence intervals are similar, it is deemed that the model has a 
satisfactory internal validity.
Assessment of the external validity of the prediction rule can be undertaken by testing its performance 
in a different population from the one where it was initially developed. Several methods exist, each 
representing different levels of validity. The prediction model can be validated in a retrospective 
cohort, in a narrow prospective cohort, in a large prospective cohort including a broad spectrum of 
patients or in several smaller settings that differ from one another [64]. 
Following validation of the prediction model, the impact analysis phase entails measuring the 
usefulness of the rule in a clinical setting in terms of cost-benefit, patient satisfaction and time-
resource allocation [65]. A proper implementation of the prediction rule assumes that its use changes 
physicians’ behaviours, and this leads to either improvement of the outcomes or optimization of costs 
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while maintaining the standard of care [64]. Only after all of these conditions are filled, a prediction 
model can be accepted and adopted in clinical practice.
2.6.2.     Developed prediction tools in the musculoskeletal literature
To our knowledge, one model predicting the identity of patients at risk of poor outcomes after THA 
has been developed [69]. The model consisted of patient age, BMI and gender, and had a sensitivity of 
87.5% (95% CI 52.9 – 97.8), a specificity of 72.4% (95% CI 54.3 – 85.3) and a positive likelihood 
ratio of 3.17 (95% CI 1.66 – 6.05). Unfortunately, the model was developed in a small sample of 37 
patients, and surgical success was defined uniquely by functional outcomes (change between the 
preoperative and six-month Lower Extremity Functional Scale - LEFS- score). A priority-setting tool 
for TKA and THA has been developed and validated by the Western Canada Waiting List project 
partnership [23, 70]. This tool is able to quantify the level of urgency of the status of patients awaiting 
total knee or hip replacement; however, its predictive capabilities have not been studied. Other 
prediction tools intended at improving the management of patients with different musculoskeletal 
pathologies have been developed and validated. The Ottawa Knee and Ankle rules are well-known, 
validated clinical prediction tools that are extensively employed in the evaluation of the requirement of 
radiological assessment of suspected cases of knee and ankle fractures in the emergency department
[71, 72].  The 5-item Cassandra Rule has been developed in order to identify patients with non-specific 
back pain who are most likely to develop or sustain long-term functional limitations [73].
3. Objectives
The objectives of this memoir were:
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x To systematically review the literature of determinants of poor short- and medium-term surgical 
outcomes in terms of pain and functional limitations following THA and TKA in order to 
identify the determinants with the greatest level of evidence
x To develop preliminary clinical prediction tools allowing the preoperative identification of 
patients at risk of poor short- and medium-term outcomes following joint arthroplasties
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CHAPTER 2
Methodology
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1.  Systematic reviews
This section describes the methodology of the systematic reviews of the literature of determinants of 
pain and function following THA and TKA (Chapters 3 and 5 respectively). Both reviews had similar 
methodologies, and are therefore presented conjointly. 
1.1.  Type of study
These studies entailed a systematic review of the literature of determinants of pain and functional 
outcomes following THA and TKA respectively. 
1.2.  Literature search and study identification
With the help of a qualified documentation technician, four databases (Medline, Pubmed, Embase and 
CINAHL) were searched from their respective inception dates using a combination of keywords and 
Medical Subject Headings (MESH) terms (see Appendices C and D). The search strategy was 
developed in order to identify all possible determinants of THA or TKA outcomes. Manual searches of 
previously published reviews as well as of the reference lists of representative articles were also 
conducted. Two reviewers (Eugen Lungu and Janie Bary) independently reviewed the titles, abstracts 
and full texts of articles in order to evaluate their eligibility. A third reviewer (François Desmeules) 
was available to remediate any differences, if required. 
  
1.3.  Selection criteria
The following selection criteria were applied in order to ensure homogeneity of the included studies as 
well as appropriate generalizability.
x Participants were patients undergoing primary unilateral THA or TKA with ≤ 10% of 
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the sample undergoing UKA (in the case of the review on determinants of TKA 
outcomes), bilateral or revision TJA.
x ≥90% of the study sample was diagnosed with hip or knee OA
x Results are presented for a follow-up between 6 weeks and 2 years
x The outcome measure was a disease-specific validated PROM assessing pain and/or 
function
x Identification of determinants was obtained using multivariate analysis
x Article was published in English or French due to the restrictions imposed by the 
languages mastered by the reviewers.
1.4.  Data extraction
A standardized form was employed to extract data. Participants’ characteristics (diagnosis, type of 
surgery, age and gender proportion), number of patients, follow-up period, outcome measure 
employed, statistical methods used and statistical adjustments, as well as significant and non-
significant determinants reported by the study were recorded. Each article was extracted by one of the 
raters and verified by another in order to reduce the risk of extraction errors.
1.5.  Appraisal of the methodological quality
Two trained reviewers independently performed the appraisal of the methodological quality of the 
included studies and results were discussed in order to reach consensus. In case of disagreement, a 
third reviewer was available for mediation of differences. 
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The methodological quality of the included studies was assessed by evaluating the risk of bias using a 
modified version of the Methodology Checklist for Prognostic Studies developed by Hayden et al. 
(2003) [74] (see Appendix E). Six items define this tool: “Study participation”, “Study attrition”, 
“Prognostic factor measurement”, ‘Outcome measurement”, “Confounding measurement and account” 
and ‘Analysis”. Each item evaluates the risk of potential methodological bias: “yes” indicates a low 
risk of bias, “no” indicates a high risk of bias and “unclear” indicates an unclear or an unknown risk 
given the information available from the article. A score of 2 was attributed if a low risk of bias was 
present, a score of 1 if the risk was judged unclear and 0 if the risk was high. For the ‘Study 
participation” item, a score of 1 was given if the study was retrospective in nature and that information 
regarding patients not included in the study because of incomplete data was lacking. For the “Study 
attrition” item, a score of 0 was given automatically if the follow-up proportion at the relevant time-
point was inferior to 80%. A score of 0 was given for the “Confounding measurement and account” 
item if confounding factors such as age, gender and BMI were not accounted for in the multivariate 
analysis. A total score was calculated by summating the individual scores of items, and a final 
standardized score was provided.
1.6.  Data synthesis
Determinants of THA and TKA outcomes were summarized based on whether pain and function were 
assessed as separate or combined constructs. Moreover, due to a greater number of included studies 
yielding more data compared to the THA review, determinants of TKA outcomes were also reported 
based on whether pain and function were measured as postoperative change (difference between 
postoperative and preoperative levels) or postoperative status. A quantitative analysis was envisaged in 
order to pool the magnitude of association of the significant determinants with the outcomes. Given the 
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nature of the study designs and the heterogeneity of the included studies regarding variables’ 
constructs and definitions, only a qualitative synthesis of results was eventually performed. 
2. Prediction models
This section describes the methodology employed for the development of the prediction models 
presented in the chapters 4 and 6. 
2.1.  Preliminary prediction algorithm – hip arthroplasty
2.1.1.    Type of study
This study has entailed a retrospective review of prospectively collected repeated-measures data of 
patients undergoing hip arthroplasty, with the follow-up ranging from just before the intervention until 
12 to 24 months following surgery. This type of study allowed the assessment of the patient evolution 
from the preoperative to the postoperative period.
2.1.2.    Recruitment location
The prospectively collected arthroplasty database of the HMR was consulted in order to select patients 
eligible for inclusion in the study. The database contains extensive preoperative and follow-up 
information on patients undergoing numerous orthopaedic hip interventions, including THA and HR. 
Independent assessors not involved in the medical care of the patients collect the prospective data. All 
patients provide informed consent prior to their inclusion in the database.
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2.1.3.    Patient selection
Patients were eligible for inclusion in the study if they satisfied the following criteria: 1) patients 
undergoing primary unilateral THA or HR, 2) diagnosis of primary hip OA, 3) complete preoperative 
and one to two-year postoperative self-reported outcome questionnaire responses. 
Patients were excluded based on the following exclusion criteria: 1) THA or HR of the contralateral 
hip before the relevant follow-up evaluation, 2) revision of the implant before the 12 to 24 month 
follow-up, 3) diagnosis of inflammatory hip arthritis, paediatric hip disease, post-traumatic hip or any 
hip disease other than primary OA. 
2.1.4.    Variables and measures
The arthroplasty database of the HMR contains an extensive set of variables collected both 
preoperatively and postoperatively. However, a non-negligible proportion of data is missing. 
Therefore, in order to ensure the development of a prediction model with proper accuracy, we aimed to 
maximize the number of patients with complete preoperative and postoperative data for the greatest 
number of variables. Because we intended to build a model with an utmost clinical applicability, the 
limiting factors for the inclusion of patients were the presence of complete data for each item of the 
preoperative WOMAC, a number of individual answers of the postoperative WOMAC that would 
allow imputation of the total score as well as presence of an answer to the joint perception question. In 
the case of availability of complete data at 12 and at 24 months postoperatively, data at 12 months was 
included. Potential resulting selection bias associated with present design is addressed in the discussion
sections of Chapter 4.
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Dependent variable
Pain and functional status were assessed preoperatively and 12 to 24 months postoperatively with the 
WOMAC, a disease-specific patient-reported outcome measure, specifically designed to assess pain, 
stiffness and function in patients with hip or knee OA [75] (See Appendix F). It consists of the 
following domains: pain (5 items), stiffness (2 items) and functional limitation (17 items). Items are 
scored on a 5-point Likert scale representing different degrees of intensity (none, mild, moderate, 
severe or extreme). The scores of each domain as well as the total score were standardized on a 0 to 
100 scale, with a greater score indicating more pain, stiffness or functional limitation. The 
psychometric qualities of the WOMAC, including its responsiveness, convergent construct validity 
and reliability have been found excellent for evaluating patients with hip and knee OA undergoing 
TJA [75, 76]. Moreover, a French-Canadian version of the WOMAC has been successfully validated 
[77]. Missing postoperative values were imputated as described in the WOMAC User Manual [78].
Patients’ perception of their operated joint was measured at the 12 to 24 month follow-up with a 
multiple-choice question: “How do you perceive your operated hip?”. The possible responses were 
“Like a native or natural joint”, “Like an artificial joint with no restriction”, “Like an artificial joint 
with minimal restriction”, “Like an artificial joint with major restriction” and “Like a non-functional 
joint” (See Appendix G). Evaluation of joint perception has been strongly correlated with validated 
clinical scores of patient-reported outcome measures in patients undergoing TJA and can be employed 
as a measure of patient satisfaction [79]. Moreover, joint perception was found to be similar among 
patients undergoing THA and HR [79]. 
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No consensus exists regarding what constitutes a poor outcome following hip arthroplasty. We 
therefore attempted to classify patients as having a poor outcome based on different definitions, and 
build prediction models accordingly, with the intent to ultimately choose the best algorithm (see 
Statistical Analysis). Definitions included a combination of patients being in the worst teritle or 
quartile of the total postoperative WOMAC score and different levels of joint perception. Ultimately, 
because this categorization yielded the best model in terms of predictive capabilities, clinical 
applicability and ease-of-use, patients were classified as having a poor outcome if they were in the 
worst quartile of the postoperative WOMAC score and perceived their joint “Like an artificial joint 
with minimal restriction”, “Like an artificial joint with major restriction” or “Like a non-functional 
joint”. 
Independent variables
Demographic variables
Among the available demographic variables, age at the time of surgery, gender and employment status 
(employed, household, retired or other) were collected from the arthroplasty database. Complete data 
was only available for age and gender, which were included in the final analyses.
Clinical variables
BMI and presence of back pain were available from the arthroplasty database. Comorbidities that were 
obtainable included diabetes, gastrointestinal disease, immunosuppression, cardiac disease, obesity, 
osteoporosis, pulmonary disease, neurological disease, urological disease and other conditions.  Pain 
localization was defined as presence of pain at any of the following locations: buttocks, greater 
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trochanters, groin, thigh, knee, calf, radicular or elsewhere. Presence of hip pain at rest, after first few 
steps, after a long walk and during sexual intercourse was also surveyed.
Several other variables that had a missing proportion of up to 15% were not included in the analysis 
but were collected in order to better characterize the study population. Contralateral hip status was 
defined as unaffected by OA or affected by OA but not operated (THA, HR nor other intervention). 
Knee status was defined as affected or unaffected by OA. Level of walking performance was 
determined according to whether the patient was unable to walk with aid, used crutches, two canes, 
one cane on a permanent basis with instability, one cane exclusively for outdoor activities or one cane 
for long distance walking. The level of activity in the three months before surgery was quantified as 
performing heavy work or sport, moderate work, mild work/sport, sedentary or immobile. Duration of 
walk before eliciting pain was determined as follows: walking unaffected, 31-60 minutes, 11-30 
minutes, 2-10 minutes, less than 2 minutes or walking impossible. Patients’ Charnley class was 
recorded and defined as follows: patients assigned to the class A had a single joint arthroplasty and no 
significant medical comorbidity; patients in class B had one other joint in need of arthroplasty or an 
unsuccessful or failing arthroplasty in another joint; class C patients have multiple joints in need of 
arthroplasty, multiple failing arthroplasties or significant medical or psychosocial impairment [80]. 
The Charnley classification is a commonly used scale in the orthopaedic literature that allows the 
stratification of patients according to their variability in outcome, which is quantified as the walking 
ability [80]. It has been shown that the patient’s Charnley class also influences their outcome as 
measured by the WOMAC scale [81]. 
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     2.1.5.    Statistical analysis
Descriptive statistics (mean, standard deviation and frequencies) were employed accordingly to 
describe the included patients’ characteristics. Baseline and follow-up mean individual subscale and 
total WOMAC scores along with their standard deviations were calculated. Graphical representations 
of the scores were used in order to observe their distribution and assess their normality. Differences 
between time points in relation to total WOMAC scores and the respective domains was assessed 
using paired samples Student-t tests, with a significance level set at 0.05. Analyses were carried out 
with the IBM SPSS Statistics Version 20.0 (SPSS Inc., Chicago).
One of the most effective algorithms of recursive partitioning is the CART approach, and it was 
therefore employed to develop the preliminary PA [82]. It is based on maximizing the within-node 
homogeneity and minimizing the within-node error by evaluating all combinations of potential 
predictors. The Gini impurity measure was used as a splitting criterion for the development of the 
decision trees [83]. Because we aimed to develop a PA with the highest possible validity and due to the 
relatively small sample size, data for all the patients in the training set was used to develop the models. 
Firstly, all the variables were included in the analysis and models were developed using an automated 
approach. Secondly, several potential predictor variables were manually chosen based on several 
criteria, including statistical, clinical and ease-of-use qualities, in order to develop further models. For 
example, information on variables such as age and gender would be more readily attainable clinically 
compared to the number of comorbidities. Sensitivity, specificity, positive and negative predictive 
values as well as positive and negative likelihood ratios were calculated for all the developed models 
along with their 95% confidence intervals [84]. The model that showed the highest level of sensitivity 
and an appropriate level of specificity as well as fitting the ease-of-use criterion was selected among 
27
all of the proposed models. This method was employed seeing that we aimed to develop a screening 
tool, i.e. a model able to identify patients at risk of poor surgical outcomes with the smallest proportion 
of false negatives. Internal validity of the model was then appraised using 1,000 bootstrap resamples 
[85].
2.1.6.    Ethics and confidentiality
This study was part of a larger research protocol that was reapproved annually by the Comité d’éthique 
de la recherche of the HMR entitled “Évaluation de vos capacities fonctionnelles et de votre qualité 
de vie en pré chirurgie, péri chirurgie et post chirurgie” (see Appendix H). The ethics committee 
approved annually the information and consent form, as well as the database politics (see Appendix I).
2.2.  Clinical prediction rule – total knee arthroplasty
This study was based on a prospectively collected cohort that recruited patients undergoing TKA from 
February 2006 to July 2007. As mentioned in the Foreword section, I have not participated in the study 
design, patient recruitment or data collection, but the methodology will be summarized briefly in the
following sections.
2.2.1.    Type of study
A prospective longitudinal design with repeated-measures was employed. This study was part of a 
larger study evaluating the effect of waiting time on the preoperative state and the postoperative 
outcome of patients awaiting TKA.
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2.2.2.    Settings and patient recruitment
Patients who were newly enrolled on the waiting lists for TKA in three teaching hospitals in Québec 
City, Canada (CHUL, HSFA and HDQ) were recruited weekly between February 2006 and July 2007. 
All seven orthopaedists practicing TKA in these hospitals participated in the study. Patients were 
followed until September 2010.
2.2.3.    Participants
A research nurse contacted patients who were newly enrolled on the surgical wait lists of the three 
hospitals weekly via telephone. The following inclusion criteria were employed: (1) age > 40 years 
old; (2) scheduled for primary unilateral TKA; 3) understands, reads and speaks French. Patients were 
excluded from the study if they were suffering from a severe cardiac condition, a severe degenerative 
disease (other than OA) such as Parkinson’s disease, Alzheimer’s disease, any type of dystrophies or 
other type of medical condition potentially interfering with recovery after TKA or any severe mental 
disorder (severe depression, bipolar disorder, schizophrenia or dementia) that could impede the ability 
to answer the required questionnaires. Patients with a previous hip or knee arthroplasty were also 
excluded. Subjects who suffered major knee trauma in the previous year or who underwent urgent 
surgery within 30 days of inclusion on the waiting list were further excluded.
2.2.4.    Data collection and variables
Structured 45 minute telephone interviews conducted by three trained interviewers and review of the 
subjects’ medical files were employed in order to collect data. The interviews took place several days 
after enrolment on the wait lists (mean ± SD: 12.6 ± 4.7 days) and six months following the 
intervention (mean ± SD: 188.7 ± 5.4 days). 
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Dependent variables 
Pain, stiffness and function at enrolment and six months after surgery were measured with the 
WOMAC. The WOMAC score was transformed in order to obtain a score that varied from 0 to 100, 0 
indicating no pain, no functional limitations nor knee joint stiffness. In the light of a lack of consensus 
regarding the definition of a poor outcome following TKA, it was defined as the poorest quintile of the 
six-month postoperative WOMAC score (i.e. WOMAC score >40.4); an optimal outcome was defined 
as a WOMAC score in the best four quintiles of the distribution (i.e. score ≤ 40.4).
Independent variables 
In order to develop a model with the highest possible validity, independent variables that were 
collected for the purpose of being considered as potential predictors included known important 
determinants of TKA outcomes reported in the literature (see Chapter 1). Variables were collected at 
the time of the patients’ inclusion on the wait list and 6 months following TKA.
Potential predictors at enrolment on surgical wait list
Initial diagnosis, anthropometric data and comorbidities were extracted from the patients’ medical 
files. The CIRS was employed in order to determine the burden of comorbidities [86]. During the 
initial interview, questions drawn from the questionnaire of the 1998 Quebec Health Survey were used 
to determine the level of education, the employment status, the household income and the level of 
social support [87].  The level of social support was also measured with questions from the Quebec 
Health Survey [87].  Marital status, household living status, and clinical variables such as duration of 
disease symptoms were also recorded at the time of the first interview. Psychological distress was 
documented by using a modified version of the Psychological Symptom Index (PSI). This version 
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includes 13 questions assessing depression and anxiety during the past week (range: 0-42) [88]. In an 
effort to minimize the number of questions to include in the final tool, individual items from the 
validated questionnaires (social support tool, PSI and WOMAC) were also employed as independent 
variables in order to develop the CPR. 
Other variables
Several surgical variables such as type of implant, bearing type, implant fixation, patella resurfacing 
and the number and type of in-hospital complications (wound infection, dislocation, knee ankylosis 
and manipulation, cardiovascular/ pulmonary/ circulatory complications, peripheral/ central nervous 
system involvement, urinary infection, acute confusion, tendon and ligament rupture and blood 
transfusion) following TKA were documented by reviewing the patients’ medical files. Hospital length 
of stay and discharge to a rehabilitation or recovery facility were also available through a review of the 
medical files. The pre-surgery wait times were calculated using the information in the wait list 
database of each hospital. Patients reported use of walking aid and the number of community 
physiotherapy treatment hours received since discharge from the hospital six months following the 
intervention.
2.2.5.    Statistical analysis
The statistical methodology employed by this study was identical to the one described in section 2.1.5
in this chapter.
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2.2.6.    Ethics and confidentiality
Participants signed an informed consent form. The research protocol was approved annually by the 
Research ethics board of all three participating hospitals (CHUL, HSFA, HDQ).
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1. Abstract
Background
A thorough understanding of the determinants of patient-reported pain and function following THA
can help plan interventions directed at improving surgical results. Therefore, the objective was to 
summarize the preoperative determinants of pain and disability up to two years following THA in 
studies with appropriate methodological quality.
Methods
Four databases (Medline, Pubmed, Embase and CINAHL) were screened from their respective 
inception dates until April 2015 using a combination of keywords and MESH terms. Criteria for 
inclusion were 1- participants with primary unilateral THA followed up to 2 years, 2- validated 
disease-specific patient-reported outcome measures assessing pain and/or disability, 3-identification of 
determinants obtained via multivariate analyses. Methodological quality was assessed using a modified 
version of the Methodology Checklist for Prognostic Studies. 
Results
Twenty-two manuscripts were included. Mean score of the methodological quality was 81.0±10.3 %. 
Among socioeconomic determinants, a lower educational level was significantly related to worse pain 
and function (three out of three studies evaluating the relationship). Clinical determinants of poor 
outcomes included preoperative levels of pain and physical function (nine out of 12 studies), higher 
BMI (six out of ten studies), presence/greater level of comorbidities (five out of seven), worse general 
health (four out of four studies) and lower radiographic OA severity (three out of four studies). Study 
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heterogeneity limited the pooled assessment of the strength of association between the preoperative 
variables and THA outcomes. 
Discussion
Moderate-to-high quality of evidence allowed to elaborate a list of determinants of THA pain and 
function in the medium term with the greatest amount of evidence. This knowledge may assist the 
management of patients at risk of suboptimal results. Further research is required to clarify the force of 
association between determinants and THA outcomes. 
Keywords: Total hip arthroplasty, Hip osteoarthritis, Determinants, Pain, Disability
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2. Résumé
Introduction
Une bonne compréhension des déterminants de la douleur et des incapacités fonctionnelles suivant une 
arthroplastie totale de la hanche (ATH)  peut aider à la prise en charge de ces patients et améliorer 
ultimement le succès de la chirurgie. L’objectif de cette étude était de synthétiser les déterminants de la 
douleur et des incapacités fonctionnelles jusqu’à deux ans suivant une ATH.
Méthodes
Une recherche bibliographiques dans quatre banques de données (Medline, Pubmed, Embase et 
CINAHL) a été réalisée jusqu’en avril 2015 en utilisant une combinaison de mots-clés et de termes 
MESH. Les critères d’inclusion étaient 1 – patients subissant une ATH primaire unilatérale avec d’au 
plus deux ans de suivi, 2 – emploi de questionnaires validés auto-rapportés  évaluant la douleur et la 
fonction et 3 – identification dans ces études, des déterminants potentiels à l’aide d’analyses 
multivariées. La qualité méthodologique des différentes études a été évaluée à l’aide d’une version 
modifiée de Methodology Checklist for Prognostic Studies.
Résultats
Vingt-deux études ont été incluses. Le score méthodologique total moyen des études était de 
81.0±10.3%. Parmi les facteurs psychosociaux identifiés dans les études incluses, un niveau de 
scolarité plus bas a été significativement associé avec des douleurs et des incapacités fonctionnelles 
plus sévères post-chirurgie (trois des trois études investiguant cette association). Les déterminants 
cliniques significativement associés avec des niveaux des douleurs et des incapacités post-arthroplastie
incluaient les niveaux préopératoires de douleur et de fonction (neuf études sur 12), un indice de masse 
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corporelle plus élevé (six études sur dix), la totalité et/ou la sévérité des comorbidités (cinq études sur 
sept) et une arthrose radiographique plus sévère (trois études sur trois). Les différentes méthodes 
statistiques utilisées afin d’identifier les déterminants limitaient l’évaluation de la force des 
associations entre les différents déterminants et les douleurs et la fonction post-ATH.
Discussion
Des données probantes de qualité moyenne à haute suggèrent la présence de plusieurs déterminants 
associées à la douleur et à la fonction suivant l’ATH. L’identification de ces différents déterminant 
pourrait améliorer la prise en charge des patients à risque de résultats chirurgicaux sous-optimaux. 
Davantage de recherches sont nécessaires afin d’élucider formellement les déterminants
significativement associés ainsi que la force de ces différentes associations avec la douleur et les 
incapacités suivant l’ATH.
Mots-clés : Arthroplastie totale de la hanche, Arthrose de la hanche, Déterminant, Douleur, Incapacité 
fonctionnelle
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3. Introduction
Hip OA is a chronic debilitating condition, limiting the affected individuals in terms of functioning and 
causing important levels of physical pain [3, 89, 90]. Numerous pharmacological and non-
pharmacological approaches aimed at relieving the ailments accompanying hip OA have been 
advocated. THA is currently the mainstay treatment in candidates experiencing important levels of 
pain and physical limitations who are unresponsive to other treatments [8]. Although generally 
effective in reducing pain and disability, THA may yield suboptimal results in up to 25% of patients 
[3]. A sound knowledge of determinants of THA results can ultimately provide an estimate of the 
likelihood of surgical success. Moreover, it can assist in the creation of an efficacious plan in order to 
improve outcomes. 
Hence, there is a clear necessity of comprehensively summarizing the determinants of pain and 
function levels after THA with the greatest amount of high-quality evidence. This is more so motivated 
by the increasing amount of evidence published in the recent years on the topic, including the 
identification of novel determinants. An appropriate knowledge of determinants of THA outcomes can 
be achieved by reviewing studies employing validated and disease-specific PROMs of pain and 
function evaluating the independent effect of THA determinants by using multivariate analysis [91]. 
Identification of determinants in a timeframe up to two years following THA is particularly relevant, 
as patients are thoroughly monitored by their surgeons, and any outcome considered unsatisfactory can 
potentially be addressed promptly. 
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Consequently, the purpose of this systematic review was to identify the preoperative determinants of 
patient-reported pain and disability up to two years following primary unilateral THA for hip OA in 
studies with appropriate methodological quality. 
4. Methods
4.1.  Literature search and study identification
Four databases (Medline, Pubmed, Embase and CINAHL) were reviewed from their respective 
inception dates until April 2015 using a combination of keywords and MESH terms (see Appendix C
for detailed search strategy). References of previously published reviews and relevant articles were 
scanned manually. In order to evaluate the eligibility, two authors independently reviewed the titles, 
abstracts and full texts of the articles.
4.2.  Study selection
The eligibility of the studies was evaluated by considering the following criteria:
1.Participants underwent primary unilateral THA for hip OA
2.Results are presented for a follow-up of up to two years
3.The outcome measure was a disease-specific validated PROM assessing pain and/or function
4. Identification of determinants was obtained using multivariate analyses
5.Full-text article was published in English or French
4.3.  Data extraction
The following characteristics were recorded using a standardized form: participants’ age and gender 
proportion of the sample, number of patients, follow-up period, outcome measure, statistical methods 
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used and adjustments, as well as statistically significant and non-significant determinants reported by 
the study. Data from each article was recorded by one of the raters and verified by another.
4.4.  Methodological quality appraisal
Two trained evaluators independently appraised the methodological quality of the studies. 
Subsequently, results were discussed to facilitate consensus. A third evaluator intervened in case of 
differences. The appraisal of the risk of bias was undertaken with a modified version of the 
Methodology Checklist for Prognostic Studies [74]. This tool evaluates the following characteristics: 
“Study participation”, ‘Study attrition”, “Prognostic factor measurement”, ‘Outcome measurement”, 
“Confounding measurement and account” and “Analysis”. Each item assesses the risk of potential 
bias: low (0), unclear or unknown given the information available in the article (1) and high (2), with a 
maximal total score of 12, a higher score indicating a better methodological quality. If the included 
study was retrospective and no information regarding patients excluded from the study was provided, a 
score of 1 was automatically attributed to the “Study participation” item. A follow-up proportion 
inferior to 80% prompted the attribution of a score of 0 to the “Study attrition” item. Studies not 
accounting for either age, gender or BMI in their multivariate analysis received a score of 0 for the 
“Confounding measurement and account” item. Total methodological score was subsequently 
standardized.
4.5. Data synthesis
In their multivariate analyses, studies employed two approaches when defining the dependent 
variables: either pain and function were evaluated separately (such as the pain and the function 
subscale of the WOMAC) or as part of a combined construct (total WOMAC score). Therefore, data 
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on determinants was summarized according to both approaches. Solely a qualitative analysis was 
performed due the heterogeneity of included studies in terms of study designs, variables’ constructs 
and definitions as well as statistical analyses. 
5. Results
5.1.  Description of the included studies
After exclusion of titles and abstracts, 129 full-text articles were further evaluated. One hundred and 
seven full-text articles were subsequently excluded, leaving 22 manuscripts published from 1997 to 
2015 for inclusion (Figure 1). Details of study characteristics can be found in Table 1. Results from 
two studies are shown conjointly because of results based on the same cohort [52, 53]. The WOMAC 
was the most frequently employed validated tool (14 studies), followed by the HHS, the OHS and the 
LEFS (two studies each) and the HOOS used in one study. 
5.2.  Methodological quality 
Details of the methodological quality of the included studies can be found in Table 2. Mean total score 
was 81.0% (SD: 10.3%), representing moderate-to-high methodological quality. No study received a 
score lower than 66.7% and four studies were graded higher than 90% [11, 89, 92, 93]. The “Study 
attrition” domain received the lowest mean score of 35.7% (SD 42.3%), with 11 studies having a 
follow-up proportion under 80%. 
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5.3.  Preoperative determinants of pain and function levels following THA
5.3.1.    Demographic determinants
Among the demographic variables that were investigated, older age was found to be associated with 
poor pain and functional outcomes in four studies [89, 93-95]. Kessler et al. showed that being older
was associated with a lower odds of achieving a higher total WOMAC score three months 
postoperatively [93].  Quintana et al. found that in their cohort of 590 patients, an age of over 70 was 
associated with a smaller change in the WOMAC pain subscale score six months after the surgery, but 
did not find similar results for the two-year change in pain and in function [94]. Dowsey et al. showed 
that higher age was associated with worse function at one and two years postoperatively as measured 
with the Harris Hip Function score [89]. In addition, Stevens et al. showed that being older than 70 
years old which was associated worse function at one year as per the function subscale of the 
WOMAC score [95]. Nevertheless, seven studies did not identify a significant association between age 
and THA outcomes [11, 45, 52, 53, 96-99]. 
Only two studies concluded to a significant relationship between gender and postoperative pain and 
function, and their findings are contradictory. Being female was associated with a higher change in the 
WOMAC pain score six months following THA in the first study [11], but to a lower total WOMAC 
score one year postoperatively in the other [95]. Seven studies were unable to establish such a 
significant association [11, 52, 53, 93, 94, 98-100]. 
The living arrangements was the sole other demographic determinant investigated in one study. Jones 
et al. showed that living alone was significantly associated with a lower change in the function 
subscale of the WOMAC score six months postoperatively [11].
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5.3.2.    Socioeconomic determinants
Among socioeconomic determinants of THA outcomes, a higher educational level was shown to be 
associated to lower levels of postoperative pain and to better functional status. Fortin et al. (1999 & 
2002) report that a greater number of years of education was associated to lower levels of pain and 
better function six and 12 months after THA [52, 53]. Judge et al. (2010 & 2011) showed that patients 
with more education had a higher chance of being responders according to the OMERACT-OARSI 
criteria (Table 1), in addition to the greater likelihood of returning to a normal state (decrease in the 
total WOMAC score by 2 standard deviations compared to baseline) one year after THA. 
Regarding the socioeconomic status, in their cohort of 1744 subjects followed for 18 months, Jenkins 
et al. found that a greater level of social deprivation predicted a poorer HHS 18 months after THA 
[101].
5.3.3.    Psychosocial determinants
Only one study investigated psychosocial determinants of THA outcomes. Judge et al. (2011) found 
that having a greater number of expectations regarding functional, activity and pain levels following 
surgery were associated with higher odds of achieving the OMERACT-OARSI responder criteria and 
the MCID on the one-year function domain of the WOMAC score (Table 1), but not associated to the 
pain domain [98]. 
5.3.4.    Clinical determinants
The associations between clinical variables and THA outcomes were the most studied relationships, 
with the greatest amount of evidence present for the preoperative levels of hip-related pain and 
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function. In the case where outcomes were measured as a function of postoperative state, worse levels 
of preoperative pain and function were associated with worse levels in the respective domains [11, 94, 
102]. In contrast, studies that employed a change in status as a dependent variable showed that better 
preoperative levels of pain and function were associated with smaller changes [52, 53, 99, 103-105]. 
Only two studies showed no significant associations between preoperative and postoperative pain and 
function [45, 96]. 
A greater BMI at the time of surgery was associated with worse THA results in terms of pain and 
function. In a cohort of 707 THA patients, a BMI superior to 30 was associated with lower total 
WOMAC scores at one year [92]. Similar results were found for subjects having a BMI greater than 25 
in another study [95] and comparable results have been observed by four other studies [11, 89, 96, 97], 
while two studies report a non-significant association between BMI and THA outcomes [45, 93].
Regardless of the method of measurement of comorbidity, i.e. either the presence of a specific medical 
condition or the number of concomitant disorders, comorbidities were significantly associated with 
worse pain and function following THA in a consistent manner. Peter et al. showed that a greater 
number of preoperative comorbidities were associated with worse HOOS pain and physical 
functioning scores up to 22 months after THA [106]. Moreover, the same study showed that, 
arteriosclerosis, cardiac disorders, dizziness in combination with episodes of falling, asthma, chronic 
obstructive pulmonary disease and cancer were all associated with worse pain and functioning. Four 
other studies concluded to similar findings regarding the association between greater comorbidity and 
poor THA pain and functional outcomes [11, 92, 95, 99], while two others found no association 
between comorbidity and THA results [94, 103].
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Back pain and contralateral hip OA could be considered special instances of comorbidity and were 
evaluated in several studies. Presence of preoperative back pain was associated with a smaller change 
on the pain subscale of the two-year WOMAC score, and to a smaller change in function at six months 
and two years postoperatively [94].  Similarly, severe back pain was associated to poor HOOS pain 
and functional scores seven to 22 months postoperatively [106]. Regarding contralateral hip 
involvement, two studies found it to be associated to poor pain and function outcomes after THA [11, 
94].
A worse general health level, as measured by the SF-36 and the SF-12 questionnaires, was associated 
with poor outcomes after THA in all the four studies that evaluated such an association [11, 89, 94, 
100]. According to Dowsey et al, better physical and mental health are both independent determinants 
of hip pain and function, and were associated with better Harris Hip pain and function Scores at one 
and two year follow-ups [89].
A lower radiographic OA severity was associated to poor outcomes in three studies [89, 98, 100]. 
Judge et al. (2011) found that a Kellgren-Lawrence grade of 1, 2 or 3 was associated with a lower odds 
of being a responder according to the OMERACT-OARSI responder criteria (Table 1) 1 year 
postoperatively when compared to a grade of 4 [100]. 
Table 3 presents other clinical variables that were found significantly associated with pain and function 
after THA, including greater widespread pain sensitivity [107], radiographical medial concentric 
disease [89] and lower knee extensor muscles strength [90].
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5.3.5.    Surgical determinants
Surgical determinants of THA outcomes received modest attention. Braeken et al. investigated the type 
of implant fixation and found that having a cemented prosthesis was associated with a worse six to 12 
month level of pain as measured by the WOMAC scale [96]. Jones et al. found that a cementless 
prosthesis was related to a lower change in WOMAC pain scores six months postoperatively [11]. 
Dowsey et al. showed that a greater femoral head size was significantly associated with worse 
functional outcomes, but not with pain levels [89].
5.3.6.    Healthcare-related determinants
One study investigated the relationship between waiting time and THA outcomes. Vergara et al. 
showed that a waiting time longer than six months for THA was associated to lower gains in function 
one year after the surgery when compared to a waiting time shorter than three months [102]. 
6. Discussion
6.1.  Highlight points
A proper understanding of the determinants of THA outcomes could lead to improved results in terms 
of pain and functional status outcomes in the significant proportion of patients experiencing 
suboptimal results following this intervention. The objective of our study was to systematically review 
the literature of all the studied determinants of patient-reported, disease-specific pain and functional 
limitation following primary unilateral THA in patients with hip OA. Twenty-two prognostic studies 
identified demographic, psychosocial, clinical, surgical and healthcare-related determinants with a 
moderate-to-high methodological quality and allowed the elaboration of a list of determinants with the 
highest amount of available evidence (Table 4).
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6.2.  Strengths and limitations of the review
The strictness of the eligibility criteria allowed for the inclusion of studies with the highest 
methodological quality from four important databases. Focus on all variables investigated for a 
possible association with THA outcomes permitted the elaboration of a comprehensive list of 
determinants with the highest level of evidence to date. 
In terms of limitations, study heterogeneity reduced the ability to pool results in order to evaluate the 
strength of association between significant determinants and THA outcomes. Study findings do not 
apply to patients undergoing bilateral and revision THA, nor can be extended to determinants of long-
term outcomes. Moreover, regardless of the sound statistical methods employed to identify 
determinants of THA results in the included studies, the extent of the clinical and practical significance 
of the determinants remains elusive. 
6.3.  Main findings
In contrast with previously published systematic reviews on the same subject [10, 18], the findings of 
the current study do not suggest a significant association between demographic variables such as age 
and gender with THA outcomes. Although moderate level evidence indicates that older age may be 
associated with worse pain and function, a non-negligible number of included studies point to no 
significant association. Regarding gender, the two studies that found a significant association with 
THA outcomes have contradictory results for males and females. 
In terms of psychosocial variables, a lower educational level is associated with poor outcomes 
following THA in all the studies (n=4) where it was investigated. Although the reasons for such an 
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association are not directly discussed by the included studies, it is likely that the level of education is 
related to the patients’ socioeconomic status, which has been consistently associated with outcomes of 
other musculoskeletal conditions [108, 109]. 
Clinical factors received the greatest amount of attention. The preoperative levels of pain and function 
are the determinants with the highest amount of evidence in the current review. The direction of the 
association depends on the approach employed for the evaluation of surgical results. Indeed, a lower 
preoperative status of pain and function is associated with a lower postoperative status, but with a 
higher change in these domains. Because the amount of pain and the extent of disability are often 
indications of proceeding with THA, this finding highlights the paradigm where patients with worse 
preoperative status have larger gains, but generally do not achieve the same levels as their counterparts 
who underwent THA earlier in the disease process. Unfortunately, there does not seem to be a clinical 
consensus regarding the necessity and timing for performing the surgery in patients with worse or 
better preoperative state [110].
BMI was significantly associated with worse THA outcomes in six out of ten studies in our review. 
Some of these studies emphasize that the clinical significance of such a relationship may however be 
limited, as the individual weight of other variables such as preoperative levels of pain, function or 
comorbidities is more substantial [95, 97]. For example, Stevens et al. report that a when compared to 
a BMI smaller than 25, a BMI greater than 25 was significantly associated with a poorer one-year total 
WOMAC score with a multivariate regression coefficient of -0.63, p<0.001, whereas having more than 
two comorbidities had a coefficient of -14.5, p<0.001.  
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A greater level of comorbidity and worse general health are somewhat related clinical factors that were 
found to have sizeable evidence. Traditionally, the level of comorbidity is evaluated preoperatively 
using the American Society for Anaesthesiology Scale in order to assess the risk of complications 
associated with the surgery [106]. The link between other medical conditions as well as general health 
with THA outcomes is increasingly recognized, and some authors suggest that addressing these before 
undergoing the surgery may be indicated [95]. 
A lower radiographic OA severity has been associated with worse changes in pain and function in 
three studies. Although the relationship between radiographic severity with preoperative hip pain and 
function is inconsistent, this finding may parallel the association between higher preoperative levels of 
pain and disability with lower changes in status after the surgery [111].
Some studies focused on evaluating determinants of THA for either pain or function independently, 
whereas others assessed the associations between preoperative variables and pain and function as part 
of a combined measure, such as in the case of the total WOMAC score. We attempted to compare 
whether the two approaches yielded different results in terms of the identity of the determinants. On 
occasion, individual studies report different determinants according to the method of outcome 
assessment; however, the results are ultimately similar when viewing the overall picture (Table 3).
7. Conclusion
Studies with a moderate-to-high methodological quality indicate that a lower educational status, worse 
or better preoperative levels of pain and function, greater BMI, more comorbidity and worse general 
health as well as a lower radiographical OA severity are significant determinants of pain and function 
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up to two years following primary unilateral THA with the highest amount of evidence. Knowledge of 
these determinants could aid the clinician and the patients in assessing the risks and benefits associated 
with the procedure. Moreover, interventions targeted at diminishing the risk profile of patients 
undergoing THA in order to potentially ameliorate their outcomes could be developed based on these 
determinants. More standardized approaches of future studies evaluating determinants of pain and 
function following THA could diminish the heterogeneity associated with the results, and improve the 
likelihood of establishing the strengths of the association between variables. Evaluating the extent of 
the clinical applicability of the relationship between determinants and THA outcomes should also be 
targeted in future studies.
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Search results
(n= 13,799)
Located citations
Pubmed, n= 3,095
Medline, n= 4,521
Embase, n= 5,003
CINAHL, n= 1,180
Titles after duplicates removed
(n= 8,113)
Records screened
(n= 8,113)
Records excluded
(n= 7,984)
Full-text articles assessed for 
eligibility
(n= 129)
Full-text articles excluded
(n= 107)
Conference abstracts or brief items, n = 13
Articles in languages not mastered by 
reviewers, n = 2
Did not meet eligibility criteria, n = 92
Studies included
(n= 22)
Medline: 19
Pubmed: 3
Embase: 0
CINAHL: 0
Figure 1 Flowchart of the literature search
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B
etter physical health (+): β
= 0.36, 95%
 C
I 0.16 
to 0.55, p < 0.001
B
etter m
ental health (+): β
= 0.16, 95%
 C
I 0.07 to 
0.26, p = 0.001
W
orse m
odified K
-L
 grade
(+):β
= 1.12, 95%
 C
I 
0.13 to 2.12, p = 0.028
M
edial concentric (vs. supero-lateral) (+):β
= 
2.58, 95%
 C
I 0.70 to 4.46, p = 0.07
H
arris H
ip Pain score at 2 years
B
etter physical health (+): β
= 0.36, 95%
 C
I 0.16 
to 0.55, p < 0.001
B
etter m
ental health (+): β
= 0.16, 95%
 C
I 0.07 to 
0.26, p = 0.001
M
edial concentric (vs. supero-lateral) (+):β
= 
2.07, 95%
 C
I 0.17 to 3.98, p = 0.07
H
arris H
ip Function score at 1 year
H
igher age (-):β
= -0.25, 95%
 C
I -0.39 to -0.10, p 
= 0.001
H
igher B
M
I (-):β
= -0.32, 95%
 C
I -0.49 to -0.14, p 
= 0.001
H
igher A
SA
 score (-):β
= -1.99, 95%
 C
I -3.74 to -
0.24, p = 0.026
H
igher preoperative function (+): β
= 0.35, 95%
 
C
I 0.23 to 0.48, p < 0.001
B
etter physical health (+): β
= 0.27, 95%
 C
I 0.07 
to 0.47, p = 0.01
B
etter m
ental health (+): β
= 0.20, 95%
 C
I 0.10 to 
0.30, p < 0.001
Surgical approach (unclear): β
= 3.71, 95%
 C
I 
1.67 to 5.75, p < 0.001
H
arris H
ip Pain score at 1 year
A
ge
G
ender
B
M
I
A
SA
 score
Preoperative hip pain 
Preoperative hip function
Surgical approach
C
em
entation
Fem
oral head size
H
arris H
ip Pain score at 2 years
A
ge
G
ender
B
M
I
A
SA
 score
Preoperative hip pain 
Preoperative hip function
Surgical approach
C
em
entation
Fem
oral head size
M
odified K
-L
 grade
H
arris H
ip Function score at 1 year
G
ender
Preoperative hip pain 
C
em
entation
H
ypertrophic/atrophic radiographic disease 
pattern
C
hondrocalcinosis
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G
reater fem
oral head size (-): β
= -2.03, 95%
 C
I -
4.02
to -0.03, p = 0.047
W
orse m
odified K
-L
 grade
(+):β
= 1.43, 95%
 C
I 
0.34 to 2.52, p = 0.01
H
arris H
ip Function score at 2 years
H
igher age (-):β
= -0.33, 95%
 C
I -0.49 to -0.17, p 
< 0.001
H
igher B
M
I (-):β
= -0.23, 95%
 C
I -0.43 to -0.04, p 
= 0.021
H
igher A
SA
 score (-):β
= -2.04, 95%
 C
I -4.00 to -
0.09, p = 0.04
H
igher preoperative function (+): β
= 0.34, 95%
 
C
I 0.20 to 0.49, p < 0.001
B
etter physical health (+): β
= 0.31, 95%
 C
I 0.09 
to 0.53, p = 0.007
B
etter m
ental health (+): β
= 0.23, 95%
 C
I 0.11 to 
0.34, p < 0.001
Surgical approach (unclear): β
= 4.83, 95%
 C
I 
2.54 to 7.12, p < 0.001
W
orse m
odified K
-L
 grade
(+):β
= 1.64, 95%
 C
I 
0.44 to 2.85, p = 0.008
M
ID
 in H
arris H
ip Pain score at 1 year
M
odified K
-L
 ≤ 3a  (vs. M
odified K
-L 4b)(-): O
R
 
= 0.03, 95%
 C
I 0.00 to 0.35
M
ID
 in H
arris H
ip Pain score at 2 years
M
odified K
-L
 ≤ 3a  (vs. M
odified K
-L 4b)(-): O
R
 
= 0.04, 95%
 C
I 0.00 to 0.49
M
ID
 in H
arris H
ip Function score at 1 year
M
odified K
-L
 ≤ 3a  (vs. M
odified K
-L 4b)(-): O
R
 
= 0.22, 95%
 C
I 0.08 to 0.64
M
odified K
-L
 3b  (vs. M
odified K
-L 4b)(-): O
R
 = 
0.36, 95%
 C
I 0.17 to 0.75
M
odified K
-L
 4a  (vs. M
odified K
-L 4b)(-): O
R
 = 
0.30, 95%
 C
I 0.14 to 0.64
M
ID
 in H
arris H
ip Function score at 2 years
A
dvanced age (-): O
R
 = 0.96, 95%
 C
I 0.92 to 1.00
M
odified K
-L
 ≤ 3a  (vs. M
odified K
-L 4b)(-): O
R
 
= 0.13, 95%
 C
I 0.05 to 0.35
M
odified K
-L
 3b  (vs. M
odified K
-L 4b)(-): O
R
 = 
H
arris H
ip Function score at2 years
G
ender
Preoperative hip pain  
C
em
entation
Fem
oral head size
H
ypertrophic/atrophic radiographic disease 
pattern
C
hondrocalcinosis
M
ID
 in H
arris H
ip Pain score at 1 year
A
ge
G
ender
B
M
I
A
SA
 score
Preoperative physical health
Preoperative m
ental health
Posterior vs. H
ardinge approach
C
em
entation vs. uncem
ented
Fem
oral head > 28m
m
M
odiefied K
-L
 3b
M
odified K
-L
 4a
M
edial-concentric O
A
 vs. supero-lateral
M
ID
 in H
arris H
ip Pain score at 2 years
A
ge
G
ender
B
M
I
A
SA
 score
Preoperative physical health
Preoperative m
ental health
Posterior vs. H
ardinge approach
C
em
entation vs. uncem
ented
Fem
oral head > 28m
m
M
odified K
-L
 3b
M
odified K
-L
 4a
M
edial-concentric O
A
 vs. supero-lateral
M
ID
 in H
arris H
ip Function score at 1 year
A
ge
G
ender
B
M
I
A
SA
 score
Preoperative physical health
Preoperative m
ental health
Posterior vs. H
ardinge approach
C
em
entation vs. uncem
ented
Fem
oral head > 28m
m
M
ID
 in H
arris H
ip Function score at 2 years
G
ender
B
M
I
A
SA
 score
Preoperative physical health
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0.26, 95%
 C
I 0.12 to 0.54
M
odified K
-L
 4a  (vs. M
odified K
-L 4b)(-): O
R
 = 
0.37, 95%
 C
I 0.17 to 0.80
Preoperative m
ental health
Posterior vs. H
ardinge approach
C
em
entation vs. uncem
ented
Fem
oral head > 28m
m
Fortin et al.
(1999) and  
Fortin et al. 
(2002)
O
A
Prim
ary 
TH
A
68 (9.1)
56 
116 and 84
6 m
onths 
and 2 years
W
O
M
A
C
 pain 
and function 
scores 
M
ultiple linear 
regression
N
one
W
O
M
A
C
 pain at 6 m
onths
H
igher preoperative pain (-): β = 0.27 ±
0.08
H
igher education (+): β = -0.18 ±
0.09
r 2= 0.20
W
O
M
A
C
 function at 6 m
onths
H
igher preoperative function (+): β = 0.36 ±
0.08
H
igher education (+): β = -0.41 ±
0.28
r 2= 0.24
Sim
ilar results for (2002); data not show
n
A
ge
G
ender
C
enter
G
andhi et 
al. (2010)
Prim
ary and 
secondary O
A
Prim
ary 
unilateral 
TH
A
66.5
77.4 %
707
1 year
W
O
M
A
C
 total 
score at 1 year
Linear 
regression 
m
odelling
A
ge
G
ender
B
aseline total 
W
O
M
A
C
 scores
C
om
orbidity
2 m
etabolic syndrom
e risk factors (-): β = 3.1, 
95%
 C
I 0.3 to 5.1
4 m
etabolic syndrom
e risk factors (-):β = 15.0, 
95%
 C
I 1.4 to 28.
H
ypertension (-):β = 7.3, 95%
 C
I 2.4 to 13.2
O
besity (B
M
I > 30) (-): β = 2.4, 95%
 C
I 1.4 to 4.2
3 m
etabolic syndrom
e risk factors:β = 0.4, 95%
 C
I 
-6.1 to 5.3
r 2for the num
ber of m
etabolic syndrom
e risk factors 
m
odel= 0.32
H
ypercholesterolem
ia: β = 4.5, 95%
 C
I      -0.2 to 
4.9
D
iabetes: β = -2.3, 95%
 C
I -8.3 to 
3.7
r 2for the individual m
etabolic syndrom
e factors 
m
odel= 0.41
G
arbuz et 
al. (2006)
O
A
Prim
ary 
TH
A
65
56.4
147
1 year
B
etter than 
expected 
W
O
M
A
C
 pain 
and function 
outcom
es
W
O
M
A
C
 pain 
and function 
scores
Logistic 
regression 
m
odelling
A
ge
G
ender
C
om
orbidity
B
etter than expected W
O
M
A
C
 function
E
ach m
onth of pre-surgical w
aiting tim
e
(-): O
R
 
= 0.92, p = 0.05
W
O
M
A
C
 pain 
‘’[…
] the postoperative W
O
M
A
C
 pain score w
ill 
increase by 30%
 w
hen the preoperative W
O
M
A
C
 
pain score increases by three points (pain score 
range, 0–20; p =
0.0036).‘’
W
O
M
A
C
 function
‘’The postoperative W
O
M
A
C
 functional score w
ill 
increase by 35%
 w
hen the preoperative W
O
M
A
C
 
functional score increases by 10 points (functional 
score range, 0–68; p = 0.0005).‘‘
B
etter than expected W
O
M
A
C
 pain
Pre-surgical w
aiting tim
e
H
olstege et 
al. (2011)
O
A
Prim
ary 
unilateral 
TH
A
72.1 (6.8)
74.5
37
12 w
eeks
W
O
M
A
C
 
function score
M
ultiple linear 
regression
A
ge
Sex
B
aseline W
O
M
A
C
 
function score
B
M
I
H
igher knee extensors strength (+): β = -0.105, p 
= 0.004
H
ip flexors strength
H
ip extensors strength
H
ip abductors strength
H
ip adductors strength
K
nee flexors strength
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Jones et al. 
(2001)
O
A
 (93%
)
Prim
ary 
unilateral 
TH
A
71.4
61.2
197
6 m
onths
C
hange in 
W
O
M
A
C
 pain 
and function 
scores at 6 
m
onths
M
ultiple linear 
regression 
m
odels
N
one
C
hange in W
O
M
A
C
 pain:
Fem
ale gender (+): β
= 6.49, 95%
 C
I 1.10 to 11.91
H
igher preoperative bodily pain (SF-36) (-): β
= -
0.59, 95%
 C
I -0.7 to -0.41
H
igher num
ber of com
orbid conditions  (-):β  = -
1.67, 95%
 C
I -2.83 to -0.50
C
em
entless prosthesis (-): β
= -7.08, 95%
 C
I -
14.15 to -0.01
C
hange in W
O
M
A
C
 function:
H
igher preoperative joint pain (W
O
M
A
C
) (-): β
= -0.59, 95%
 C
I -0.76 to -0.41
H
igher B
M
I (-): β
= -0.68, 95%
 C
I -1.20 to -0.17
C
ontralateral hip involvem
ent (-): β  = -6.83, 95%
 
C
I -11.00 to -2.65
L
iving alone (-): β
= -10.01, 95%
 C
I -15.92 to -4.10
H
igher num
ber of com
orbid conditions  (-): β
= -
2.06, 95%
 C
I -3.28 to -0.84
C
hange in W
O
M
A
C
 pain:
A
ge
W
aiting tim
e
L
ength of stay
C
hange in W
O
M
A
C
 function:
L
ength of stay
A
ge
G
ender
W
aiting tim
e
Preoperative bodily pain (SF-36)
Jenkins et 
al. (2009)
O
A
U
nilateral 
TH
A
68.2 (10.2)
62.8
1744
18 m
onths
H
arris H
ip 
Score at 18 
m
onhts
M
ultivariate 
linear 
regression
A
ge
Sex
M
ore socioeconom
ic deprivation (-): B
 = -0.63, p 
= 0.004
N
one
Judge et al. 
(2010)
O
A
Prim
ary 
TH
A
N
/A
56.2
908
1 year
R
eturn to 
norm
al: 2 SD
 
below
 m
ean 
baseline 
W
O
M
A
C
 total 
scores
O
M
E
R
A
C
T
-
O
A
R
SI 
response 
criteria 
B
ased on 
W
O
M
A
C
 total 
score
M
inim
ally 
Im
portant 
D
ifference: 
0.5*m
ean 
difference 
betw
een 1 year 
W
O
M
A
C
 total 
score and 
baseline 
W
O
M
A
C
 total 
score
Logitstic 
regression 
analysis
N
one
R
eturn to norm
al:
U
niversity degree (vs. no education)(+): O
R
 = 2.9, 
95%
 C
I 1.4 to 5.9
C
ollege diplom
a or equivalent (vs. no education)
(+): O
R
 = 2.1, 95%
 C
I 1.3 to 3.4
A
SA
 status 1 (vs. A
SA
 status 2) (+):  O
R
 = 2.5, 
95%
 C
I 1.2 to 5.3
O
M
E
R
A
C
T
-O
A
R
SI responder criteria:
U
niversity degree (vs. N
o education)(+): O
R
 = 
14.4, 95%
 C
I 1.8 to 117.8
M
inim
ally Im
portant D
ifference:
K
/L
 grade 3 (vs. K
/L grade 4) (-):O
R
 = 0.5, 95%
 
C
I 0.4 to 0.8
R
eturn to norm
al:
A
ge
Sex
O
besity
E
m
ploym
ent status
Post-graduate degree
A
SA
 status 3 
A
SA
 status 4
K
/L
 grade
O
M
E
R
A
C
T
-O
A
R
SI responder criteria:
A
ge
Sex
O
besity
E
m
ploym
ent status
C
ollege diplom
a or equivalent
Post-graduate degree
A
SA
 status
K
/L
 grade
M
inim
ally Im
portant D
ifference:
A
ge
Sex
O
besity
E
m
ploym
ent status
E
ducation level
A
SA
 status
K
/L
 grade 1
K
/L
 grade 2
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Judge et al. 
(2011)
O
A
Prim
ary 
TH
A
65.9 (10.9)
56.2
1025 
(com
plete 
data for 908 
patients, 117 
patients, data 
w
ere 
im
putated 
using 
m
ultiple 
im
putation)
1 year
O
M
E
R
A
C
T
-
O
A
R
SI 
response 
criteria 
B
ased on total 
W
O
M
A
C
 total 
score
M
inim
ally 
Im
portant 
D
ifference: 
0.5*m
ean 
difference 
betw
een 1 year 
W
O
M
A
C
 pain 
score, function 
score and total 
score and 
baseline 
W
O
M
A
C
 total 
score
Logitstic 
regression 
analysis
M
inim
ally Im
portant 
D
ifference:
A
ge
Sex
School education
A
SA
 grade
K
&
L grade
O
besity
M
edication use
Pre-op W
O
M
A
C
 score
Pre-op EQ
5D
 score
O
M
E
R
A
C
T
-O
A
R
SI response criteria 
H
igher num
ber of expectations (+):  O
R
 = 1.36, 
95%
 C
I 1.07 to 1.73
U
niversity degree (vs. N
o education)(+): O
R
 = 
6.24, 95%
 C
I 2.76 to 14.13
C
ollege diplom
a or equivalent (vs. no education)
(+): O
R
 = 1.80, 95%
 C
I 1.08 to 2.99
K
/L
 grade 0, 2, 3 (vs. K
/L grade 4) (-): O
R
 = 0.61, 
95%
 C
I 0.38 to 0.95
M
inim
ally Im
portant D
ifference 
W
O
M
A
C
 function
H
igher num
ber of expectations (+):  O
R
 = 1.20, 
95%
 C
I 1.09 to 1.32
O
M
E
R
A
C
T
-O
A
R
SI response criteria
A
ge
Sex
A
SA
 status
B
M
I
N
um
ber of m
edications
Pre-op W
O
M
A
C
 total score
Pre-op E
Q
5D
 score
M
inim
ally Im
portant D
ifference 
W
O
M
A
C
 pain
N
um
ber of expectations
Judge et al. 
(2014)
O
A
Prim
ary 
TH
A
68.9
60.8
4413
1 year
O
xford H
ip 
Score at 12 
m
onths
M
ultiple linear 
regression
A
ge
Sex
H
igher B
M
I (-): 5-unit increase in
B
M
I, the 12-m
onth O
H
S decreases by 0.84 95%
C
I 
(0.59
to1.08) points
N
one
K
ennedy et 
al. (2011)
O
A
Prim
ary 
TH
A
61
42.6
75
1 year
LEFS at 1 year
M
ultiple linear 
regression
N
one
N
one
A
ge
B
M
I
Preoperative
L
E
FS
K
essler et 
al. (2007)
O
A
Prim
ary 
TH
A
63.6
44.8
67
3 m
onths
W
O
M
A
C
 total 
score
M
ultiple 
regression 
analysis
N
one
H
igher age (-):  O
R
 = 0.43, 95%
 C
I 0.04 to 0.82
Sex
A
ffected side
B
M
I
A
nchorage
D
uration of surgery
H
ospital length of stay
W
O
M
A
C
 preoperatively
Peter et al. 
(2014)
O
A
Prim
ary 
TH
A
69.8 (9.5)
64.0
281
7-22 m
onths
H
O
O
S pain and 
physical 
functioning 
scores
M
ultivariate 
regression 
analysis
A
ge
Sex
B
M
I
H
O
O
S pain score
Presence of 3 and 4 com
orbidities (-): β
= -12.8, 
95%
 C
I -20.9 to -4.7
Presence of 5 or m
ore com
orbidities (-): β
= -
15.9, 95%
 C
I -25.3 to -6.4
H
O
O
S physical functioning score
Presence of 1 and 2 com
orbidities (-): β
= -8.6, 
95%
 C
I -16.4 to -0.9
Presence of 3 and 4 com
orbidities (-): β
= -14.9, 
95%
 C
I -23.8 to -6.1
Presence of 5 or m
ore com
orbidities (-): β
= -
22.1, 95%
 C
I -32.4 0to -11.7
H
O
O
S pain score
A
rteriosclerosis in abdom
en or legs (-): β
= -12.3, 
95%
 C
I -21.7 to -2.9
D
izziness in com
bination w
ith falling (-): β
= -
12.1, 95%
 C
I -23.5 to -0.7
C
ardiac disorders (-): β
= -10.6, 95%
 C
I -17.6 to -
3.6
Severe back pain (-): β
= -8.0, 95%
 C
I -14.0 to -
2.0
C
ancer (-): β
= -6.7, 95%
 C
I -12.6 to -0.7
R
2= 0.147
H
O
O
S physical functioning score
A
rteriosclerosis in abdom
en or legs (-): β
= -14.9, 
95%
 C
I -25.3 to -4.5
D
izziness in com
bination w
ith falling (-): β
= -
H
O
O
S pain score
Presence of 1 and 2 com
orbidities 
H
O
O
S physical functioning score
N
one
H
O
O
S pain score
N
one
H
O
O
S physical functioning score
N
one
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22.0, 95%
 C
I -34.2 to -9.9
A
sthm
a or C
O
PD
 (-): β
= -9.0, 95%
 C
I -16.8 to -
1.3
Severe back pain (-): β
= -12.9, 95%
 C
I -19.3 to -
6.4
C
ancer (-): β
= -8.0, 95%
 C
I -14.3 to -1.7
R
2= 0.2015
Q
uintana et 
al. (2009)
O
A
TH
A
69.3 (8.5)
48.6
590
6 m
onths 
and 2 years
W
O
M
A
C
 pain 
and function 
change scores
M
ultiple 
regression 
analysis
N
one
6 m
onths
W
O
M
A
C
 pain change score
H
igher pre-intervention pain (+): β
= -8.85, p < 
0.001
B
etter m
ental health (+):β
= -0.32, p < 0.001
A
ge  > 70 years (-):β
= -2.93, p = 0.04
C
ontralateral hip O
A
 (-): β
= 3.95, p = 0.006
W
O
M
A
C
 function change score
H
igher pre-intervention functional lim
itation (+): 
β
= -8.23, p < 0.001
B
etter m
ental health (+):β
= -0.44, p < 0.002
C
ontralateral hip O
A
 (-): β
= 6.39, p < 0.001
2 years
W
O
M
A
C
 pain change score
H
igher pre-intervention pain (-): 
β
= 8.68, p < 
0.001
B
etter m
ental health (-):β
= 0.71, p < 0.001
B
ack pain (-):β
= -5.32, p = 0.004
W
O
M
A
C
 function change score
H
igher pre-intervention functional lim
itation (-): 
β
= 8.37, p < 0.001
B
etter m
ental health (-):β
= 0.75, p < 0.001
C
ontralateral hip O
A
 (-): β
= -5.62, p = 0.01
B
ack pain (-):β
= -7.23, p = 0.004
6 m
onths
W
O
M
A
C
 pain change score
G
ender
B
urden of com
orbidities (C
harlson C
om
orbidity 
Index)
B
ack pain
W
O
M
A
C
 function change score
A
ge
B
urden of com
orbidities (C
harlson C
om
orbidity 
Index)
2 years
W
O
M
A
C
 pain change score
A
ge
G
ender
C
ontralateral hip O
A
B
urden of com
orbidities (C
harlson C
om
orbidity 
Index)
W
O
M
A
C
 function change score
A
ge
G
ender
B
urden of com
orbidities (C
harlson C
om
orbidity 
Index)
R
am
aesh et 
al. (2013)
A
rthrosis
TH
A
67.1
55
184
1 year
12-m
onth 
O
xford H
ip 
Score
M
ultiple 
regression 
analysis
N
one
M
ore com
orbidity (-): B
 = -1.77, 95%
 C
I -2.35 to -
1.19
H
igher preoperative pain/function (+):  B = 0.26, 
95%
 C
I 0.10 to 0.43
A
ge
G
ender
Personality type
Slaven et al. 
(2012)
O
A
TH
A
68.2 (8.2)
55
37
6 m
onths
Increase in 
LEFS score by 
≥9 points or 
ability to w
alk 
w
ithout and 
assistive device
Logistic 
regression 
analysis
N
one
N
one
W
alking speed
T
im
ed-U
p and G
o test score
Functional R
each test score
Stevens et 
al. (2012)
Prim
ary O
A
Prim
ary 
TH
A
70.3 (8.2)
74.2
653
1 year
W
O
M
A
C
 total 
score
Linear 
regression 
analysis
Postoperative
com
plications
B
M
I >25 (-): Estim
ate = -0.63,p < 0.001
A
ge  > 70 years (-): Estim
ate = -0.18,p = 0.04
Fem
ale (-): Estim
ate = -4.41,p = 0.01
1 or 2 com
orbidities (-):  Estim
ate = -7.25,p = 0.01
> 2 com
orbidities(-):  Estim
ate = -14.50
N
one
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* O
M
ER
A
C
T-O
A
R
SI responder criteria -im
provem
ent in W
O
M
A
C
 pain or in function of 50%
 and an absolute change of 20/100, or, if the patient does not fulfill them
, im
provem
ent in 2 of 
the 3 follow
ing: pain of 20%
 and an absolute change of 10/100, function of 20%
 and an absolute change of 10/100, and patient’s global assessm
ent (total W
O
M
A
C
 score) of20%
 and an 
absolute change of 10/100.
(+): determ
inant of successful outcom
e; (-): determ
inant of poor outcom
e
A
SA
 –A
m
erican Society of A
naesthesiologists; β –
regression coefficient;K
-L –
K
ellgren-Law
rence; O
R
 –
O
dds R
atio; r 2–
coefficient of determ
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1. Abstract
Background
The ability to predict preoperatively the identity of patients undergoing hip arthroplasty who are at risk of 
suboptimal outcomes could help implement interventions targeted at improving surgical results. The 
objective was to develop a preliminary PA allowing the identification of patients at risk of unsatisfactory 
outcomes one to two years following hip arthroplasty.
Methods
Retrospective data on a cohort of 265 patients having undergone primary unilateral hip replacement (188 
total arthroplasties and 77 resurfacing arthroplasties) from 2004 to 2010 were collected from our 
arthroplasty database. Hip pain and function, as measured by the WOMAC, were collected as well as self-
reported hip joint perception after surgery. Demographic and clinical variables recorded at the time of the 
surgery were considered as potential predictors. Patients were considered as having a suboptimal surgical 
outcome if they were in the worst quartile of the postoperative total WOMAC score and perceived their 
operated hip as artificial with minimal or major limitations. The PA was developed using recursive 
partitioning.
Results
Mean postoperative surgical follow-up was 446 ± 171 days. Forty patients (15.1%) had a postoperative 
total WOMAC score in the worst quartile (≥ 11.5/100) and perceived their joint as artificial with minimal 
or major restrictions. A PA consisting of the following variables achieved the most acceptable level of 
prediction: gender, age at the time of surgery, BMI, and three items of the preoperative WOMAC (degree 
of pain with walking on a flat surface and during the night as well as degree of difficulty with putting 
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socks or stockings). The rule had a sensitivity of 75.0% (95% CI: 59.8-85.8), a specificity of 77.8% (95% 
CI: 71.9-82.7), a positive predictive value of 37.5% (95% CI: 27.7-48.5), a negative predictive value of 
94.6% (95% CI: 90.3-97.0) and positive and negative likelihood ratios of 3.38 (95% CI: 2.49-4.57) and 
0.34 (95% CI: 0.19-0.55) respectively.
Conclusions
The preliminary PA shows promising results at identifying patients at risk of significant functional 
limitations, increased pain and inadequate joint perception after hip arthroplasty. Clinical use should not 
be implemented before additional validation and refining.
Keywords: Hip arthroplasty, Osteoarthritis, Prediction, Surgical outcomes
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2. Résumé
Introduction
La capacité d’identifier les patients à risque de mauvais résultats suivant une arthroplastie de la hanche 
pourrait cibler des interventions afin d’améliorer leurs résultats. L’objectif était de développer un 
algorithme de prédiction clinique (APC) afin d’identifier les patients à risque de résultats inadéquats un à 
deux ans suivant une arthroplastie de la hanche.
Méthodes
Des données rétrospectives sur une cohorte de 265 patients ayant subi une arthroplastie de la hanche 
unilatérale (188 arthroplasties totales et 77 arthroplasties de resurfaçage de la hanche) de 2004 à 2010 ont 
été colligées à partir de la banque de données de l’Hôpital Maisonneuve-Rosemont. La douleur, la raideur 
et la fonction de la hanche, telles que mesurées à l’aide du Western Ontario and McMaster Osteoarthritis 
Index (WOMAC) ont été recueillies, ainsi que la satisfaction des patients par rapport à leur hanche 
opérée. Des données démographiques et cliniques ont été considérées comme des prédicteurs potentiels. 
Les patients étaient considérés à risque s’ils avaient un score WOMAC total dans le quartile le plus faible 
de la cohorte et s’ils percevaient leur prothèse comme une articulation artificielle avec des limitations 
fonctionnelles minimales ou majeures. L’algorithme de prédiction a été bâti à l’aide de la partition 
récursive.
Résultats
Le suivi chirurgical moyen (± écart-type) a été de 446 ± 171 jours. Quarante patients (15.1%) avaient un 
score WOMAC postopératoire dans le pire quartile (≥ 11.5/100)  et percevaient leur hanche comme une 
articulation artificielle avec des limitations fonctionnelles minimales ou majeures. Un APC utilisant les 
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variables suivantes a fourni le meilleur niveau de prédiction : le genre, l’âge au moment de la chirurgie, 
l’indice de la masse corporelle pré-chirurgie et trois items du WOMAC préopératoire (niveau de douleur 
à la marche sur une surface plane et durant la nuit ainsi que le niveau de difficulté à mettre des bas). 
L’APC présente une sensibilité de 75.0% (95% IC 59.8-85.8), une spécificité de 77.8% (95% IC 71.9-
82.7), une valeur prédictive positive de 37.5% (95% IC: 27.7-48.5), une valeur prédictive négative de
94.6% (95% IC : 90.3-97.0)  et des rapports de vraisemblance positif et négatif de 3.38 (95% IC 2.49-
4.57) et 0.34 (95% IC: 0.19-0.55) respectivement.
Conclusions
Cet algorithme préliminaire démontre des capacités prédictives prometteuses pour identifier les patients à 
risque de douleurs et incapacités fonctionnelles sévères post-chirurgie. Une validation externe formelle de 
cet algorithme est nécessaire avant de recommander son utilisation clinique.
Mots-clés : Arthroplastie de la hanche, Arthrose, Prédiction, Douleur, Fonction
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3. Background
Recent recommendations suggest that THA is indicated when the patients’ functional limitations and pain 
levels due to hip OA are refractory to pharmacological and non-pharmacological treatments [7, 8]. HR is 
an alternative to THA in patients who are younger, more active, with normal kidney function and 
appropriate proximal femoral bone morphology and quality [43]. Both THA and HR are considered 
efficacious for the great majority of patients undergoing these procedures [10, 13, 112, 113]. Although 
generally successful at alleviating coxarthrosis-related ailments, hip arthroplasty can yield subpar results 
in terms of pain and functional outcomes as well as degree of satisfaction in a non-negligible proportion 
of patients. For example, a recent systematic review reports that 7 to 23% of the patients undergoing THA 
experience unfavourable pain outcomes three months to five years after the procedure [3]. Moreover, up 
to 15% of the patients report dissatisfaction with surgery [4, 17]. To our knowledge, no formal data on 
proportions of patients with poor pain, functional and satisfaction levels after HR exists. However, it can 
be posited that these proportions are similar to the ones observed among patients undergoing THA, as 
studies indicate that these outcomes are similar between the two procedures [114, 115]. 
In light of these observations, careful case management must be implemented in order to minimize 
unsuccessful outcomes. Potential interventions directed at improving surgical outcomes include patient 
education and intensive rehabilitation. However, identification of patients at risk of severe pain and 
functional limitations after THA or HR is difficult. A multitude of factors related to poor functional and 
pain outcomes following hip arthroplasty have been identified. These include worse preoperative levels of 
pain and function, lower educational level, comorbidities, presence of back pain or higher BMI, among 
others [11, 52, 53, 92, 94, 95, 97, 99, 103, 105].  Nevertheless, regardless of the quantity of the evidence 
of potential risk factors, no definitive consensus has been reached concerning their identity and the 
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magnitude of their association with postoperative pain, functioning and satisfaction. In light with these 
observations, an algorithm aimed at identifying with sufficient accuracy which patients present the 
greatest risk of unsuccessful outcomes may assist in the care process. Therefore, the objective of this 
study was to develop a preliminary PA used to identify patients at risk of unfavourable functional status, 
pain and joint perception one to two years following THA or HR. 
4. Methods
4.1.  Study design
This study entailed a retrospective analysis of longitudinal, prospectively collected data. The 
methodology adheres to the Strengthening the Reporting of Observational Studies in Epidemiology 
(STROBE) guidelines for observational cohort studies (Appendix K). 
4.2.  Data collection
Our prospective arthroplasty database was consulted in order to identify patients eligible for inclusion in 
the study. The database contains extensive baseline and follow-up data on patients undergoing hip 
procedures, including THA and HR. All patients provide informed consent to participate. Independent 
assessors who are not involved in the medical care of the patients collect the prospective data. 
Inclusion criteria were 1) patients undergoing primary unilateral THA or HR, 2) diagnosis of primary hip 
OA, 3) complete preoperative and one to two-year postoperative self-reported outcome questionnaire 
responses. The main exclusion criteria were 1) THA or HR of the contralateral hip before the relevant 
follow-up evaluation, 2) revision of the implant before the one to two-year follow-up, 3) diagnosis of 
inflammatory hip arthritis, pediatric hip disease, post-traumatic hip or any hip disease other than primary 
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OA. Data on all patients having undergone hip interventions were assessed for inclusion. All patients 
were initially interviewed just before their intervention.  Postoperative outcomes were collected 12 to 24 
months after the surgery.
4.3.  Dependent variables
Functional status and pain levels were assessed preoperatively and at follow-up with the WOMAC [116]. 
The WOMAC consists of the following domains: pain (5 items), stiffness (2 items) and functional 
limitation (17 items). Items are scored on a 5-point Likert scale representing different degrees of intensity 
(none, mild, moderate, severe or extreme). The scores of each domain as well as the total score were 
standardized on a 0 to 100 scale, with a greater score indicating more pain, stiffness or functional 
limitation. The psychometric qualities of the WOMAC, including its responsiveness, convergent 
construct validity and reliability have been found excellent for evaluating patients with hip OA 
undergoing hip arthroplasty [75, 76].
At follow-up, self-perceived joint perception was measured by asking the patient a multiple-choice 
question: “How do you perceive your operated hip?” with the possible responses being “Like a native or 
natural joint”, “Like an artificial joint with no restriction”, “Like an artificial joint with minimal 
restriction”, “Like an artificial joint with major restriction” and “Like a non-functional joint” [79].
Evaluation of joint perception has been strongly associated with validated clinical scores of patient-
reported outcome measures and can be employed as a measure of patient satisfaction [79]. 
No consensus exists regarding what represents poor outcome following hip arthroplasty. Hence, patients 
of risk of suboptimal outcomes were defined as the ones in the worst quartile of the total WOMAC score 
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at follow-up (i.e. WOMAC score >11.5) and perceiving their hip “like an artificial joint with minimal 
restriction”, “like an artificial joint with major restriction” or “like a non-functional joint”. 
4.4.  Independent variables
Several of the variables that were collected preoperatively and available in the database were considered 
as potential predictors of suboptimal hip arthroplasty outcome. Demographic variables included age and 
gender. Clinical variables included BMI, previous hip interventions and medical comorbidities (diabetes, 
gastrointestinal disease, immunosuppression secondary to corticosteroid use or other causes, cardiac 
disease, obesity, pulmonary disease, neurologic disease, urologic disease, and other comorbidities). Pain 
localization (back, radicular, buttocks, trochanter, groin, thigh, knee and/or calf) as well as whether hip 
pain was present at rest, after the first few steps, after a long walk and during sexual relations were also 
considered. Answers to the 24 individual items of the preoperative WOMAC questionnaire were 
additionally included in the analysis as potential predictors.
4.5.  Statistical analysis
Baseline and follow-up mean WOMAC scores along with their standard deviations were calculated. 
Differences between time points in relation to total WOMAC scores and the respective domains were
assessed using paired samples Student-t tests, with a significance level set at 0.05. 
The CART approach was used to build the PA as it is one of the most effective algorithms of recursive 
partitioning [82]. It is based on maximizing the within-node homogeneity by evaluating all combinations 
of potential predictors, thus minimizing the within-node error. The Gini impurity measure was used as a 
splitting criterion to develop the decision trees [83]. Data for all the patients in the training set was used to 
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develop the PA. Firstly, all the potential predictor variables were employed to develop models using an 
automated approach. Secondly, a manual approach entailed the development of additional models by 
inputting independent variables that were judged to be more readily available and easier to employ in a 
clinical setting. For example, age and gender were favoured over the number of comorbidities and 
previous hip interventions because the latter two could be affected by a recall bias or would require 
extensive medical file review. The predictive values of every model were calculated along with their 95% 
confidence intervals, namely sensitivity, specificity, positive and negative predictive values as well as 
positive and negative likelihood ratios [84]. Among all the proposed models, the one that showed the 
highest level of sensitivity and an acceptable level of specificity and that fit the ease-of-use criterion was 
selected in order to develop the screening tool. Internal validity of the model was then evaluated by the 
use of 1,000 bootstrap resamples [85]. All analyses were performed using IBM SPSS Statistics Version 
20.0 (SPSS Inc., Chicago).
4.6.  Ethics
The research ethics committee of our centre approved the study annually.
5. Results
5.1.  Participants
Our database yielded 2963 entries with at least some preoperative data on hip arthroplasty procedures 
performed from October 2004 to February 2014. Out of these, 1207 procedures (40.7%) fit the inclusion 
criteria. Incomplete preoperative and/or postoperative data required for the purposes of the current study 
obliged the exclusion of a further 942 entries. Thus, a total of 265 primary hip arthroplasty interventions 
(60 classical THAs, 128 large-femoral head diameter THAs, and 77 HRs) with complete preoperative and 
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postoperative data were included in the study (follow-up mean ± SD: 446.3 ± 171.1 days), representing a 
participation proportion of 22.0%. 
Table 1 shows selected characteristics of the 265 patients included in the study. The mean age of the 
participants was 52.0 (SD 9.0) and 67.4 % were male. The mean BMI was 28.2 (SD 5.1) and each patient 
had on average 0.79 comorbidities (SD 0.96). Mean follow-up was 446 SD: ± 171.1 days and ranged 
from 253 to 1638 days. Postoperatively, the patients had significantly improved on pain (-44.9, SD: ± 
22.6, 95% CI -42.1 to -47.6), stiffness (-44.6, SD: ±25.1, 95% CI -41.6 to -47.7), function (-43.6, SD:
±21.9, 95% CI -40.9 to -46.2) as well as total WOMAC score (-43.9, SD: ±21.1, 95% CI -41.4 to -46.5) 
(Table 2). Seventy-six patients (29%) reported that they perceived their prosthetic joint as artificial with 
minimal or major restrictions (Table 3). 
Out of the 265 patients eligible for inclusion in the study, 40 (15.1%) had a total WOMAC score > 11.5 
and perceived their joint as artificial with minimal or major restrictions. Hence, these patients were 
considered as having suboptimal surgical outcomes.
5.2.  Final prediction algorithm
After developing several prediction rules, the algorithm with the highest level of sensitivity and an 
appropriate level of specificity was chosen. It consists of patient gender, age at the time of surgery, BMI
and 3 items of the preoperative WOMAC, namely degree of pain with walking on a flat surface and 
during night and degree of difficulty with putting socks or stockings (Figure 1). Patients respond 
sequentially to the questions and their risk status is determined according to the classification algorithm 
(Figure 2). 
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The final PA correctly identified 30 out of the 40 patients considered at risk of suboptimal outcome based 
on their surgical outcomes and 175 patients out 225 were identified as not at risk of suboptimal outcome 
(Table 3). Therefore, the PA had a sensitivity of 75.0% (95% CI: 59.8-85.8), a specificity of 77.8% (95% 
CI: 71.9-82.7) and a positive likelihood ratio of 3.38 (95% CI: 2.49-4.57)  (Table 4). The other prediction 
models that were also considered are presented in Appendix L. 
5.3.  Internal validation
Validation of the rule was established using 1,000 bootstrap re-samples. Table 4 shows the estimated 
bootstrap values of the predictive measures being close to the original ones, thus suggesting an 
appropriate accuracy of the proposed model. 
6. Discussion
Since THA and HR can bring significant improvement in patients suffering from hip OA, careful 
management of subjects at risk of having unsuccessful outcomes is indicated. We aimed to develop a 
prediction tool in order to facilitate the preoperative identification of these patients, which could possibly 
ameliorate their surgical outcomes.  With a cohort of 265 patients undergoing primary hip arthroplasty for 
OA, we were able to create a PA predicting the identity of patients that are at the highest risk of
unsuccessful outcomes. Albeit preliminary in nature and requiring further development and validation, 
our PA has excellent predictive capacities, with a sensitivity of 75.0% (95% CI 59.8.4-85.8), a specificity 
of 77.8% (95% CI 71.9-82.7) and a positive likelihood ratio of 3.38 (95% CI 2.49-4.57).
To our knowledge, one model predicting the identity of patients at risk of poor outcomes after THA has 
been developed [69]. Consisting of patient age, BMI and gender, the model was able to correctly predict 
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patients’ outcomes with a sensitivity of 87.5% (95% CI 52.9 – 97.8), a specificity of 72.4% (95% CI 54.3 
– 85.3) and a positive likelihood ratio of 3.17 (95% CI 1.66 – 6.05). However, surgical success was 
determined solely based on functional outcomes (change between the preoperative and six-month LEFS
score), and the results are based on a cohort of 37 patients. 
The selection of patients for inclusion in the study was based on the availability of complete data for 
important determinants of hip arthroplasty outcomes as reported in the literature. This allowed the 
development of a prediction rule that is consistent with the clinical reality. Because there is no 
unequivocal definition of what represents suboptimal outcome following hip replacement, several criteria 
of classifying patients who are at risk have been considered and different prediction models were built 
accordingly. The choice of the final model was based on the principle of selecting a screening tool 
minimizing the number of false negatives that is easily employable in a clinical setting. Accordingly, an 
algorithm with a sensitivity of 75.0% and a specificity of 77.8% was deemed suitable. Although the 
positive likelihood ratio of 3.38 of the PA can be considered subpar when compared to accepted 
diagnostic standards, the PA performs similarly to other validated prediction models in the 
epidemiological literature. For example, the positive likelihood ratios of the Ottawa Knee and Ankle rules 
assessing the necessity of a roentgenographic evaluation in cases of acute knee and ankle injuries 
respectively are both inferior to the one reported by our PA [71, 72]. 
The algorithm with the most appropriate predictive capabilities contains two demographic variables 
(gender and age), one clinical (BMI) and 3 items of the preoperative WOMAC questionnaire (two pain-
related and one function scale). All of these variables have been consistently related to hip arthroplasty 
outcomes [11, 93-97]. Moreover, the PA comprises all the predictors reported by Slaven et al. (2012) in 
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their model, namely age, gender and BMI, thus pointing towards the importance of these factors for 
prediction of hip arthroplasty results. It is noteworthy to mention that the prediction of surgical outcomes 
in women is achieved by age and BMI, with the body mass being the only modifiable risk factor. In the 
case of men, potential modifiable risk factors include BMI, degree of hip pain walking on a flat surface 
and during the night as well as degree of difficulty putting on socks or stockings. However, caution 
should be used, as recursive partitioning does not imply a causative relationship between variables [117]. 
Indeed, interventions targeted at ameliorating either of the items of the PA, such as weight loss in the case 
of high BMI, will not necessarily improve the outcome of the surgery; it will merely imply that the patient 
will be classified as not at risk of suboptimal outcomes by the PA. Further research in terms of 
appropriate interventions to improve surgical outcomes should be undertaken.
When developing the PA, we intended for it to be a clinically pertinent tool. The decision to include 
patients with different types of hip arthroplasties was taken in order to generate a PA that has the ability 
to perform successfully in a heterogeneous population. Moreover, we included subjects with complete 
information one to two years following the procedure, as patients are followed closely by their surgeons 
during this period, and the rehabilitation process can easily be altered if the progression is judged 
suboptimal. 
In one instance, the interpretation process may yield a counterintuitive situation. For example, it is 
possible, in an extreme scenario, for a 49 year-old male patient with a BMI of 22 kg/m2 and with no pain 
when walking on a flat surface as well as with no difficulty with putting on socks or stockings to be 
classified as at risk of suboptimal surgical outcomes.  This pattern of answers was however shown to have 
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the best predictive capabilities when developing the algorithm with recursive partitioning. This situation 
underlines the concept that a predictor is not necessarily a determinant. 
Strengths of the study
The developed PA is, to our knowledge, the first one of its kind to discriminate THA or HR results based 
on more than one parameter, namely patients’ functional, stiffness and pain levels as well as their 
perception of the replaced hip joint. In the context of a lack of an accepted standard of surgical failure, 
this approach increases the likelihood of the patients thusly classified to truly present subpar outcomes. 
Moreover, this classification identified 15% of the patients as having unsuccessful outcomes, well in line 
with the published proportions of what can be considered a suboptimal outcome [3]. Finally, the rigorous 
statistical analysis employed in the development of the PA underlines the stringency of our approach.
Limitations of the study
Due to its retrospective design, the study has a certain risk of selection bias. Compared to the subjects 
excluded due to missing data, the included participants were, on average, younger, had a greater number 
of comorbidities and a greater proportion were male (p < 0.05, data not shown). Nevertheless, the 
preoperative baseline status as measured by the WOMAC domains as well as the total WOMAC score 
was not statistically significantly different between the included and the non-included subjects (p > 0.05, 
data not shown). Additionally, only 265 out of the 1207 procedures (22.0%) that were performed during 
the study time period met the inclusion criteria, therefore potentially limiting the generalizability of the 
results. Moreover, the population under study was patients undergoing primary unilateral hip replacement 
procedures, which precludes the utilization of this tool for patients undergoing revision or bilateral 
interventions. Recent evidence identifies other variables potentially associated with hip arthroplasty 
outcomes that were not included in our study, thus potentially limiting the pool of candidate predictor 
variables. Although there is no consensus regarding the optimal sample size for developing models 
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employing recursive partitioning, the progressively smaller number of cases in the leafs as the tree was 
built may limit the reliability of the findings, prompting further development in a subsequent study. 
Before employing it in a clinical setting, the decision rule has to be validated in a different sample of 
patients. Moreover, the performance of the PA has to be compared to clinical judgement alone and its 
financial impacts require evaluation. 
7. Conclusions
The developed PA may discriminate with excellent capabilities the patients undergoing hip arthroplasty 
that are at the highest risk of suboptimal pain, functional limitations and joint perception outcomes on an 
average of 15 months following the intervention. Its implementation has the potential of targeting 
susceptible individuals such as to modify their risk profile, and eventually, improve surgical results. 
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Table 1 Selected characteristics of the participants who underwent hip arthroplasty (n = 
265)1
Variables considered for PA development n (%) Mean (SD) Other collected variables n (%)
Demographics Contralateral hip status
Age (years) 52  (9.0) Unaffected 134 (50.4)
Female 89 (33.6) Affected, not operated 105 (39.7)
Clinical characteristics Unavailable 26 (9.9)
BMI ¬ (kg/m2) 28.2 (5.1) Charnley class
Medical comorbidities Charnley A 124 (46.8)
Diabetes 19 (7.2) Charnley B 87 (32.8)
Gastrointestinal disease 16 (6.0) Charnley C 13 (4.9)
Immunosuppression 3 (3.0) Unavailable 41 (15.5)
Cardiac disease 21 (7.9) Employment status
Obesity 41 (15.5) Employed 163 (61.5)
Osteoporosis 2 (0.8) Household 44 (16.6)
Pulmonary disease 15 (5.7) Retired 9 (3.4)
Neurological disease 1 (0.4) Other 11 (4.2)
Urological disease 1 (0.4) Unavailable 38 (14.3)
Other 91 (34.3) Walking aid
None 124 (46.8) Incapable with aid 5 (1.9)
Presence of back pain 40 (15.1) Crutches 1 (0.4)
Pain localization Two canes 31 (11.7)
Buttocks 128 (48.3) Cane on a permanent basis, instability 118 (44.5)
Trochanter 164 (61.9) Cane for outdoor activities 42 (15.8)
Groin 177 (66.8) Cane for long distance walking 43 (16.2)
Thigh 124 (46.8) Unavailable 25 (9.5)
Knee 111 (41.9) Knee(s) status
Calf 36 (13.6) Affected 28 (10.5)
Radicular 6 (2.2) Unaffected 204 (77.0)
Elsewhere 3 (1.1) Unavailable 33 (12.5)
Presence of hip pain Level of activity in the 3 months before surgery
At rest 148 (55.8) Heavy work/sport 26 (9.8)
After first few steps 182 (68.8) Moderate work 53 (20.0)
After a long walk 224 (84.5) Mild work/walking 112 (42.3)
During sexual intercourse 156 (58.9) Sedentary 34 (12.8)
Immobile 6 (2.3)
Unavailable 34 (12.8)
Duration of walking before eliciting pain
Walking unaffected 37 (14.0)
31-60 minutes 51 (19.2)
11-30 minutes 82 (30.9)
2-10 minutes 53 (20.0)
< 2 minutes 16 (6.0)
Walking impossible 1 (0.4)
Unavailable 25 (9.5)
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Table 2 Changes in WOMAC scores of the participants between preoperative measurement 
and following hip arthroplasty (n = 265)
Mean score 
preoperatively†
(SD)
Mean score 
postoperatively†
(SD)
Change in 
score ‡
(SD)
95% CI 
Comparison 
between time 
points 
(p value)
WOMAC
Pain 55.4 (19.2) 10.5 (16.7) - 44.9 (22.6) - 42.1 to – 47.6 <0.001*
Stiffness
Function
57.1 (19.4)
53.2 (20.0)
12.5 (18.1)
9.6 (15.3)
- 44.6 (25.1)
- 43.6 (21.9)
- 41.6 to – 47.7
- 40.9 to – 46.2
<0.001*
<0.001*
Total score 54.0 (18.7) 10.1 (15.1) - 43.9 (21.1) - 41.4 to – 46.5     <0.001*
SD: standard deviation
CI: confidence interval
† Scores presented as standardised scores. Lower scores sign a better condition. Scores were measured on the day of the 
surgery.
‡ Negative changes in score indicate an improvement of the condition. Scores were measured on 446.3 ± 171.1 days 
following the intervention.
* p < 0.05
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Table 5 Validity measures of the prediction algorithm
x * 95% asymptotic confidence intervals
x Sensitivity:  number of participants classified at risk both by the PA and the postoperative WOMAC score and joint perception divided by all 
participants classified at risk by the postoperative WOMAC score and the joint perception (actual outcome).
x Specificity: number of participants classified not at risk by the PA and the postoperative WOMAC score and joint perception divided by all 
participants classified not at risk by the postoperative WOMAC score and joint perception (actual outcome).
x Positive predictive value: number of participants classified at risk by the PA and the postoperative WOMAC score and joint perception divided by 
all participants classified at risk by the PA (predicted outcome).
x Negative predictive value: number of participants classified not at risk by the PA and the postoperative WOMAC score and joint perception divided 
by all participants classified not at risk by the PA (predicted outcome).
x Positive likelihood ratio: sensitivity/ (1-specificity)
x Negative likelihood ratio: (1-sensitivity)/specificity. 
Measure Estimates in training sample Estimates with 1,000 bootstrap resamples
Sensitivity % (95% CI) 75.0 (59.8.4-85.8) 75.0 (60.0-88.0*)
Specificity % (95% CI) 77.8 (71.9-82.7) 77.8 (72.2-82.9*)
Positive predictive value % (95% CI) 37.5 (27.7-48.5) 37.2 (27.2-47.2*)
Negative predictive value % (95% CI) 94.6 (90.3-97.0) 94.7 (91.2 to 97.8*)
Positive likelihood ratio (95% CI) 3.38 (2.49-4.57) 3.38  (2.50 to 4.63*)
Negative likelihood ratio (95% CI) 0.32 (0.19-0.55) 0.32 (0.15 to 0.52*)
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Figure 1 Prediction algorithm to identify patients at risk of suboptimal outcomes after 
hip arthroplasty
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Figure 2 Graphical representation of the prediction algorithm identifying patients at risk 
of suboptimal surgical outcomes after hip arthroplasty
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1. Abstract
Background
A sound knowledge of the determinants of TKA outcomes could help in patient selection, preparation 
and education before they undergo surgery. We aimed to assess the current status of the literature 
evaluating preoperative determinants of early and medium term patient-reported pain and disability 
following TKA.
Method
A search in Medline, Pubmed, Embase and CINAHL until October 2014 was undertaken. Selection 
criteria included: 1- participants undergoing primary unilateral TKA with a follow-up up to 2 years, 2-
validated disease-specific patient-reported outcome measures assessing pain and/or function used as 
outcome measure and 3- identification of preoperative determinants obtained via multivariate analyses. 
Risk of bias was assessed using a modified version of the Methodology checklist for prognostic 
studies. 
Results
Thirty-four prognostic explanatory studies were included. Mean total score of the methodological 
quality was 80.0±12.7 %. Sociodemographic and psychosocial determinants included greater 
socioeconomic deprivation (two out of two studies), greater levels of depression and/or anxiety (seven
out of 11 studies) and greater preoperative pain catastrophizing (all four studies). Significant clinical 
determinants included worse preoperative pain and disability  (21 out of 23 studies), presence or 
greater levels of comorbidity (12 out of 23 studies), back pain (five out of six studies) and lower 
general health (all 11 studies). 
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Conclusions
Several significant determinants of short to medium-term pain and functional outcomes following 
TKA have been summarized by studies with moderate-to-high methodological quality. No conclusions 
can be reached regarding the strength of the associations between significant determinants and TKA 
results because of heterogeneity of study methodologies and results. Further high-quality research is 
required. 
Keywords: Knee Osteoarthritis, Total Knee Arthroplasty, Pain, Functional limitation, Determinants
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2. Résumé
Introduction
Une meilleure connaissance des déterminants des résultats de l’arthroplastie totale du genou (ATG) 
pourrait aider dans la sélection, la préparation et à l'éducation des candidats à la chirurgie. L’objectif 
de cette étude était d’évaluer la littérature identifiant les déterminants à court et moyen terme de la 
douleur et des incapacités fonctionnelles suivant l’ATG. 
Méthodes
Une recherche dans Medline, Pubmed, Embase et CINAHL jusqu’en octobre 2014 a été réalisée. Les 
critères de sélection pour l’inclusion des études étaient : 1 – patients subissant une ATG primaire 
unilatérale avec un suivi post-opératoire d’au plus 2 ans, 2 – les études  utilisaient des mesures de 
résultats auto-rapportés validés évaluant la douleur et la fonction et 3 – l’identification des 
déterminants était réalisée à l’aide d’analyses statistiques multivariées. La qualité méthodologique  
était évaluée à l’aide d’une version modifiée de Methodology checklist for prognostic studies.
Résultats
Trente-quatre études pronostiques ont été incluses. Le score total moyen de la qualité méthodologique 
des études était de 80.0%±12.7%. Les facteurs sociodémographiques et psychosociaux 
significativement associés avec des douleurs et des incapacités post-opératoires incluaient un niveau
socioéconomique plus faible (deux études sur un total de deux), des symptômes de dépression et/ou 
d’anxiété (sept études sur 11) ainsi que la catastrophisation de la douleur (quatre études sur quatre). 
Les déterminants cliniques considérés comme significativement associés avec la douleur et les 
incapacités post-opératoires incluaient un niveau préopératoire de douleur et d’incapacité plus élevé
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(21 études sur 23), la présence ou un plus grand nombre de comorbidités (12 études sur 23), la
présence de lombalgie (cinq études sur six) et un état plus précaire de la santé générale (11 études sur 
11).
Conclusions
Plusieurs déterminants de la douleur et des incapacités fonctionnelles à court et moyen terme suivant
l’ATG ont été identifiés en se basant sur des études de qualité méthodologique modérée à élevée. Une 
hétérogénéité importante des méthodologies et des résultats empêche des conclusions formelles quant 
à la force d’association entre les déterminants significatifs et les résultats de l’ATG. Davantage de 
recherches de haute qualité sont nécessaires.
Mots-clés : Arthrose du genou, Arthroplastie totale du genou, Douleur, Incapacité fonctionnelle, 
Déterminants
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3. Introduction
TKA is a common procedure intended at treating patients with knee OA suffering from pain and 
disability [118]. Its predominant success rendered it the second most common type of orthopaedic 
intervention [14]. This tendency will likely maintain, as projections suggest a six-fold increase in the 
number of primary TKAs performed in the next decades [14]. Although TKA is generally a successful 
intervention, leading to amelioration in pain levels and functional status, it yields suboptimal results in 
up to one third of patients [4, 5, 12, 16, 119]. Sound knowledge of determinants of TKA outcomes can 
help in patient selection, preparation and education, especially regarding possible risks and benefits of 
the procedure [18]. This is particularly relevant with respect to early and medium-term outcomes, as 
after a significant amelioration three to six months postoperatively, pain and physical function levels 
vary little subsequently until two years following surgery [19, 53]. During this time, patients are 
closely monitored by their surgeons, and the medical treatment and rehabilitation can be readily altered 
if progress is deemed unsatisfactory.
Previous systematic reviews attempted to summarize the determinants of TKA outcomes. Santaguida 
et al. (2008) identified older age and female gender to be associated with worse function following 
TKA [18]. However, their results are based on studies published until 2001. Van Jorbegen et al. (2014) 
focused on protective determinants of anterior knee pain following TKA, and their findings included 
mostly surgical factors, namely femoral components with a posterior centre of rotation, resection of 
Hoffa’s pad, patellar rim electrocautery and preventing combined component internal rotation [21]. 
Vissers et al. (2012) focused their systematic review on psychosocial factors associated with TKA 
outcomes and identified pain catastrophizing and lower preoperative mental health as significant 
determinants of poor TKA outcomes [22]. Regardless of the evidence summarized by these systematic 
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reviews, no consensus exists concerning either the identity or the strength of association between TKA 
determinants and poor outcomes. Consequently, there is an evident necessity of a comprehensive 
review encompassing the highest quality of evidence, which can be achieved by focusing on studies 
employing validated PROMs of pain and function that also gauge the independent effect of 
determinants via multivariate analyses [91].
The purpose of this systematic review was to assess the current status of the literature evaluating the 
determinants of poor outcomes in terms of pain and functional levels following TKA. We also aimed 
to compare the determinants according to the approach of quantifying TKA results, i.e. as a measure of 
patients’ postoperative status or of postoperative change. Finally, because some studies evaluate pain 
and function either separately, such as in the case of WOMAC pain and function subscales, or in a 
combined manner (total WOMAC score), we intended to parallel determinants according to this 
categorization. 
4. Materials and methods
4.1.  Literature search and study identification
A search in four databases (Medline, Pubmed, Embase and CINAHL) from their respective inception 
dates until October 2014 was undertaken using a combination of keywords and MESH terms (see 
Appendix D). Manual searches of previously published reviews and reference lists from relevant 
articles were also conducted. Two authors independently reviewed the titles, abstracts and full texts of 
the articles in order to evaluate their eligibility.  
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4.2. Study selection
The following selection criteria were applied:
1.Participants were primary unilateral TKA patients with ≤10% of the sample undergoing 
unicompartmental knee arthroplasty, bilateral TKA or revision TKA
2.t90% of the study sample was diagnosed with knee OA
3.Results are presented for a follow-up between 6 weeks and 2 years
4.The outcome measure was a disease-specific validated PROM assessing pain and/or function
5. Identification of determinants was obtained using multivariate analyses
6. Article is published in English or French
4.3.  Data extraction
A standardized form was employed to extract data. Participants’ characteristics (diagnosis, type of 
surgery, age and gender proportion), number of patients, follow-up period, outcome measures, 
statistical methods used and statistical adjustments, as well as significant and non-significant 
determinants reported by each study were recorded. Each article was extracted by one of the raters and 
verified by another in order to reduce the risk of extraction errors.
4.4.  Methodological quality appraisal
Two trained reviewers independently performed the appraisal of the methodological quality of the 
included studies and results were discussed in order to reach consensus. In case of disagreement, a 
third reviewer was available for mediation of differences. 
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The risk of bias and the methodological quality of the included studies was assessed using a modified 
version of the Methodology Checklist for Prognostic Studies developed by Hayden et al. (2003) [74]. 
This tool includes six items: “Study participation”, ‘Study attrition”, “Prognostic factor measurement”, 
‘Outcome measurement”, “Confounding measurement and account” and ‘Analysis”. Each item is 
evaluated according to its risk of potential bias: “yes” indicates a low risk of bias, “no” indicates a high 
risk of bias and “unclear” indicates an unclear or an unknown risk given the information available. For 
each item of the checklist, a score of 2 was given if a low risk of bias was present, a score of 1 if the 
risk was judged unclear and 0 if the risk was high. For the ‘Study participation” item, a score of 1 was 
attributed if the study was retrospective in nature and that no information was available regarding 
patients not included in the study because of incomplete data. For the “Study attrition” item, a score of 
0 was given automatically if the follow-up proportion at the relevant time-point was inferior to 80%. A 
score of 0 was given for the “Confounding measurement and account” item if confounding factors 
such as age, gender and BMI were not accounted for in the multivariate analysis.
4.5.  Data synthesis
Determinants of TKA outcomes were summarized based on whether results were reported as 
postoperative change or postoperative status, and whether pain and function were assessed as separate 
or combined constructs. Given the nature of the study designs and the heterogeneity of included 
studies in terms of depended and independent variables’ constructs and definitions, as well as 
variations in follow-up periods, only a qualitative synthesis of results was performed. 
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5. Results
5.1.  Description of the included studies
Initial literature search yielded 139 full-text articles for assessment of eligibility. After further 
exclusion of 105 full-text articles for reasons presented in Figure 1, 34 manuscripts were included. 
Table 1 indicates relevant characteristics of the included studies. Results from two manuscripts are 
presented conjointly because of analyses performed on the same cohort [52, 53]. The WOMAC was 
the validated tool used to measure postoperative pain and/or function in 25 studies, whereas the Oxford 
Knee Score (OKS) was employed in 9 studies. Nine studies have employed the change in pain and/or 
function after the surgery as an outcome measure.
Postoperative raw scores at follow-up were considered as a measure of outcome in 25 studies. Seven 
studies had a sample size smaller than 100 and 13 had a sample size greater than 500 patients. Only six 
studies presented a power calculation or considered a way of estimating required sample sizes [120-
124].
5.2.  Methodological quality of the included studies
Table 2 indicates the methodological quality scores of the included studies after consensus. Mean total 
score for the methodological quality was 80.0% (SD 12.7%). No study received lower than 58.3% and 
four studies were graded 100% [121, 123, 125, 126]. Overall, these results indicate a moderate-to-high 
methodological quality. 
Three domains of the methodology appraisal (“Prognostic factor measurement”, “Outcome 
measurement” and “Analysis”) scored on average the maximal possible grade. The domain with the 
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worse mean score (0.97, SD 1.02) was “Confounding measurement and account”, with 17 studies not 
accounting for age, gender or BMI or other potential confounding factor in the multivariate analyses. 
A noteworthy number of studies (11 out of 34) reported a follow-up proportion inferior to 80%. This 
negatively impacted the study attrition domain. 
5.3.  Preoperative determinants of TKA pain and function outcomes
5.3.1.  Demographic determinants 
Sixteen studies investigated the association of age at the time of surgery and postoperative status. 
Neuburger et al. (2012) mention that being less than 60 years old is a significant determinant of poorer 
total OKS score at six months [127]. However, the same study reports that being older than 80 years 
old was also related to worse total OKS score at six months. Four more studies identified older age at 
the time of surgery as a factor associated with worse functional level following TKA [19, 128-130]. 
Nevertheless, 11 studies report no significant effect of age on postoperative pain and function status
[52, 99, 123, 124, 128, 131-134].  Eleven studies did not report a significant relationship between 
gender and TKA outcomes [19, 52, 99, 123, 127, 128, 131, 134-136]. The three that found a 
significant association seem to yield more consistent results regarding the deleterious effect of female 
gender on TKA pain and function outcomes [129, 130, 133].
Only limited evidence can be extracted regarding demographic determinants of postoperative change
in terms of pain or function. In regards to gender, one study identified male gender to be associated 
with a smaller change in the 12-month WOMAC function score [12]. Alzharani et al. (2011) report 
that male patients were 0.72 times more likely to not achieve the MCID for total OKS score one year 
after TKA compared to women, i.e. female gender is a determinant of unsatisfactory outcome [137]. 
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Baker et al. (2012) suggest that younger age is associated with less improvement on the total OKS 
score recorded six to 12 months postoperatively, whereas Alzharani et al. (2011) indicate that older 
age is associated with lower odds of attaining the MCID of the total WOMAC score one year 
following TKA [120, 137].
5.3.2.   Socioeconomic determinants 
Although scarce, the evidence regarding socioeconomic factors seems to point to several significant 
findings only in the case of the outcomes measured as postoperative status. Greater social deprivation 
was identified in two studies as a determinant of worse pain and functional limitation when 
simultaneously controlling for multiple confounding factors [127, 129]. A lower income was linked to 
a worse WOMAC pain score at 12 months postoperatively [138]. A lower educational status has been 
associated with better pain levels at six months in a study by Lopez-Olivo et al. (2012). However, six 
studies report no significant effect of education on either pain or function following TKA [52, 53, 121, 
122, 131, 138]. 
5.3.3.    Psychosocial determinants 
Several studies that were included in the review were dedicated to exploring the relationship between 
possible psychosocial determinants and TKA outcomes measured as postoperative status. Presence or 
higher levels of anxiety and/or depression have been consistently identified as significant determinants 
of worse TKA outcomes in six of the included studies [127, 129, 134-136, 139]. Three studies report 
that greater preoperative pain catastrophizing is linked to worse pain six weeks and 12 months after 
TKA and to higher levels of disability 12 months postoperatively [132, 133, 140]. Escobar et al. (2007) 
identified absence of social support to be related to worse six-month pain and function levels [128].  
97
Other significant psychosocial variables associated to pain and function status following TKA are 
presented in Table 3.
In terms of postoperative change, Riddle et al. (2010) determined that greater pain catastrophizing was 
related to higher odds of not achieving an improvement of 50% in the pain domain of the WOMAC at 
6 months as well as not attaining a change greater than 4 points out of 20 on the WOMAC pain score 
at six months [126]. A previous diagnosis of depression and higher levels of depression/anxiety as
measured by the EuroQ5D questionnaire were related to a smaller change on the six to 12 month total 
OKS score [120]. 
5.3.4. Clinical determinants 
The investigation of the association between clinical characteristics and TKA outcomes measured as 
postoperative status has received a great deal of attention. One of the most studied potential 
determinants of knee pain and function following TKA is the baseline, preoperative levels of the 
respective variables. Eighteen studies linked a poor preoperative status to a worse postoperative status 
in terms of pain and function [19, 52, 53, 103, 121-124, 127-129, 131, 132, 134-136, 139, 141].
Poor preoperative mental health, as measured by the SF-36 questionnaire, has been associated to worse 
outcomes in seven studies [122, 124, 128, 130, 135, 139, 141]. Even if TKA is performed 
predominantly for patients with primary OA, two studies seem to point to a diagnosis of primary 
gonarthrosis as a determinant of worse outcomes, when compared to rheumatoid arthritis or other 
diagnoses [127, 129]. Higher baseline BMI has been linked to poorer functional results as well as to 
worse outcomes of pain and function combined in four studies [92, 124, 129, 130]. Six studies 
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identified the presence of back pain before surgery to be related to substandard pain and function status 
after TKA [123, 128, 131, 133, 135, 139]. Regardless of whether comorbidity was measured as the 
influence of individual comorbidities, of the number of comorbidities per patient or when considering 
their severity and impact on patients’ life, seven studies suggests it to be a significant determinant of 
worse outcomes in terms of pain and function following TKA [19, 99, 124, 127, 128, 130, 139]. More 
symptomatic joints, including ankle, feet, toes and neck were associated with greater level of pain and 
worse function 12 months after TKA in two studies [123, 134]. Other significant clinical determinants 
of TKA outcomes measured as postoperative status can be found in Table 3. 
Regarding outcomes measured as postoperative change, four studies report that better baseline levels 
of function and/or pain are related to lower levels of improvement following TKA. Jones et al. (2001) 
reported that lower preoperative pain was associated with smaller changes in functional abilities six
months after the surgery [19]. A better preoperative total OKS score was related to a smaller change 
six to 12 months following TKA in two studies [120, 142]. Better preoperative function level was 
found to be a significant determinant of lower gains in functional abilities [12]. 
Greater comorbidity was shown to significantly determine lower changes in pain and functional status
[11, 106, 120, 142]. In particular, Kauppila et al. (2011) showed that presence of osteoporosis was 
associated with a smaller level of change in function and with decreased odds of attaining the 
OMERACT-OARSI set of responder criteria 12 months after surgery [12]. A study by Gandhi et al. 
(2013) revealed that a greater level of synovial fluid levels of three inflammatory markers (TNF- α, 
MMP-13 and IL-6) were related to poor gains in physical function two years after TKA as measured 
by the WOMAC function score [125]. Other miscellaneous clinical determinants identified in the 
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included studies were worse general health status (as measured by the American Society of 
Anaesthesiology grade), presence of self-reported disability and lower self-reported general health 
[120], greater preoperative bodily pain [11], worse mental health [142, 143] and presence of back pain 
[142]. 
5.3.5.  Surgical determinants 
Only one of the included studies identified a significant surgical determinant of poor postoperative 
status as measured by pain levels at six months: cruciate-retaining implant [121]. Sullivan et al. (2011) 
studied the effect of surgery duration and of the identity of the surgeon on the 12-month WOMAC 
pain and function scales, but their analysis yielded non-significant results [132]. 
In terms of postoperative change, findings by Jones et al. (2001) indicate that cementless prosthesis is 
associated with a lower change in the WOMAC pain score six months after TKA [11]. A British study 
by Baker et al. (2012) evaluated the effect of different types of prosthesis brands on the improvement 
of the total OKS score 12 months following the intervention. They found that the NexGen prosthesis 
brand is related to greater improvements when compared to all the other brands used in their study 
(PFC, Genesis 2, AGC and Triathlon) [120]. The same study evaluated the effect of the type of 
hospital where the surgery was performed. They showed that surgeries performed at a National Health 
Services hospital are more likely to be associated with poor improvement than surgeries performed at 
an independent hospital or an Independent Sector Treatment Centre. 
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6. Discussion
6.1 Highlight points
Because TKA clinical results are still suboptimal in a large percentage of patients, a better knowledge 
of determinants of pain and function following the intervention could help improve outcomes. The aim 
of our study was to systematically assess the literature reporting the determinants of pain and 
functional outcomes following primary unilateral TKA in patients with knee OA. Thirty-four studies 
with a moderate-to-high mean methodological quality (80.0%, SD 12.7%) were included. Even if 
several significant determinants of pain and functional outcomes following TKA have been 
summarized by studies, no conclusions can be reached regarding the strength of the associations 
between significant determinants and TKA results because of heterogeneity of study methodologies 
and results.
6.2. Strengths and limitations of the review
The main strength of the present systematic review is the rigorousness of the inclusion criteria 
ensuring high quality of evidence of determinants compiled from four important databases. Moreover, 
focus on all types of determinants provides a comprehensive overview of all relevant variables with a 
significant relationship to TKA outcomes. 
The main limitation is the inability to pool the results into meta-analyses, resulting in the failure to 
conclude on the strength of association between patient factors and TKA outcomes due to the 
heterogeneity of the methodologies of the included studies. Moreover, the findings of the review do 
not necessarily apply to all patients undergoing TKA, namely those with a diagnosis different from 
OA, or undergoing bilateral or revision surgery. Also, the study does not review determinants of long-
101
term outcomes. Finally, two studies had to be excluded because they were published in languages not 
mastered by the reviewers.
6.3 Main findings 
It is difficult to conclude to a significant association of any demographic determinant with TKA pain 
or functional outcomes based on the results of the included studies. Although female gender and older 
age were found significant in several studies, there is an overwhelming amount of evidence pointing to 
either an association in an opposite direction or to no relationship at all. These findings contrast the 
ones by Santaguida et al. (2008) in their systematic review. We therefore suggest that according to the 
available evidence, patients should not be denied surgery based on gender or age.
Regarding socioeconomic determinants, greater social deprivation achieved statistical significance in 
both studies evaluating its association with TKA outcomes among patients in the United Kingdom 
[127, 129]. Patients with greater social deprivation may experience worse TKA outcomes because of 
an inequality in the continuity of care following discharge compared to patients with less deprivation 
[127]. Caution should be warranted regarding the generalizability of these findings however, as they 
may not apply to other countries, although the impact of social deprivation in terms of pain and 
function on other musculoskeletal disorders is well established [108, 109].
Psychosocial determinants with considerable evidence include the presence or a greater level of 
depression and/or anxiety. The previous review by Vissers et al. (2012) did not find definite evidence 
that supports the significance of this association. However, all of the seven studies included in our 
review that conclude to such a relationship were published after the aforementioned systematic review. 
102
The causes behind the significant association are not well understood; depressed patients may be less 
likely to participate actively in the rehabilitation process, thus experiencing worse outcomes [122]. 
Greater preoperative pain catastrophizing was also significantly associated to pain and functional 
outcomes after TKA, a finding consistent with the review by Vissers et al. (2012). It has been 
suggested that pain catastrophizing is linked with neurophysiological processes related to modulation 
of pain, and that greater levels of catastrophizing promote sensitization to pain [133].
The greatest amount of evidence is available for clinical determinants, the frontrunner being the 
relationship between worse or better preoperative levels in the respective dimensions  (depending on 
the outcome being measured as postoperative patient state or change) and pain or functional outcomes. 
Although studies consistently refer to this relationship as a well-known fact, to our knowledge, this is 
the first systematic review underlining this fact. Our findings suggest that in the case of measuring 
outcome as a change in status, a higher preoperative status is related to a lower chance of 
improvement. In the case of measuring outcome as health status postoperatively, lower preoperative 
status is related to worse outcome. The importance of these concepts relies in the dilemma encountered 
when employing this information clinically: should intervention be undertaken in patients with worse 
preoperative state in order to obtain greater gains or should TKA be performed in patients as early as 
possible before they deteriorate considerably in order to guarantee better status after the surgery? 
Unfortunately, there does not seem to be a consensus regarding this predicament, and our review only 
emphasizes its importance, as other authors have done as well [110]. 
Presence or greater levels of comorbidities were also related to a worse outcome after TKA. The 
reasons behind such a relationship are unclear. Patients with other comorbidities may not meet the 
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demands of the intensive rehabilitation process following TKA, thus explaining their increased risk of 
poor surgical outcomes [130]. Several studies advocate that patients should receive appropriate 
counselling from their surgeon preoperatively according to the identity and number of their 
comorbidities [92, 130]. Of interest, presence of back pain was associated to poor TKA outcomes as 
well. The mechanism behind this association is however uncertain. Back pain may impede 
postoperative recuperation and rehabilitation or it may directly affect how patients rate their condition 
in terms of knee pain and function on the WOMAC, or on other outcome measures .
Worse measures of general health were significantly related to poor TKA outcomes in a surprisingly 
consistent manner. Among the included studies, general health was mainly measured with the SF-36 
questionnaire, and a poorer mental health domain in particular was consistently related to poor pain 
and function after TKA. This may underline the importance of the overall health status, especially the 
extent of psychological distress, in selecting individuals for knee arthroplasty. 
Limited evidence has been identified regarding surgical determinants of poor TKA outcomes. This 
may be due to the fact that surgical factors are traditionally investigated by studies employing a 
clinical trial methodology, whereas this review encompasses prognostic cohort studies. Association of 
surgical and technical factors with TKA outcomes is clearly a complex issue, and a different approach 
than the one employed by this review may be required to identify significant determinants.
No variable was consistently identified as non-significantly related to TKA outcome. The amount of 
evidence for certain significant determinants is nevertheless countered by numerous studies stating 
their non-significance and this inconsistency represents a limitation of the available literature. Several 
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reasons behind this discrepancy can emerge. Firstly, a low sample size can impact the ability to detect 
a truly present statistically significant relationship; type II errors may effectively limit the findings.  
Also, the duration of follow-up may lead to a disagreement as a significant relationship may arise at a 
critical time-point following the surgery. Finally, the methodological quality of the studies can lead to 
heterogeneous results. 
It has previously been suggested that the determinants of pain and function after TKA are not the same 
[129]. We attempted to appraise this by capturing the results of the included studies based on whether 
determinants were assessed for pain and function as separate dependent variables or part of a combined 
construct (Tables 3 and 4). On several occasions, individual studies that evaluated significant 
determinants of pain and function separately concluded that they indeed presented different 
determinants. However, when viewing the overall picture, the determinants of pain and function seem 
to be similar regardless of the method of measurement. This is most probably due to the overlap 
between the findings of the studies.
As mentioned previously, outcomes after TKA are generally evaluated as a function of health change 
or of health state postoperatively [46-49, 144]. In our review, we identified fewer studies evaluating 
determinants based on postoperative change. Generally, from the available evidence, determinants are 
similar between the two approaches, with the exception of the preoperative status as discussed 
previously. 
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7. Conclusion
Moderate-to-high methodological quality of included studies suggests that preoperative determinants 
of pain and function outcomes following TKA include greater social deprivation, the presence or a 
greater level of depression and/or anxiety, greater preoperative pain catastrophizing, preoperative pain 
or function levels, presence or greater levels of comorbidity, presence of back pain and lower general 
health. Consensus is however limited by contradictory results regarding the importance of several 
determinants. The heterogeneity in the measurement of the outcome limits the ability to generalize the 
magnitude of association of determinants with TKA outcomes. Further high-quality research and a 
more standardized reporting of results is required in order to elucidate with greater precision the 
identity of determinants of pain and function following TKA in order to provide the best possible care 
for patients with severe knee OA.
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Search results
(n= 10,394)
Located citations
Pubmed, n= 2,630
Medline, n= 3,057
Embase, n= 3,872
CINAHL, n= 835
Manual search, n = 0 
Titles after duplicates removed
(n= 5,871)
Records screened
(n= 5,871)
Records excluded
(n= 5,732)
Full-text articles assessed for 
eligibility
(n= 139)
Full-text articles excluded
(n= 105)
Conference abstracts, n = 13
Articles not in French or English, n = 2
Did not meet eligibility criteria, n = 90
Studies included
(n= 34)
Medline: 30
Pubmed: 4
Embase: 0
CINAHL: 0
Figure 1 Flowchart of the literature search
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(excluding 
hypertension, 
hypercholesterolem
ia 
and diabetes)
O
besity (B
M
I > 30) (-): β = 3.6,95%
 C
I 0.02 
to 7.2
N
um
ber of m
etabolic syndrom
e risk factors
H
ypertension
H
ypercholesterolem
ia
D
iabetes
G
andhi et 
al. (2013) 
O
A
U
nilateral TK
A
68.5 (9.4)
57
28
2 years
C
hange in 
W
O
M
A
C
 pain 
score at 2 years
Linear 
regression 
m
odelling
A
ge
G
ender
B
M
I
C
om
orbidity count
G
reater synovial fluid T
N
F-α levels (-): p = 
0.001
G
reater synovial fluid M
M
P-13
levels (-): p = 
0.03
G
reater synovial fluid IL
-6
levels (-): p = 
0.001
Serum
 levels of:
IL
-6
IL
-1β
M
M
P-9
M
M
P-13
M
IP-1β
M
C
P-1
A
diponectin
L
eptin
T
N
F-α
IFN
-γ
V
C
A
M
-1
Synovial fluid levels of:
IL
-1β
M
M
P-9
M
IP-1β
M
C
P-1
A
diponectin
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L
eptin
IFN
-γ
V
C
A
M
-1
H
anusch et 
al. (2014) 
O
A
Prim
ary TK
A
71 (42 to 92)
45
100
6 w
eeks and 
1 year
6 w
eek and 1 
year O
K
S score
Stepw
ise 
m
ultiple linear 
regression
N
O
N
E
6 w
eeks
M
odel 1
H
igher illness coherence (stronger belief about 
patient’s understanding of their illness) (+): β
= 
-0.224, p = 0.02
M
odel 2
B
etter preoperative
function and low
er pain 
(+): β
= -0.257, p = 0.03
1 year
M
odel 1
N
one
M
odel 2
B
etter preoperative
function and low
er pain 
(+): β
= -0.296, p = 0.008
H
igher anxiety  (-):β
= 0.270, p = 0.01
M
odel 3
B
etter preoperative
function and low
er pain  
(+): β
= -0.239, p = 0.04
H
igher anxiety (-):β
= 0.296, p = 0.01
6 w
eeks
M
odel 1
A
ge
G
ender
Preoperative
O
K
S score
C
onsequences (patient’s beliefs about im
pact of 
illness on their life
E
m
otional representation (patient’s negative 
em
otions caused by their illness)
M
odel 2
A
ge
G
ender
D
epression
1 year
M
odel 1
A
ge
G
ender
Preoperative
O
K
S score
C
onsequences (patient’s beliefs about im
pact of 
illness on their life
E
m
otional representation (patient’s negative 
em
otions caused by their illness)
M
odel 2
A
ge
G
ender
M
odel 3
A
ge
G
ender
Jones et al. 
(2001) 
O
steoarthritis 
(93%
)
Prim
ary 
unilateral TK
A
70.6 
59
257
6 m
onths
C
hange in 
W
O
M
A
C
 pain 
and function 
scores at 6 
m
onths
M
ultiple linear 
regression 
m
odels
N
O
N
E
C
hange in pain
H
igher preoperative bodily pain (SF-36) (-): β
= -0.42, 95%
 C
I -0.56 to -0.27
C
em
entless prosthesis (-): β
= -9.48, 95%
 C
I -
16.20 to -2.77
C
hange in function
L
ow
er preoperative joint pain (W
O
M
A
C
)    
(-): β
= -0.43, 95%
 C
I -0.57 to -0.28
H
igher num
ber of com
orbid conditions  (-): 
β
= -1.56, 95%
 C
I -2.74 to -0.37
H
igher preoperative bodily pain (SF-36) (-):
β
= -0.21, 95%
 C
I -0.35 to -0.07
C
hange in pain
A
ge
G
ender
W
aiting tim
e
N
um
ber of com
orbid conditions
C
hange in function
A
ge
G
ender
W
aiting tim
e
B
M
I
C
ontralateral joint involvem
ent
L
iving alone
Jones et al. 
(2003) 
O
A
 (94%
)
Prim
ary TK
A
69.2 (9.2)
59
273
6 m
onths
W
O
M
A
C
 
function score 
M
ultiple linear 
regression
N
O
N
E
O
lder age (+): β
= 0.35, 95%
 C
I 0.10 to 0.60
H
igher preoperative function (W
O
M
A
C
) (+): 
G
ender
112
at 6 m
onths
β
= 0.30, 95%
 C
I 0.16 to 0.43
G
reater num
ber of com
orbid conditions (-): β
= -1.62, 95%
 C
I -2.75 to -0.49
U
se of w
alking devices preoperatively (-):  β
= 
-4.15, 95%
 C
I -7.23 to -1.06
Judge et al 
(2012)
O
A
 (93.7%
)
Prim
ary TK
A
 
(92%
) 
U
K
A
 (8%
)
71.7 (9.1)
61
1991
6 m
onths
M
odel 1:
Total O
K
S, 
O
K
S pain score 
and O
K
S 
function score 
at 6 m
onths
M
odel 2:
PA
SS score for 
Total O
K
S, 
O
K
S pain score 
and O
K
S 
function score 
at 6 m
onths
M
odel 1: 
M
ultiple linear 
regression
M
odel 2: 
Logistic 
regression 
M
odel 1:
N
O
N
E
M
odel 2:
N
O
N
E
M
odel 1:
Total O
K
S 
H
igher baseline O
K
S (+): m
ultivariable 
coefficient = 1.70, 95%
 C
I 1.43 to 1.96
Fem
ale sex (-): m
ultivariable coefficient = -
0.88, 95%
 C
I -1.68 to -0.08
H
igher preoperative B
M
I (-): m
ultivariable   
coefficient = -0.44, 95%
 C
I -0.86 to -0.01
G
reater social deprivation  (higher log of 
Index of M
ultiple D
eprivation-IM
D
 2004)(-):  
m
ultivariable coefficient = -1.40, 95%
 C
I -1.96 
to -0.85
R
A
 diagnosis (vs. Prim
ary O
A
)(+):  
m
ultivariable coefficient = 2.90, 95%
 C
I 0.42 to 
5.37
M
oderately anxious/depressed (vs. N
ot 
A
nxious/D
epressed) (-): m
ultivariable   
coefficient = -0.85, 95%
 C
I -1.68 to -0.03
E
xtrem
ely anxious/depressed (vs. N
ot 
A
nxious/D
epressed) (-): m
ultivariable   
coefficient = -2.21, 95%
 C
I -4.34 to -0.09
O
K
S pain score 
H
igher baseline O
K
S (+): m
ultivariable   
coefficient = 1.30, 95%
 C
I 1.03 to 1.57
G
reater social deprivation  (higher log of IM
D
 
2004)(-): m
ultivariable coefficient = -0.64, 95%
 
C
I -0.91 to -0.37
R
A
 diagnosis (vs. Prim
ary O
A
)(+):  
m
ultivariable coefficient = 1.75, 95%
 C
I 0.61 to 
2.89
M
oderately anxious/depressed (vs. N
ot 
A
nxious/D
epressed) (-): m
ultivariable   
coefficient = -0.43, 95%
 C
I -0.83 to -0.03
E
xtrem
ely anxious/depressed (vs. N
ot 
A
nxious/D
epressed) (-): m
ultivariable   
coefficient =
-1.19, 95%
 C
I -2.19 to -0.18
O
K
S function score 
H
igher baseline O
K
S (+): m
ultivariable   
coefficient = 1.82, 95%
 C
I 1.58 to 2.06
H
igher age (-):  m
ultivariable coefficient = -
0.21, 95%
 C
I -0.34 to -0.08
Fem
ale sex (-): m
ultivariable coefficient = -
0.79,95%
 C
I -1.25 to -0.33
H
igher preoperative B
M
I (-): m
ultivariable   
coefficient = -0.33, 95%
 C
I -0.57 to -0.09
G
reater social deprivation  (higher log of IM
D
 
2004)(-): m
ultivariable coefficient = -0.79, 95%
 
C
I -1.11 to -0.46
M
odel 2:
PA
SS total O
K
S score
H
igher baseline O
K
S (+): O
R
 = 1.52, 95%
 C
I 
1.40 to 1.66
Total O
K
S
A
ge
O
perated side
D
iagnosis other than O
A
 or R
A
A
SA
 grade 
Y
ear surgery w
as perform
ed
O
K
S pain score
A
ge
G
ender
Preoperative B
M
I 
O
perated side
D
iagnosis other than O
A
 or R
A
A
SA
 grade
Y
ear surgery w
as perform
ed
O
K
S function score
O
perated side
D
iagnosis other than O
A
 or R
A
R
A
 diagnosis 
A
SA
 grade
A
nxiety/depression level
Y
ear surgery w
as perform
ed
M
odel 2:
PA
SS total O
K
S score
A
ge
G
ender
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G
reater social deprivation  (higher log of 
Index of M
ultiple D
eprivation 2004) (-): O
R
 = 
0.73, 95%
 C
I 0.62 to 0.87
R
A
 diagnosis (+):  O
R
 = 2.17, 95%
 C
I 1.02 to 
4.60
PA
SS O
K
S pain score
H
igher baseline O
K
S (+): O
R
 = 1.81, 95%
 C
I 
1.52 to 2.17
G
reater social deprivation  (higher log of 
Index of M
ultiple D
eprivation 2004) (-): O
R
 = 
0.80, 95%
 C
I 0.68 to 0.94
R
A
 diagnosis (+):  O
R
 = 2.33, 95%
 C
I 1.03 to 
5.29
M
oderately anxious/depressed (vs. not 
anxious/depressed) (-):O
R
 = 0.67, 95%
 C
I 0.54 
to 0.84
E
xtrem
ely anxious/depressed (vs. not 
anxious/depressed) (-):O
R
 = 0.51, 95%
 C
I 0.31 
to 0.84
PA
SS O
K
S function score
H
igher baseline O
K
S (+): O
R
 = 2.08, 95%
 C
I 
1.82 to 2.39
O
lder age (-):O
R
 = 0.93, 95%
 C
I 0.87 to 0.99
G
reater social deprivation  (higher log of 
Index of M
ultiple D
eprivation 2004) (-): O
R
 = 
0.76, 95%
 C
I 0.64 to 0.89
M
oderately anxious/depressed (vs. not 
anxious/depressed) (-):O
R
 = 0.77, 95%
 C
I 0.61 
to 0.97
B
M
I
O
perated Side
D
iagnosis other than O
A
 or R
A
A
SA
 grade
A
nxiety/depression level
Y
ear surgery w
as perform
ed
PA
SS O
K
S pain score
A
ge
G
ender
B
M
I
O
perated Side
D
iagnosis other than O
A
 or R
A
A
SA
 grade
Y
ear surgery w
as perform
ed
PA
SS O
K
S function score
G
ender
B
M
I
O
perated Side
D
iagnosis other than O
A
 or R
A
A
SA
 grade
E
xtrem
ely anxious/depressed (vs. not 
anxious/depressed)
Y
ear surgery w
as perform
ed
K
auppila et 
al. (2011) 
O
A
Prim
ary TK
A
70.7 (5.5)
75
88
12 m
onths
12 m
onth 
W
O
M
A
C
 
function change 
score
O
M
ER
A
C
T-
O
A
R
SI 
responder 
criteria
M
ultiple linear 
regression
M
ultivariate 
logistic 
regression
N
O
N
E
M
ultiple linear regression
M
ale gender (-): β
= -12.0, 95%
 C
I -23.1 to -
0.9
Presence of osteoporosis (-): β
= -17.5, 95%
 
C
I -32.9 to -2.1
H
igher preoperative
function (-): β
= 0.31, 
95%
 C
I 0.06 to 0.56
M
ultivariate logistic regression
Presence of osteoporosis (-): O
R
 = 14.7, 95%
 
C
I 1.1 to 106.1
M
ultiple linear regression
A
ge
Preoperative
function of the opposite knee
M
ultivariate logistic regression
D
ata not show
n
Lingard et 
al. 
(2004) 
O
A
Prim
ary TK
A
69.9
59.2
860
12 and 24 
m
onths
W
O
M
A
C
 pain 
and function at 
12 and 24 
m
onths
H
ierarchical 
linear 
m
odelling
N
O
N
E
W
O
M
A
C
 pain
A
t 12 m
onths
Fem
ale gender (-): F = 7.06, p < 0.05, 
param
eter estim
ate
= -3.77, 95%
 C
I -6.55 to -
0.99
L
ow
er preoperative pain (W
O
M
A
C
 pain 
score) (-):  F = 29.16, p <
0.0005, param
eter 
estim
ate
= 0.20, 95%
 C
I 0.13 to 0.28
L
ow
er preoperative m
ental health (SF-36 
m
ental health score) (-):  F = 17.53, p < 
0.0005, param
eter estim
ate
= 0.16, 95%
 C
I 0.09 
to 0.24
M
ore com
orbid conditions (-):  F = 5.85, p < 
W
O
M
A
C
 pain
A
t 12 m
onths
A
ge
C
ountry
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0.05, param
eter estim
ate
= -1.33, 95%
 C
I -2.41 
to -0.25
A
t 24 m
onths
Fem
ale gender (-): F = 3.98, p < 0.05, 
param
eter estim
ate
= -2.98, 95%
 C
I -5.91 to -
0.05
L
ow
er preoperative pain (W
O
M
A
C
 pain 
score) (-):  F = 25.13, p < 0.0005, param
eter 
estim
ate
= 0.20, 95%
 C
I 0.12 to 0.28
L
ow
er preoperative m
ental health (SF-36 
m
ental health score) (-):  F = 9.53, p < 0.005, 
param
eter estim
ate
= 0.13, 95%
 C
I 0.05 to 0.21
M
ore com
orbid conditions (-):  F = 4.59, p < 
0.05, param
eter estim
ate
= -1.24, 95%
 C
I -2.38 
to -0.11
W
O
M
A
C
 function
A
t 12 m
onths
H
igher age (-):  F = 5.62, p < 0.05, param
eter 
estim
ate
= -0.19, 95%
 C
I -0.35 to -0.03
L
ow
er preoperative function (W
O
M
A
C
 
function score) (-):  F = 51.58, p < 0.0005, 
param
eter estim
ate =
0.30, 95%
 C
I 0.22 to 0.38
L
ow
er preoperative m
ental health (SF-36 
m
ental health score) (-):  F = 17.04, p < 
0.0005, param
eter estim
ate
= 0.17, 95%
 C
I 0.09 
to 0.25
H
igher B
M
I (-):  F = 4.70, p < 0.05, param
eter 
estim
ate
= -0.30, 95%
 C
I -0.57 to -0.03
M
ore com
orbid conditions (-):  F
= 11.96, p < 
0.005, param
eter estim
ate
= -1.95, 95%
 C
I -3.05 
to -0.84
A
t 24 m
onths
L
ow
er preoperative function (W
O
M
A
C
 
function score) (+):  F = 55.75, p < 0.0005, 
param
eter estim
ate =
0.34, 95%
 C
I 0.25 to 0.43
L
ow
er preoperative m
ental health (SF-36 
m
ental health score) (-):  F = 6.02, p < 0.05, 
param
eter estim
ate
= 0.11, 95%
 C
I 0.02 to 0.20
R
estricted knee flexion (-):  F = 6.04, p < 0.05, 
param
eter estim
ate
= 0.12, 95%
 C
I 0.02 to 0.21
M
ore com
orbid conditions (-):  F = 13.96, p < 
0.0005, param
eter estim
ate = -2.26, 95%
 C
I -
3.45 to -1.07
A
t 24 m
onths
A
ge
W
O
M
A
C
 function
A
t 12 m
onths
G
ender
A
t 24 m
onths
A
ge
G
ender
Lingard et 
al. (2007) 
O
A
Prim
ary TK
A
70.8
60.3
952
3, 12 and 24 
m
onths
W
O
M
A
C
 pain 
and function at 
3, 12 and 24 
m
onths
G
eneral linear 
m
odels
A
ge
G
ender
N
um
ber of 
com
orbidities
C
ountry
C
enter w
ithin country
Preoperative scores
W
ith substitution of m
issing values
W
O
M
A
C
 pain 
H
igher preoperative m
ental health (SF-36) 
(+)
A
t 3 m
onths: param
eter estim
ate
= 0.095, p = 
0.0143
A
t 12 m
onths: param
eter estim
ate
= 0.128, p = 
0.0008
A
t 24 m
onths: param
eter estim
ate
= 0.096, p = 
0.0109
W
O
M
A
C
 function
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H
igher preoperative m
ental health (SF-36) 
(+)
A
t 3 m
onths: param
eter estim
ate
= 0.129, p = 
0.0001
A
t 12 m
onths: param
eter estim
ate = 0.150, p = 
0.0001
A
t 24 m
onths: param
eter estim
ate
= 0.106, p = 
0.0071
Lopez-
O
livo et al. 
(2011) 
O
A
Prim
ary TK
A
65 (9)
65
232
6 m
onths
W
O
M
A
C
 pain 
and function at 
6 m
onths
M
ultiple 
regression 
m
odelling
N
O
N
E
W
O
M
A
C
 pain
M
ore education (+): β = -0.17, p =0.01
M
ore com
orbidities (-):  β = 0.17, p = 0.008
M
ore problem
 solving-style coping  (+):  β = -
0.14, p =0.03
M
ore dysfunctional coping (-):  β = 0.13, p 
=0.04
M
ore internal belief of control over health 
(+):  β = -0.14, p =0.02
W
O
M
A
C
 function
M
ore frequent availability of tangible 
support (+):  β = -0.15, p =0.01
W
orse depressive state (-):  β = 0.15, p = 0.02
M
ore problem
 solving-style coping  (+):  β = -
0.20, p =0.001
L
ow
er baseline function level (-):  β = 0.25, p 
=0.0001
W
O
M
A
C
 pain
B
M
I
B
aseline pain level
W
O
M
A
C
 function
B
M
I
C
om
orbidities
N
euburger 
et al. (2013) 
O
A
 (90%
)
Prim
ary TK
A
 
(95%
)
R
evision TK
A
 
(5%
)
N
/A
57%
62,303
6 m
onths
Total O
K
S 
score at 6 
m
onths
Logistic 
regression 
analysis
M
odel 1:
A
ge
Sex 
Ethnicity
Self-reported com
orbid 
conditions
Self-reported general 
health
Prim
ary O
A
Prim
ary TK
A
 or 
revision TK
A
H
ospital
M
odel 2:
A
ge
Sex 
Ethnicity
Self-reported com
orbid 
conditions
Self-reported general 
health
Prim
ary O
A
Prim
ary TK
A
 or 
revision TK
A
H
ospital
Preoperative O
K
S
Longstanding problem
s
M
odel 3:
N
O
N
E
M
odel 1:
M
ore social deprivation (2nd quintile vs. 1st 
quintile) (-):β
= -0.7, 95%
 -0.9 to -0.5
M
ore social deprivation (3rd quintile vs. 1st 
quintile) (-): β
= -1.1, 95%
 -1.3 to -0.9
M
ore social deprivation (4th quintile vs. 1st 
quintile) (-):  β
= -2.2, 95%
 -2.4 to -2.0
M
ore social deprivation (5th quintile vs. 1st 
quintile) (-):  β
= -3.5, 95%
 -3.8 to -3.3
M
odel 2:
M
ore social deprivation (2nd quintile vs. 1st 
quintile) (-):β
= -0.4, 95%
 -0.6 to -0.2
M
ore social deprivation (3rd quintile vs. 1st 
quintile) (-): β
= -0.6, 95%
 -0.8 to -0.4
M
ore social deprivation (4th quintile vs. 1st 
quintile) (-):  β
= -1.5, 95%
 -1.8 to -1.3
M
ore social deprivation (5th quintile vs. 1st 
quintile) (-):  β
= -2.4, 95%
 -2.7 to -2.2
M
odel 3:
A
ge < 51 years (vs. 71-80 years)(-): β
= -2.9, 
95%
 -3.4 to -2.4
A
ge 51-60 years (vs. 71-80 years)(-): β
= -1.6, 
95%
 -1.8 to -1.3
M
odel 1:
N
O
N
E
M
odel 2:
N
O
N
E
M
odel 3:
G
ender
A
ge 61-70 years (vs. 71-80 years)
L
ung disease
C
ancer
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A
ge > 80 years(vs. 71-80 years)(-): β
= -0.5, 
95%
 -0.7 to -0.2
South-A
sian, black or other ethnicity (vs. 
w
hite ethnicity)(-): β
= -2.5, 95%
 -2.9 to -2.2
H
eart disease (-): β
= -0.6, 95%
 -0.8 to -0.3
H
igh blood pressure (+):β
= 0.3, 95%
 0.2 to 
0.5
Stroke (-): β
= -0.9, 95%
 -1.5 to -0.3
Poor circulation (-): β
= -2.3, 95%
 -2.6 to -2.0
D
iabetes (-): β
= -0.7, 95%
 -1.0 to -0.5
D
epression (-): β
= -1.8, 95%
 -2.1 to -1.5
V
ery good general health (vs. excellent) (-): β
= -1.2, 95%
 -1.6 to -0.9
G
ood general health
(vs. excellent) (-): β
= -
3.6, 95%
 -4.1 to -3.3
Fair general health (vs. excellent) (-): β
= -7.3, 
95%
 -7.7 to -6.9
Poor general health vs. excellent) (-): β
= -
11.0, 95%
 -11.6 to -10.4
D
iagnosis of O
A
 (-): β
= -0.5, 95%
 -0.9 to -0.3
R
evision operation (-): β
= -6.3, 95%
 -6.7 to -
5.8
L
ongstanding problem
s (+): β
= 0.4, 95%
 0.3 
to 0.6
B
etter preoperative pain/function (2nd decile 
of preoperative O
K
S score vs. 1st decile –
low
est) (+): β
= 2.5, 95%
 2.0 to 2.9
B
etter preoperative pain/function (3rd decile 
of preoperative O
K
S score vs. 1st decile –
low
est) (vs. 1st decile -low
est(+): β
= 3.9, 
95%
 3.5 to 4.2
B
etter preoperative pain/function (4th decile 
of preoperative O
K
S score vs. 1st decile –
low
est) (+): β
= 4.8, 95%
 4.5 to 5.2
B
etter preoperative pain/function (5th decile 
of preoperative O
K
S score vs. 1st decile –
low
est) (+): β
= 5.6, 95%
 5.3 to 6.0
B
etter preoperative pain/function (6th decile 
of preoperative O
K
S score vs. 1st decile –
low
est) (+): β
= 6.7, 95%
 6.4 to 7.0
B
etter preoperative pain/function (7th decile 
of preoperative O
K
S score vs. 1st decile –
low
est) (+): β
= 7.3, 95%
 7.0 to 7.7
B
etter preoperative pain/function (8th decile 
of preoperative O
K
S score vs. 1st decile –
low
est) (+): β
= 8.2, 95%
 7.9 to 8.5
B
etter preoperative pain/function (9th decile 
of preoperative O
K
S score vs. 1st decile –
low
est) (+): β
= 9.2, 95%
 8.8 to 9.5
B
etter preoperative pain/function (10th decile 
of preoperative O
K
S score vs. 1st decile –
low
est) (+): β
= 10.5, 95%
 10.2 to 10.8
Papakostidu 
et al. (2012) 
O
A
 (96%
)
Prim
ary TK
A
69.17 (6.69)
79.4
204
12 m
onths
W
O
M
A
C
 pain 
and function at 
12 m
onths
G
eneral linear 
m
odelling
N
O
N
E
W
O
M
A
C
 pain
H
igher pre-intervention pain (-): D
iff = 0.10, 
95%
 C
I 0.02 to 2.29
W
O
M
A
C
 function
W
O
M
A
C
 pain
G
ender
A
ge
B
M
I
E
ducation
Social support
R
esidence
W
O
M
A
C
 function
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L
ow
er pre-intervention function (-):D
iff = 
0.17, 95%
 C
I 0.06 to 0.28
G
ender
A
ge
B
M
I
E
ducation
Social support
R
esidence
Perruccio et 
al. (2012) 
O
A
Prim
ary 
unilateral TK
A
65
65
494
12 m
onths
W
O
M
A
C
 pain 
and function at 
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1. Abstract
Background
Identification of patients experiencing poor outcomes following TKA before the intervention could 
allow better case selection, patient preparation and, likely, improved outcomes. The objective was to 
develop a preliminary prediction rule (PR) to identify patients enrolled on surgical wait lists who are at 
the greatest risk of poor outcomes six months after TKA.
Methods
141 patients scheduled for TKA were recruited prospectively from the wait lists of three hospitals in 
Quebec City, Canada. Knee pain, stiffness and function were measured six months after TKA with the 
WOMAC and participants in the lowest quintile for the WOMAC total score were considered to have a 
poor outcome. Several variables measured at enrolment on the wait lists (baseline) were considered 
potential predictors: demographic, socioeconomic, psychosocial, and clinical factors including pain, 
stiffness and functional status measured with the WOMAC. The PR was built with recursive 
partitioning.
Results
The best prediction was provided by five items of the baseline WOMAC. The rule had a sensitivity of 
82.1% (95% CI: 66.7-95.8), a specificity of 71.7% (95% CI: 62.8-79.8), a positive predictive value of 
41.8% (95% CI: 29.7-55.0), a negative predictive value of 94.2% (95% CI: 87.1-97.5) and positive and 
negative likelihood ratios of 2.9 (95% CI: 1.8-4.7) and 0.3 (95% CI: 0.1-0.6) respectively. 
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Conclusions
The developed PR is a promising tool to identify patients at risk of worse outcomes six months after 
TKA as it could help improve the management of these patients. Further validation of this rule is 
however warranted before clinical use.
Keywords: Total Knee Arthroplasty. Osteoarthritis, Prediction rule, Determinants
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2. Résumé
Introduction
L’identification préopératoire des patients à risque de résultats chirurgicaux insatisfaisants suivant une 
arthroplastie totale du genou (ATG) pourrait permettre une meilleure sélection des cas, une meilleure 
préparation des patients et, vraisemblablement, des meilleurs résultats suivant la chirurgie. L’objectif 
de cette étude était de développer une règle de prédiction clinique (RPC) permettant d’identifier chez 
des patients en attente d’un ATG, les candidats à risque de douleurs et d’incapacité plus sévères 
suivant l’intervention.
Méthodes
141 patients en attente d’une ATG ont été recrutés des listes d’attente de trois hôpitaux à Québec, 
Canada. La douleur, la raideur du genou ainsi que la fonction étaient mesurées six mois suivant l’ATG 
avec le Western Ontario and McMaster Osteoarthritis Index (WOMAC) et les participants dans le 
quintile le plus faible (niveau de douleurs et d’incapacités élevées) étaient considérés comme ayant un 
résultat défavorable. Un ensemble de variables mesurées à l’inscription sur la liste d’attente 
(démographiques, socio-économiques, psychosociales et cliniques) étaient considérées comme des 
prédicteurs potentiels. La partition récursive a été utilisée pour bâtir la RPC.
Résultats
Le meilleur modèle prédictif comprenait cinq items du WOMAC préopératoire. La règle présente une 
sensibilité de 82.1% (IC 95%: 66.7-95.8), une spécificité de 71.7% (IC 95%: 62.8-79.8), une valeur 
prédictive positive de 41.8% (IC 95%: 29.7-55.0), une valeur prédictive négative de 94.2% (IC 95%: 
87.1-97.5) et des rapports de vraisemblance positifs et négatifs de 2.9 (IC 95%: 1.8-4.7) et de 0.3 (IC 
128
95%: 0.1-0.6) respectivement.
Conclusions
La RPC est un outil prometteur pour identifier des patients à risque de résultats défavorables six mois 
suivant l’ATG. Cette règle pourrait améliorer la prise en charge de cette population. La validation de 
cet outil est nécessaire avant une implémentation et une utilisation clinique.
Mots-clés : Arthroplastie totale du genou, Arthrose, Règle de prédiction, Déterminants
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3. Background 
TKA surgery is widely regarded as the treatment of choice for patients suffering from knee OA once 
the options for conservative treatment have been exhausted [118]. TKA is the second most popular 
type of orthopaedic surgery and projective data suggests a six-fold increase in the number of primary 
TKAs in the following decades in North America [14]. TKA is an effective procedure and the majority 
of patients will show important improvements in pain, disabilities and HRQoL [146]. However, a 
growing body of evidence suggests that 10-30% of patients undergoing TKA have very poor or no 
improvement following surgery [4, 5, 16, 119]. Several factors that are associated to such negative 
outcomes have been identified; inappropriate expectations, contralateral knee pain, higher 
psychological distress, high body mass index, use of a walking aid, advanced age, female gender, 
lower OA grade and thyroid disease have all been found to be significantly associated to worse 
physical function following TKA [4, 11, 18, 19, 52-54, 121, 128, 133, 139, 147-152].  Nonetheless, 
these findings are often not consistent across studies and the exact strength of the associations between 
these factors and the outcomes remain elusive. It thus remains a challenge to identify which TKA 
candidates will likely do well, or do poorly following TKA [121].
The fact that the surgery might not be successful for many patients prompts the necessity of identifying 
those who are at the greatest risk of having poor outcomes following TKA. Their identification could 
orient both clinicians and patients regarding the decision of undertaking the procedure [18]. Moreover, 
medical or rehabilitation interventions could be initiated preoperatively or postoperatively [19]. 
Successful identification of patients at risk of adverse outcomes after TKA could not only benefit 
patients, but also clinicians and policy makers in more efficiently allocating necessary healthcare 
resources required by the condition of these patients [19, 20].
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By developing an accurate and easy-to-use prediction tool, better case management of patients enrolled 
on a wait list for TKA could be achieved. To our knowledge, no such tool has ever been developed for 
this population. Few clinical predictive rules have been built and validated to allow for better case 
management of other types of musculoskeletal complaints. The Ottawa Ankle and Knee Rules are used 
in order to identify the need for roentgenographic investigation following acute ankle and knee injuries 
respectively [71, 72]. The Cassandra Rule has been developed to identify patients with non-specific 
back pain that are most likely to develop or sustain long-term functional limitations [73]. Therefore, 
the objective of the present study was to develop a PR that would allow a better identification of 
patients at the greatest risk of poor outcome six months after TKA upon enrolment on a wait list for 
surgery. 
4. Methods
4.1.  Study design
This study employed a prospective longitudinal design with repeated measures. It was part of a broader 
study targeted at measuring the effects of wait time on patients undergoing TKA [148, 153]. It adheres 
to the STROBE guidelines for observational cohort studies (see Appendix M).
4.2.  Settings
From 02/2006 to 09/2007, patients newly included on the waiting lists of the departments of 
orthopaedic surgery of three teaching hospitals in Quebec City, Canada (CHUL, HSFA and HDQ) 
were recruited. Follow-up of participants ended in 09/2010 because of the extensive wait times in the 
participating hospitals. All seven orthopaedic surgeons performing TKA in these three hospitals 
collaborated in the study. 
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4.3.  Participants
Every week, patients newly enrolled on the surgical wait lists of the three hospitals were contacted by 
a research nurse by phone. Eligible subjects had to meet the following inclusion criteria: (1) age > 40 
years old; (2) scheduled for primary unilateral TKA; 3) understands, reads and speaks French. Patients 
were excluded if they were suffering from a severe cardiac condition, a severe degenerative disease 
(other than OA) such as Parkinson’s disease, Alzheimer’s disease, any type of dystrophies or other 
type of sclerosis with the potential to interfere with patient recovery following TKA or any severe 
mental disorder (severe depression, bipolar disorder, schizophrenia or dementia) that could interfere 
with the ability to answer the protocol questionnaires. Subjects with a previous joint arthroplasty (hip 
or knee) were also excluded. Those who suffered a major trauma to the knee in the previous year or 
underwent surgery urgently within 30 days of registration on the waiting list were further excluded.
4.4.  Data collection
Data were collected via a review of the patients’ medical files and structured 45 minutes phone 
interviews conducted by three trained interviewers. The interviews were performed a few days after 
enrolment on the wait lists (mean ± SD: 12.6 ± 4.7 days) and six months after the TKA (mean ± SD: 
188.7 ± 5.4 days). Patients were also interviewed before surgery; these results have been reported 
previously [148].
4.5.  Dependent variables 
Pain, stiffness and function at enrolment and six months after surgery were measured with the 
WOMAC, a 24-question tool [116]. The WOMAC has been found to have very good reliability, 
convergent construct validity and responsiveness, and has been used extensively with similar 
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populations [76, 77, 154]. The WOMAC score was transformed in order to obtain a score that varied 
from 0 to 100, 0 indicating no pain, no functional limitations nor knee joint stiffness. As there is no 
universal agreement on what is considered poor outcome following TKA surgery, it was defined as the 
last quintile of the six-month postoperative WOMAC score (i.e. WOMAC score >40.4); a satisfactory 
outcome was defined by a WOMAC score in the first four other quintiles of the distribution (i.e. score 
≤ 40.4).
4.6.  Independent variables 
Independent variables collected to be considered as potential predictors in the final predictive model 
included known important determinants of TKA outcomes reported in the literature [4, 11, 18, 19, 52-
54, 121, 128, 133, 147-152]. Variables were collected at the time of the patients’ enrolment on the wait 
list and six months after TKA.
4.6.1.    Potential predictors at enrolment on surgical wait list
Initial diagnosis, anthropometric data and comorbidities were recorded from the subjects’ medical 
files. The burden of comorbidities was assessed using the CIRS [86]. At the initial interview, questions 
drawn from the questionnaire of the 1998 Quebec Health Survey were used to measure formal 
education, employment status, and household income.  Social support was also measured with 
questions from the Quebec Health Survey [87].  Marital status, household living status, and clinical 
variables such as duration of disease symptoms were also noted during the initial interview. 
Psychological distress was recorded with a modified version of the PSI. The modified PSI includes 13 
questions that measure depression and anxiety during the past week (range: 0-42) [88]. We also 
considered individual questions from validated questionnaires (i.e.: social support tool, PSI and 
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WOMAC) to build the rule. This was done in an effort to simplify the number of items to include in 
the final PR. 
4.6.2.    Other variables
Several surgical variables such as type of implant, bearing type, implant fixation, patella resurfacing 
and the number and type of in-hospital complications (wound infection, dislocation, knee ankylosis 
and manipulation, cardiovascular/ pulmonary/ circulatory complications, peripheral/ central nervous 
system involvement, urinary infection, acute confusion, tendon and ligament rupture, blood 
transfusion) following TKA were recorded by reviewing the subjects’ medical files. The same 
procedure was used to document hospital length of stay and discharge to a rehabilitation or recovery 
facility. The pre-surgery wait times were calculated from the data extracted from the wait list database 
of each hospital. Six months following the surgery, patients were asked about walking aid usage and 
the number of community physiotherapy treatment hours received since discharge from the hospital.
4.7.  Statistical analysis
Less than 2% of the data of the WOMAC questionnaire was missing, and it was handled according to 
the recommendations of the tool’s guidelines [116]. Recursive partitioning analyses were used to build 
the PR. One of the most effective algorithm is CART [82]. It relies on considering all combinations of 
the predictors in order to maximize homogeneity within nodes. The Gini heterogeneity coefficient was 
used as a criterion to build the models [83]. Since the sample size was relatively small, we used all data 
in the training set. An automatic approach was first used to build PRs. Then, a set of eligible candidate 
predictors was created by manual adjustment based on statistical, clinical and ease of use 
considerations. For each resulting PR, sensitivity, specificity, area Uuder the receiver operating 
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characteristics – ROC – Curve (AUC), predictive value of positive and negative tests, as well as 
positive and negative likelihood ratios were calculated with their 95% confidence intervals [84]. The 
simplest rule demonstrating the highest sensitivity with acceptable level of specificity was selected as 
the final tool. The accuracy of the proposed model using 1,000 bootstrap resamples was then 
calculated for internal validation [85]. All analyses were carried out using SPSS Answer Tree 3.1 
(SPSS Inc., Chicago) and SAS statistical suite software version 9.2 (SAS Institute Inc., Cary, NC, 
U.S.A.).
4.8  Ethics
All participants signed an informed consent form. The study was approved annually by the Research 
Ethics Boards of all three hospitals (CHUL, HSFA and HSFA). 
5. Results
5.1.  Participants
Figure 1 shows the flow of subjects through the duration of the study. A total of 588 patients enrolled 
on the wait list of the three hospitals. Thirty-two patients could not be reached within three weeks of 
inclusion on the wait list and 45 declined participation. Out of 511 patients whose eligibility was 
assessed, 220 patients met the eligibility criteria. Following 23 further declinations, 197 patients were 
interviewed at the time of enrolment on the wait list. A further six patients withdrew from the study. 
Six others could not be reached before surgery. Thirteen had surgery performed in a different 
institution. Eleven decided not to undergo surgery. The surgeries of seven patients were cancelled due 
to medical reasons. One patient passed away while waiting for TKA and one after the surgery was 
performed (both deaths unrelated to TKA). Therefore, 153 patients underwent TKA. Of these, three 
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withdrew from the study, one could not be reached six months after the surgery and seven underwent 
contralateral knee arthroplasty within six months. A total of 141 patients where thus interviewed six 
months after TKA. The overall eligibility proportion was calculated as (220 / 511) = 0.43; the 
participation proportion was calculated as (197 / (220 + ((45 + 32) x 0.43))) = 77.8%, and the follow 
up proportion was calculated as (141 / (197 – 44)) = 92.2%.
Participants had a mean age of 66 (SD: ± 9.5) years. The majority of patients were women (66%) and 
suffered from contralateral knee pain (72%). The mean wait time of the participants was 184 (SD: ± 
120.8) days and median wait time was 148 days (range: 32-692). The majority of TKA implants were 
postero-stabilized (82%) and cemented (96%). Mean hospital length of stay was 7.5 days (SD: ± 3.0)
(Table 1).
Six months following TKA, participants showed a significant improvement in terms of both pain (-
30.6, SD: ± 21.8, 95% CI  -26.9 to -34.2), stiffness (-26.0, SD: ± 20.4, 95% CI -21.2 to -30.8), and 
function mean scores (-25.4, SD: ± 20.5, 95% CI  - 22.0 to -28.8), as well as in overall WOMAC mean 
score (-27.3, SD: ± 15.8, 95% CI -23.6 to -31.0) (Table 2).
5.2.  Final prediction rule 
Overall, out of the 141 participants who completed this study, 28 (20%, corresponding to the first 
quintile of the distribution) scored > 40.4% (total score) on the WOMAC questionnaire, thus being 
identified as patients with the worst outcomes. From all potential predictors measured at enrolment, the 
final PR included the answers to five questions drawn from the WOMAC at baseline: preoperative 
difficulty of taking off socks, getting on/off toilet, performing light domestic duties and rising from 
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bed as well as degree of morning stiffness after the first wakening (Figure 3). The patients answered 
these questions in a sequential manner by attributing a degree of difficulty (none, mild, moderate, 
severe or extreme) to the items described in the questions. Depending on the pattern of their answers, 
the patients could be classified as either at risk or not at risk for poor outcomes (Figure 2). 
The final PR correctly identified 23 of the 28 patients with the worst outcomes and 81 of the 113 
patients with the best outcomes (Table 3). Therefore, it had a sensitivity of 82.1% (95% CI: 64.4 to 
92.1), a specificity of 71.7% (95% CI: 62.8 to 79.2) and a positive likelihood ratio of 2.901 (95% CI: 
2.064 to 4.077).
Presented in the appendix are other prediction models developed that were also considered (see 
Appendix N). 
5.3.  Internal validation
The accuracy of the rule was confirmed using 1,000 bootstrap re-samples. For each and every measure 
of predictive validity, the estimate obtained with the bootstrap was very close to the original estimate
(Table 4).
6. Discussion
6.1.  Main Results
In this study, a cohort of 141 patients scheduled for primary TKA were followed from the moment of 
their enrolment on the waiting list until six months after the surgery. The objective of the study was to 
develop a prediction tool that would allow the early identification of patients at risk of poor outcome 
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following primary TKA. 
Important determinants of TKA outcomes measured at enrolment on the pre-surgery wait list were 
considered in the process of building the prediction rule. While the choice of the final predictive model 
could have been made from several criteria, we decided that the rule demonstrating the best sensitivity 
and an acceptable level of specificity would be the most appropriate because such a tool could identify 
patients at risk with fewer false negatives. Consequently, a model with a sensitivity of 82.1% and a 
specificity of 71.7% was chosen. Compared to published standards in clinical epidemiology, the model 
presented a somewhat weak positive likelihood ratio of 2.90 (95% CI: 2.06 to 4.08) [155]. 
Nevertheless, this rule presented the best overall predictive validity and is comparable to other PR 
found to be valid in the literature. For example, the positive likelihood ratio of the final PR is higher 
than the value reported for the Ottawa Knee Rule (2.18, 95% CI 2.04 to 2.33) designed to identify the 
necessity for use of radiography in the emergency room in cases of acute knee injuries [72] or for the 
five-item Cassandra rule allowing the identification of patients at risk of long-term back-related 
functional limitations (1.95, 95% CI: 1.75 to 2.17) [73].
To our knowledge, no such tool has ever been built for candidates waiting for TKA or any other type 
of total joint replacement. A priority-setting tool for TKA and THA has been developed and validated 
by the Western Canada Waiting List project partnership [23, 70]. This tool allows for the 
quantification of the level of urgency of the status of patients enrolled on a waiting list for total knee or 
hip replacement, but its predictive capabilities have not been investigated. 
The best predictive model developed in this study incorporates five items from the baseline WOMAC 
138
questionnaire, specifically questions regarding baseline function and stiffness, although an extensive 
set of known determinants were considered as potential predictors. The fact that four questions are 
related to preoperative function is consistent with the literature where preoperative function is a major 
determinant of postoperative function [52]. It is noteworthy to mention however that the current model 
does not include items regarding the level of pain. This can be due to the fact that patients undergoing 
TKA generally experience a notable relief in their pain level following the surgery but may still 
experience important disabilities [4, 5, 16, 119]. It must be remembered, however, that the statistical 
approach used in building the PR does not allow for the interpretation of relationships as causal [117].
When building the PR, we intended to develop an applicable tool. Orthopedic surgeons and staff who 
assess the patients’ status upon placing them on TKA wait lists could be the main users of the PR. 
However, the PR could eventually also be used by other healthcare professionals, namely physician 
assistants, physiotherapists, occupational therapists, and nurses. In this way, any healthcare 
professional who takes charge of the case can take into account the results of the PR when determining 
the most appropriate course of action for the patient’s care. The PR shows promising practical 
implications, as it is relatively simple and easy to use in a clinical setting. 
At times, the interpretation process may seem counterintuitive. Question 2 of the rule indicates that a 
patient may be categorized at risk if they experience mild difficulty when getting on or off the toilet, 
yet, depending on their answer to the Question 4, they may be classified as not at risk if they encounter 
severe difficulty performing the same task. Since the PR includes four items from the function 
subscale of the WOMAC, it would be expected that it classifies at risk those patients whose 
preoperative function is severely affected, considering that preoperative function has been consistently 
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identified as a determinant of functional outcome [52]. Nevertheless, a predictor is not necessarily a 
determinant; its purpose is to predict the desired outcome and the development with recursive 
partitioning determined that it is this answer pattern that shows the best predictive value.
6.2.  Strengths of the study
This study followed a prospective longitudinal cohort design. It had high participation and follow-up 
proportions. There does not seem to be a selection bias, as there were no significant differences 
between participants and eligible non participants on age and gender as well as no significant 
differences in terms of pain, functional limitations at enrolment on the pre-surgery wait lists between 
subjects lost to follow-up, subjects who did not undergo surgery and participants who completed the 
interview six months after surgery (data not shown). Baseline measurements of the dependent 
variables were made as soon as the patients were enrolled on the pre-surgery wait list (mean ± SD: 
12.6 ± 4.7 days). 
6.3.  Limitations of the study
The sample of 141 patients that was used to derive the PR was small. This may diminish the 
applicability of the PR to the general population. Moreover, the population under study was patients 
undergoing primary TKA. This effectively may disregard patients with revision or bilateral TKA. 
Furthermore, the clinical outcomes of TKA were assessed using the WOMAC questionnaire, a self-
reported measure. Performance-based measures such as the Timed Up and Go Test or the Six Minute 
Walking Test could have been used in order to complement the information recorded by the self-
reported measure [156]. An assessment of the patients’ status in a more comprehensive manner could 
have thusly been achieved. In addition, we considered the patients having postoperative WOMAC 
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scores in the first quintile to have a poor outcome. Since there is no consensus on what constitutes an 
appropriate measure of poor outcome following TKA, we decided that this method could be applied. It 
is important to point out that this PR allows for the identification of patients at risk of poor outcomes in 
the short term following TKA and was not tested to predict long-term outcomes. The time point of six 
months after surgery was chosen to identify patients with poor outcomes, as it is a critical time in the 
patients’ rehabilitation period when they are often seen by surgeons to monitor progress and where the 
rehabilitation protocol and conservative treatment options may be easily modified if recovery is not 
optimal. Finally, the final PR has not yet been validated with a different sample of patients, its 
predictive validity has not been compared to clinical judgment alone, and the clinical and financial 
impacts of its use have not been yet assessed. Until these further research steps are completed, the PR 
should be used with caution.
7. Conclusion
The PR developed in the current study has the potential to identify patients at risk of poor surgical 
outcomes following TKA. Such patients could then be assigned to an appropriate course of action, 
such as prehabilitation, conservative management, wait list priority or intensive postoperative
rehabilitation. These conducts may diminish the extent of deterioration of patients waiting for TKA 
and could decrease the socioeconomic burden of TKA. A further validation in an external cohort is 
needed. Impact analysis determining the usefulness of the rule in the clinical setting regarding cost-
benefit, time and resource allocation as well as patient satisfaction is equally required.
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Figure 1 Flowchart of patients’ recruitment. *Eligibility status unknown (considered in 
calculation of participation proportion). TKA, total knee arthroplasty.
144
Figure 2 Prediction algorithm to identify patients at risk of poor outcome following TKA
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Figure 3 Graphical representation of the PR and its interpretation
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Table 1 Selected characteristics of the participants who underwent primary unilateral 
total knee arthroplasty surgery (n = 141)
SD: standard deviation
* Median (range): 148 days (32-692)
** n=125 – CND $
° Social support was dichotomized around the median score: Low (≤ 80) and High (>80)
¬ Body mass index
† n=138
§ WOMAC pain score at enrolment on pre-surgery wait list dichotomized into presence or absence of contralateral knee pain
‡ In-hospital complications including: wound infection, dislocation, knee ankylosis and manipulation, 
cardiovascular/pulmonary/circulatory complications, peripheral/central nervous system involvement, urinary infection, acute confusion, 
tendon and ligament rupture or blood transfusion
Variables considered for PR development n (%) Mean (SD) Other collected variables n (%) Mean (SD)
Demographics Pre-surgery wait
Age (years) 66  (9.5) Time between enrolment on wait list and surgery (days)* 184 (120.8)
Female 93 (66) Categories of wait time
Marital status ≤3 months 30 (21) 62.5 (16.9)
Single, separated, divorced or widowed 51 (36) >3-6 months 53 (38) 130.2 (28.7)
Married or common law 90 (64) >6-9 months 31 (22) 216.8 (25.1)
Living alone 34 (24) >9 months 27 (19) 386.3 (56.7)
Socioeconomic characteristics Surgery postponed for personal reasons 9   (6)
Educational level (part or complete) Surgical characteristics
High school or less 79 (56) Implant type
College or University 62 (44) Postero-stabilized 115 (82)
Employment status Cruciate retaining 26 (18)
Unemployed or retired 108 (77) Implant fixation
Employed 33 (23) Cementless 4 (3)
Household income ** Hybrid 2  (1)
< $30 000 / year 48 (34) Cemented 135 (96)
$30 000 - $59 999/ year 43 (31) Implant bearing type
≥ $60 000/ year 34 (24) Mobile 4 (3)
Missing data 16 (11) Fixed 137 (97)
Psychosocial characteristics Patella resurfacing 132 (93)
Psychological distress (/42) 7.2   (7.0) In-hospital complications‡
      Social support° 0 109 (77)
Low 67 (48) 1 23 (16)
High 74 (52) ≥2 10   (7)
Clinical characteristics Health services utilization
Diagnosis Hospital length of stay (days) 7.5   (3.0)
Osteoarthritis 136 (96) Discharged directly home 123 (87)
Rheumatoid arthritis 5   (4) Post-surgery community physiotherapy (hours) 14.7 (18.7)
BMI ¬ (kg/m2) 31.2   (6.2)
Comorbidities ( /56) 6.5  (2.2)
Duration of knee symptoms before 
enrolment † (years) 
7.9   (8.1)
Contralateral knee pain § 101 (72)
Use of a walking aid
At enrolment on wait list 55 (39)
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Table 2 Overall changes in WOMAC scores of the participants between enrolment on the 
pre-surgery waiting lists and 6 months after TKA (n = 141)
SD: standard deviation
CI: confidence interval
† Scores presented as standardised scores. Lower scores sign a better condition
‡ Negative changes in score sign an improvement of the condition
* p < 0.05
Mean score at 
enrolment †
(SD)
Mean score 6 
months after 
TKA †
(SD)
Change in 
score ‡
(SD)
95% CI 
Comparison 
between time 
points 
(p value)
WOMAC
Pain 53.1 (17.9) 22.5 (17.1) - 30.6 (21.8) - 26.9 to - 34.2 <0.001*
Stiffness
Function
59.3 (19.7)
53.5 (14.3)
33.3 (21.1)
28.1 (17.9)
- 26.0 (20.4)
- 25.4 (20.5)
- 21.2 to - 30.8
- 22.0 to - 28.8
<0.001*
<0.001*
Total score 55.3 (15.2) 28.0 (16.3) - 27.3 (15.8) - 23.6 to - 31.0     <0.001*
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Table 3 Two by Two table of predicted versus actual outcomes of the final PR 
Actual Outcome
Predicted 
outcome
AT RISK
(Postoperative WOMAC > 40.4)
NOT AT RISK 
(Postoperative WOMAC ≤ 40.4)
AT RISK 23 32
NOT AT RISK 5 81
TOTAL 28 113
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Table 4 Validity measures of the predictive rule
x * 95%  asymptotic confidence intervals
x Sensitivity:  number of participants classified at risk both by the PR and the postoperative WOMAC score divided by all participants classified at 
risk by the postoperative WOMAC score (actual outcome).
x Specificity: number of participants classified not at risk by the PR and the postoperative WOMAC score divided by all participants classified not 
at risk by the postoperative WOMAC score (actual outcome).
x Positive predictive value: number of participants classified at risk by the PR and the postoperative WOMAC score divided by all participants 
classified at risk by the PR (predicted outcome).
x Negative predictive value: number of participants classified not at risk by the PR and the postoperative WOMAC score divided by all participants 
classified not at risk by the PR (predicted outcome).
x Positive likelihood ratio: sensitivity/ (1-specificity)
x Negative likelihood ratio: (1-sensitivity)/specificity. 
x Area under the ROC curve is defined as the area under the sensitivity vs. 1-specificity curve
Measure Estimates in training 
sample
Estimates with 1,000 
bootstrap resamples
Sensitivity % (95% CI) 82.1 (64.4-92.1) 82.1 (66.7-95.8*)
Specificity % (95% CI) 71.7 (62.8-79.2) 71.7 (62.8-79.8*)
Positive predictive value % 
(95% CI)
41.8 (29.7-55.0) 41.8 (29.1-55.8*)
Negative predictive value 
% (95% CI)
94.2 (87.1-97.5) 94.2 (88.8-98.8*)
Positive likelihood ratio 
(95% CI)
2.90 (2.06-4.08) 2.90 (1.81-4.74*)
Negative likelihood ratio 
(95% CI)
0.25 (0.11-0.57) 0.25 (0.11-0.58*)
Area under ROC curve 
(95% CI)
0.77 (0.69-0.85) 0.77 (0.69-0.85*)
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CHAPTER 7
DISCUSSION
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The objective of this memoir was twofold: firstly, we aimed to identify the determinants of pain and 
disability following TJA with the greatest level of evidence by systematically reviewing the literature. 
Secondly, we aimed to develop prediction models allowing the preoperative identification of patients 
at risk of poor outcomes after TJA. In the following sections, we discuss the main results of the 
systematic reviews as well as of the prediction models. Subsequently, we address the main strengths 
and limitations of this memoir, and conclude by discussing possible practical applications and future 
avenues. 
1. Determinants of high levels of pain and functional disabilities following THA
In this study, we identified 22 articles with a mean methodological score of 81.0%, SD 10.3% that 
describe with a moderate-to-high level of evidence the determinants of short- and medium-term pain 
and functional levels following THA. The results of this study allowed to conclude that significant 
preoperative determinants of poor pain and function following THA with the highest level and amount 
of evidence are a lower educational level, the preoperative level of pain and function, higher BMI, 
presence or a greater level of comorbidities, worse general health and lower radiographic OA severity. 
Considering that a significant proportion of patients undergoing THA experience unfavourable 
outcomes in terms of pain and disability, the identification of these determinants may help target 
patients at risk in order to ultimately ameliorate their outcomes. 
The main finding of this study is the significant relationship between the preoperative and the 
postoperative levels of pain and function. As a matter of fact, out of 12 studies that investigated this 
relationship, a significant association was found in nine studies. Although the literature consistently 
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refers to this relationship as a well-known fact, to our knowledge, our systematic review is the first 
underlining it with an appropriate extent of precision and validity. The direction of such an association 
is a function of the method of measurement of the outcome. Indeed, when the outcome is measured as 
postoperative state, i.e. the level of pain and/or function after the surgery regardless of the preoperative 
levels of the respective domains, a worse preoperative status is significantly associated with a worse 
postoperative status. When the studies investigate outcome as a measure of domain change, i.e. the 
difference between preoperative and postoperative levels, a lower preoperative status is associated with 
a higher chance of achieving an improvement on the respective domain. The clinical implication of 
these findings is challenging, as two opposite situations may emerge. THA may be performed early in 
the course of the disease when the patients’ pain and function are still relatively preserved, such as to 
lead to appropriate levels postoperatively. The patients’ pain and function will then achieve a certain 
plateau, and their ultimate outcome will be limited by the longevity of the prosthesis. If THA is 
performed later in the disease process when the patients are very limited by OA, although their 
postoperative status will be worse compared to if they had THA earlier in the course of their disease, 
the amount of improvement they would experience would be greater. In this situation, patients would 
achieve a notable relief, and will likely be very satisfied with their intervention. The caveat is their 
long-term levels of pain and function, which would be worse compared to their peers undergoing 
surgery earlier. Although this logic seems to favour performing THA for patients early in their disease 
process, it is realistically difficult to do so for all surgical candidates. It is possible that patients’ 
symptoms can be managed with less invasive procedures incurring fewer risks and smaller costs, such 
as analgesic medication, intra-articular corticosteroid injections and rehabilitation, among others, that 
can ultimately halt disease progression [6]. Unfortunately, there does not seem to be a consensus 
regarding this predicament, and our findings only complement the uncertainty that these concepts 
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instigate.
An interesting finding of this review was the amount of conflicting evidence regarding the association 
of demographic variables with THA outcomes. For example, only four out of the 12 included studies
that investigated this relationship showed that older age was associated with worse pain and disability 
following THA. Similarly, two out of ten included studies proposed gender as a significant 
determinant of THA outcomes. We can therefore conclude that these demographic variables are most
likely not associated to THA surgical results, which is in stark contrast with the previously published 
systematic reviews [10, 18]. Although our study has some advantages over the aforementioned 
systematic reviews, and may conversely be affected by the limitations of the included prognostic 
studies that will be discussed shortly, this conclusion has potential important clinical implications. For 
example, a prehabilitation program may equally target THA candidates of all ages as well as men and 
women. Moreover, surgery should not be denied based on these variables, at least with respect to pain 
and functional outcomes. 
Another original finding of our systematic review is the association between a higher BMI and poor 
THA outcomes (six out of ten studies). A longstanding paradigm, the effect of body mass on THA 
results in terms of early and long-term complications, operative times, length of hospital stay and 
clinical results has been vastly debated, yet no consensus has been reached [157]. Although the design
of the prognostic studies included in the review cannot suggest a causative link between BMI and THA 
results, this result may find clinical utility. Considering that obesity is a well-known risk factor for 
development of hip OA and that the average BMI of THA candidates has been increasing over time 
[158], patients with higher BMI may require particular attention, such as closer follow-up and possibly 
weight loss interventions. Nevertheless, some of the included studies suggest that the magnitude of 
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association between higher BMI and poor surgical outcomes in terms of pain and function is smaller 
compared to other determinants, and may not be clinically important. However, due to the current 
review’s inability to conclude on the strength of the association between determinants and THA 
outcomes, this issue may require further clarification.
The consistent association between THA outcomes and the degree of general health either measured as 
presence or level of comorbidities, back pain, physical and mental health, or involvement of the 
contralateral hip, is another important finding of this review. The nature of the relationship between 
these variables and THA outcomes is intricate, and further research is indicated to elucidate this. 
Nevertheless, these variables could represent components that should be targeted in a prehabilitation 
program aimed at improving pain and function following THA. Moreover, similar to the practice of 
assessing fitness for surgery using the American Society of Anaesthesiologists Scale because of its 
association with procedural complications, employing measures of health could potentially assess the 
merit of undergoing the procedure.
Lastly, a lower radiographic OA severity was unanimously associated with smaller changes in pain 
after THA in three studies. Radiographic OA severity is traditionally assessed using the Kellgren-
Lawrence scale, which takes into account radiographic aspects of OA such as joint space narrowing, 
osteophytes, subchondral bone sclerosis, cysts and deformity of the femoral head and acetabulum 
[159]. It has been previously suggested that less severe disease is appreciably associated to clinical 
manifestations such as pain and function levels [111]. The current finding likely parallels the 
significant association between preoperative and postoperative health state, with the implications 
previously described. It is however possible that in patients with low radiographic OA severity, the hip 
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pain actually represents referred pain from other regions, such as the lumbar spine. In this situation, the 
surgical indication is questionable, thus possibly explaining poor outcomes in terms of pain and 
function. Moreover, patients with low radiographic OA severity have low pain threshold and possible 
inadequate expectations regarding the results of the intervention, also eventually contributing to 
suboptimal outcomes.
2. Preliminary prediction algorithm identifying patients at risk of suboptimal outcomes 
following hip arthroplasty
This study entailed the development of a preliminary PA identifying patients at risk of poor outcomes 
following hip arthroplasty in a retrospective cohort of 265 patients collected from the HMR’s 
arthroplasty database. Forty patients (15.1% were in the worst quartile of the postoperative WOMAC 
score and perceived their operated hip as artificial with minimal or major limitations, and were 
therefore considered to have had a poor outcome. The final PA included age, gender, BMI as well as 
three items of the preoperative WOMAC. This algorithm shows favourable predictive capabilities, 
with a sensitivity of 75.0% (95% CI 59.8.4-85.8), a specificity of 77.8% (95% CI 71.9-82.7) and a 
positive likelihood ratio of 3.38 (95% CI 2.49-4.57). The internal validity of the PA was successfully 
determined using 1,000 bootstrap resamples. 
In order to develop a clinical prediction algorithm, candidate variables can be selected based on 
clinical and theoretical understanding, as well as on previous similar attempts reported in the literature 
[160].  The literature of predictors of hip arthroplasty outcome is however very limited, with only one 
study reporting an analogous prediction algorithm to our knowledge [69]. Consequently, in order to 
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select potential predictor variables, the pool of significant determinants of hip arthroplasty outcomes 
can be surveyed.  Out of the six predictors included in this PA, BMI and the preoperative WOMAC 
levels are also significant determinants of THA outcomes as reported by the systematic review in 
Chapter 3. Additionally, age, gender and BMI can also be found in the prediction model by Slaven et 
al. These encouraging findings are however limited by the fact that several significant determinants as 
identified by the systematic review were not considered as potential predictor variables when 
developing the PA due to the limitations associated with using a retrospective database.  For example, 
education levels, general health and radiographic OA severity were either incompletely or not 
available in the database. This represents a limitation of the current study, and a future prospective 
study should collect data on all important determinants. Interestingly, age and gender were not 
identified as significant determinants in the systematic reviews, but were included in the final 
predictive model. This situation underlines the difference between a predictor and a determinant; the 
former is able to predict an outcome, whereas the latter merely indicates that there is a significant 
association with an outcome. 
Two constructs (postoperative total WOMAC score and hip perception) were used to define patients as 
being at risk in order to maximize the likelihood of them being truly subject to poor surgical outcomes. 
Conceptually, this classification is different from the MCID and other measures of change in status 
described in Appendices A and B. Our purpose was to develop a prediction model that would help 
identify the patients with poor postoperative functional status, severe pain and poor hip perception 
regardless of the effectiveness of their intervention. We did not intend to target the prediction of a 
treatment effect, such as would have been the case if we used the MCID or other similar measure as an 
outcome measure. The latter equally present numerous potential limitations, including multiple 
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possibilities of calculation methods, different definitions of “change” and derivation based on non-
representative populations, ultimately yielding values of doubtful validity [110].  Some authors do not 
recommend their use in a clinical setting [110]. 
The proposed PA was developed on a sample of patients undergoing THA or HR, although their 
indications can be different. We decided to include both types of procedures in order to develop a tool 
capable of successfully performing in a heterogeneous population. In fact, in a clinical setting, an 
orthopaedist may consider both types of interventions for a patient, and this tool may be employed 
regardless of the final choice of the type of joint replacement. Moreover, in the case of our sample, 
there were no statistically significant differences between the two procedures in terms of age, gender 
and number of comorbidities (p > 0.05); BMI was higher for the THA group (mean ± SD: 28.8±5.3 
kg/m2 vs. 27.0±4.5 kg/m2, p = 0.01). In terms of the patients that were identified at risk (n = 40), 8 
underwent HR and 32 underwent THA; the observed and the expected counts were not statistically 
different (p = 0.171). Furthermore, the variable “Type of surgery” was not identified as a significant 
predictor. While these interventions may have different indications and outcomes such as failure rates 
[40], based on the similarities between the two groups, it is acceptable to evaluate them conjointly, 
albeit uniquely for the purpose of assessing pain, disability and joint perception. 
We intended to develop a clinically pertinent tool, whereby the prediction process is logical and 
applicable. Ideally, the direction of the link between a variable with the outcome is similar, whether it 
is considered a predictor or a determinant; for example, a higher BMI as a determinant is associated 
with a worse outcome, and as a predictor, a higher BMI predicts a worse outcome. Nevertheless, at one 
instance, the interpretation process may be counterintuitive. For example, it is possible, in an extreme 
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scenario, for a 49 year-old male patient with a BMI of 22 kg/m2 and with no pain when walking on a 
flat surface as well as with no difficulty with putting on socks or stockings to be classified as at risk of 
suboptimal surgical outcome. Development with recursive partitioning indicated that this pattern of 
answers has the best predictive capabilities, again emphasizing the difference between a predictor 
variable and a determinant.
3. Determinants of poor pain and function following total knee arthroplasty
In this study, we systematically reviewed the literature of determinants of poor short and medium-term 
outcomes in terms of pain and function following TKA. We identified 34 eligible studies, which 
allowed us to pinpoint demographic, socioeconomic, clinical, surgical and healthcare-related 
determinants with an excellent level of evidence (mean methodological score 80.0%, SD 12.7%). This 
in turn allowed us to select a list of determinants associated with poor pain and function with the 
greatest amount of high-quality evidence.
The most evidence was found for the significant relationship between the preoperative and the 
postoperative levels of pain and function (21 out of 23 studies). The logic and implications of such an 
association is identical to the similar finding for THA, as discussed in section 1 of this chapter. A 
greater level of preoperative health, whether measured as the total number of comorbidities, presence 
of specific comorbidities, the effect exerted by the comorbidities on one’s life or level of general health 
has been significantly associated to poor outcome in terms of pain and function. The effect of 
comorbidities on mortality and operative complications associated to TKA is well studied and 
understood [161, 162]. The association between comorbidities and outcomes in terms of pain and 
function is less known, and our review strongly emphasizes it. However, the rationale behind such an 
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association is poorly understood, and because it is presumed that greater levels of comorbidity is 
detrimental to rehabilitation, appropriate preoperative counselling may be recommended [92, 128, 
130]. In line with the previously described importance of comorbidities, greater amount of evidence 
regarding psychosocial variables associated with poor outcomes after TKA has started to emerge. 
Among these, pain catastrophizing likely alters the neurophysiological processes related to pain 
modulation, leading to a greater sensitization to pain [133]. Combined with the potential impact of 
preoperative depression and anxiety, this finding underlies the importance of preoperative mental 
health in determining outcome of TKA surgery. Therefore, interventions targeted at ameliorating 
surgical outcomes should also consider tackling psychological health. Finally, a lower socioeconomic 
status was associated with worse pain and function after TKA in two large cohorts. This may suggest 
that socially deprived patients are more in need of interventions such as prehabilitation, and would be 
more likely to benefit from them. Finally, regarding surgical determinants, very few studies identified 
variables such as cementless and cruciate-retaining implants as associated with pain and function after 
TKA, and none of these are consistent between the studies. This may suggest that the effect of this 
type of factors is generally investigated using a clinical trial methodology [163, 164], whereas our 
review focused solely on prognostic studies. 
This study underlines that several variables that are traditionally thought to be associated with worse 
TKA outcomes in terms of pain and function are not significant determinants when studies with high 
methodological quality are overviewed. For example, neither age, gender, nor BMI were found to be 
related to pain or function after TKA in a consistently significant manner. Several studies identified 
older patients, females and patients with higher BMI as at risk of poor outcomes in terms of pain and 
function, yet when viewing the general picture, an overwhelming amount of evidence points to an 
160
opposite direction of association or to no association at all. Therefore, according to these findings, we 
suggest that TKA should not be systematically refused to patients based on their age, gender or BMI 
with respect to pain and functional outcomes.
When comparing the findings of this review to the similar study on determinants of THA outcomes, 
some interesting observations can be made. For example, higher BMI was found to be a significant 
determinant of pain and function after THA but not TKA. Although obesity is a significant risk factor 
for developing OA for both joints [158, 165], the disparity between its association with TJA outcomes 
is difficult to explain. 
Similarly to THA, TKA outcomes are not associated with preoperative age and gender, further 
suggesting the relevance of targeting patients for outcome improvement irrespective of these variables. 
The important significant association between preoperative and postoperative levels of pain and 
function seems to be equally valid for TKA and THA, and advocates for the amelioration of pain and 
function prior to surgery by means of targeted interventions such as prehabilitation. Finally, although 
psychosocial variables were not found to be associated to THA outcomes like in the case of TKA, it is 
possible that a smaller attention to this variable in the THA literature contributes to this finding. 
4. Clinical prediction tool identifying patients awaiting surgery who are at risk of greater 
pain and disability following TKA
In this study, 141 patients were followed from their inclusion on the waiting lists for a primary 
unilateral TKA until six months following surgery in order to develop a CPR allowing the 
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identification of patients at the greatest risk of poor pain and function postoperatively. The developed 
CPR encompasses five items of the preoperative WOMAC scale measured at the time of the inclusion 
on the waiting list, namely difficulty with taking off socks, getting on/off toilet, performing light 
domestic duties and rising from bed as well as degree of morning stiffness after the first wakening. The 
CPR has good predictive capabilities, allowing it to potentially serve as an appropriate screening tool. 
This CPR was developed by considering an extensive set of variables acquired at the time of enrolment 
on the waitlist that were carefully selected based on the literature of potential determinants of TKA 
results at the moment of the inception of the prospective cohort (2006). When comparing to the 
significant determinants of TKA outcomes as identified by the systematic review, only back pain and 
extent of preoperative pain catastrophizing were not collected in this study. Moreover, the choice of 
the final tool was based on selecting a simple model with appropriate sensitivity and specificity. In this 
way, we ensured the development of a prediction rule that is both evidence-based as well as clinically 
applicable. The end-result is an applicable screening clinical tool with that is also user-friendly.
To our knowledge, this CPR is the first predictive tool developed to identify patients at risk of poor 
outcomes after TKA or any other type of joint replacement specifically in patients awaiting surgery. 
The main implication of this approach is the ability of the users of this tool to identify the patients at 
risk early in their management process. In this way, targeted prehabilitation during the waiting time 
can potentially lead to diminishing their risk. Moreover, postoperative rehabilitation of the identified 
patients could additionally improve their outcomes but has yet to be formally proven.
The fact that the CPR is formed by items of the preoperative WOMAC scale is not surprising, given 
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that the preoperative level of pain and function is the most important determinant of postoperative pain 
and function, as evidenced by the findings of our systematic review. The strength of this association is 
indirectly emphasized by the fact that such an extensive set of possible TKA determinants were 
considered for the development of the CPR. 
5. Strengths of the current memoir
One of the strengths of the systematic reviews resides in the application of rigorous eligibility criteria, 
ensuring the inclusion of studies with the greatest level of evidence for determinants of TJA outcomes 
from four prominent databases. This bears advantage over the previously published reviews, whose 
conclusions were based mainly on poor-quality studies. Moreover, the focus on all types of 
determinants of surgical outcomes ensures a thorough survey of all variables that were identified 
significantly related to joint arthroplasty outcomes. This process allowed the elaboration of a list of 
determinants with the highest level of evidence.
The PA identifying the patients at risk of suboptimal results after hip arthroplasty is, to our knowledge, 
the first model that has the ability to discriminate hip arthroplasty outcomes based on more than one 
parameter, namely patients’ functional, stiffness and pain levels as well as their perception of the 
replaced hip joint. This approach increases the likelihood of correct classification, especially in a 
context where an accepted definition of poor outcome is still controversial. Moreover, this 
classification identified 15% of the patients as having unsuccessful outcomes, well in line with the 
published proportions of what can be considered a suboptimal outcome [3].  Finally, the rigorous 
statistical analysis employed in the development of the PA underlines the stringency of our approach.
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The development of the CPR identifying the patients at risk of poor outcomes following TKA was 
based on a prospective cohort with high participation and follow-up rates (77.8% and 92.2% 
respectively). The patients’ baseline measures were collected very soon after they were included on the 
waitlist (mean ± SD: 12.6 ± 4.7 days). The risk of selection bias is very low, as there was no 
statistically significant difference between participants and eligible non participants on age and gender 
as well as no significant differences in terms of pain, functional limitations at enrolment on the pre-
surgery wait lists between subjects lost to follow-up, subjects who did not undergo surgery and 
participants who completed the interview six months after surgery.
6. Limitations of the current memoir
As mentioned previously, although we aimed to consider manuscripts with the highest methodological 
qualities, the prognostic studies that were included in the systematic reviews have several important 
limitations with respect to our aim of summarizing the determinants of TJA outcomes and especially 
evaluating the strength of association. For example, employing validated PROMs ensures a higher 
quality of evidence, yet when different tools are used, pooling of results becomes impossible. 
Moreover, the prognostic studies employ different definitions of surgical outcome (either change in 
status or postoperative status). Although we conclude that determinants are similar between the two 
definitions, pooling of regression coefficients or odds ratios is challenging.  Also, while multivariate 
analyses are more robust than their univariate counterparts, linear and logistic regressions are distinct 
methods, a fact that limits the potential for pooling the strength of associations between determinants 
and TJA outcomes. Finally, the method of measurement of independent variables is inconsistent 
among the included studies. Ideally, future prognostic studies should focus on standardizing reporting 
of associations between determinants and TJA outcomes. However, considering the lack of consensus 
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regarding the different aspects, this may prove extremely challenging.
Because of similar methodologies, the PA and the CPR have comparable limitations. The populations 
under study were patients undergoing primary unilateral hip arthroplasty or TKA, which limits the 
generalizability of these findings to patients with revision and bilateral interventions. Furthermore, the 
surgical outcomes were based on self-reported measures (WOMAC and joint perception). Use of 
performance-based measures such as the Timed Up and Go Test and the Six Minute Walking test 
could have complemented these assessments, and potentially provided a more holistic overview of the 
patients’ faring [156]. In terms of the CPR, the prospective cohort entailed a small sample of 141 
patients. The CART algorithm that was employed to develop the prediction models has several 
disadvantages as discussed in Chapter 2, and these may limit the current findings. The retrospective 
nature of the study that led to the development of the PA holds an increased risk of selection bias, 
considering that when comparing to subjects excluded due to missing data, the included participants 
were on average younger, had a greater number of comorbidities and a greater proportion were male. 
Because of their preliminary status, these prediction tools should not be implemented clinically as of 
yet, as external validation with different samples should be first undertaken. Finally, the approach 
described in this memoir, which involves implementing interventions for patients at risk of poor 
outcomes as defined, by pain, function and satisfaction, is limited by the fact that surgical results 
encompass multiple aspects. For example, other outcome variables that may or may not be associated 
with pain and disability include surgery-associated complications, implant revision or activity levels. 
These may need to be taken into account when assessing the requirements for prehabilitation, 
rehabilitation, and ultimately the decision to undergo TJA. Developing clinical tools and guidelines 
assessing all of these aspects would prove intricate, and likely of limited clinical applicability. 
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Ultimately, as described in the introduction, patient-reported outcomes are an important aspect of 
surgical results, and we believe that focusing our research on them may prove the most advantageous 
clinically, especially considering the higher occurrence of poor results in terms of pain, function and 
satisfaction compared to the other types of outcomes.
7. Impacts of current findings and future directions
In this memoir, we provided a summary of preoperative determinants of pain and physical function 
levels up to 2 years following TKA and THA. Moreover, we developed two predictive models 
allowing the identification of patients at risk of poor surgical outcomes following TJA. The main 
implication of these findings is the assistance they could bring in developing and implementing clinical 
and public health measures in order to ameliorate the outcomes of patients undergoing TJA. A possible 
intervention is the prioritization of patients or groups of patients who are suspected of being at risk of 
less successful surgical outcomes. It has been shown that a longer waiting time is associated with 
deterioration in pain and function preoperatively, and could even impact the postoperative outcome
[148, 166]. With this in mind, earlier intervention can have the potential of improving outcomes, and 
this hypothesis should be evaluated in future studies. From a clinical point of view, knowledge of 
determinants of unsuccessful outcomes as well as the ability to predict which patients will fare worse 
can lead to the implementation of intensive prehabilitation and postoperative rehabilitation. Targeting 
of modifiable risk factors, such as weight loss, amelioration of back pain or management of 
comorbidities for example, may possibly diminish the risk profile. Ultimately, if the developed 
prediction models prove valid in subsequent external validation studies, they could be employed as 
tools evaluating the necessity or the merit of undergoing the procedure. Finally, our findings may aid 
stakeholders in assessing which patients or groups would benefit the most from these prevention 
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strategies. 
A limitation of the literature that the systematic reviews identified resides in the conflicting evidence 
regarding the significance of the association of certain variables with the outcome of joint 
arthroplasties. This limitation underlines the importance of conducting higher quality studies in order 
to elucidate this association. A structured, consistent approach of future cohort studies may also 
significantly facilitate the pooling of results in ensuing systematic reviews and meta-analyses.
Subsequent steps in the development of the prediction models consist in their external validation as 
well as impact assessment, as discussed in Chapter 2. Further studies should employ a prospective 
design, and maximize the number of collected determinants of TJA outcomes in order to optimize the 
selection of predictors. If successful, these tools could significantly ameliorate the management of 
patients suffering from incapacitating knee and hip OA.
8. Conclusion
TJAs are successful and cost-effective interventions, yet their shortcomings aren’t negligible, 
especially in terms of postoperative pain and function. The first step in improving management is to 
elaborate methods of identifying which patients or groups of patients are most vulnerable to 
unsuccessful outcomes, and would ultimately benefit from further attention. A systematic review of 
the literature identified 22 manuscripts with moderate-to-excellent methodological quality suggesting 
that significant determinants of poor pain and function following THA include a lower educational 
level, the preoperative level of pain and function, higher BMI, presence or a greater level of 
comorbidities, worse general health and lower radiographic OA severity. A similar methodology 
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identified 34 eligible studies concluding that significant determinants of poor outcomes following 
TKA with the greatest amount and quality of evidence are a greater social deprivation, the presence or 
a greater level of depression and/or anxiety, greater preoperative level of pain catastrophizing, 
preoperative pain or function levels, presence or greater levels of comorbidity, presence of back pain 
and lower general health. Using data from a retrospective cohort of 265 patients undergoing THA and
HR, we developed a PA consisting of patients’ age, gender, BMI and three items of the preoperative 
WOMAC that identified patients at risk of poor outcomes on average 15 months postoperatively with a 
sensitivity of 75.0% (95% CI 59.8.4-85.8), a specificity of 77.8% (95% CI 71.9-82.7) and a positive 
likelihood ratio of 3.38 (95% CI 2.49-4.57). Finally, in a prospective cohort of 141 patients undergoing 
TKA, we developed a CPR consisting of five WOMAC measured preoperatively that identifies 
patients at risk of poor outcomes six months following TKA with a sensitivity of 82.1% (95% CI 66.7-
95.8), a specificity of 71.7% (95% CI 62.8-79.8), and a positive likelihood of 2.9 (95% CI 1.8-4.7).  
By systematically evaluating the literature of all determinants of TJA results and developing clinical 
prediction tools, we laid groundwork for future investigations of methods aimed at improving surgical 
outcomes. This work has the potential of finding applications at every level of care, and ultimately 
could improve the faring of patients with hip and knee OA. 
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O
R
2)
A
t least tw
o of the follow
ing:
a.
Pain ≥ 20%
 and absolute change ≥ 10
b.
Function ≥20%
 and absolute change ≥ 10
c.
Patients global assessm
ent of the disease ≥ 20 %
 (1 point change on the Likert scare = 20%
 global assessm
ent change)  
and absolute change ≥ 10
183
C
hesw
orth et 
al. (2007) 
C
ID
 (R
O
C
)
D
erivation C
ID
:  N
ot explicitly stated; ’’[…
] com
pared to w
hen they (patients) w
ent on the 
w
ait list for surgery, (w
ere) they better, w
orse or the sam
e (?)’’
D
erivation C
ID
Positive C
ID
If initial response is ’’B
etter’’, analysis w
as 
done on:
’’a good deal better’’ or ’’a great deal 
better’’ or ’’a very great deal better’’vs.
’’a very great deal w
orse’’ and ’’a great 
deal w
orse’’ and ’’a good deal w
orse’’ and 
’’m
oderately w
orse’’ and ’’som
ew
hat 
w
orse’’ and ’’a little w
orse’’ and ’’ alm
ost 
the sam
e-hardly any w
orse’’ and ’’sam
e’’ 
and ’’hardly any better’’ and ’’a little 
better’’ and ’’som
ew
hat better’’ and 
’’m
oderately better’’
N
egative C
ID
If initial response is ’’W
orse’’, analysis 
w
as done on:
’’a very great deal w
orse’’ and ’’a great 
deal w
orse’’ and ’’a good deal w
orse’’ and 
’’m
oderately w
orse’’ and ’’som
ew
hat 
w
orse’’ and ’’a little w
orse’’ and ’’ alm
ost 
the sam
e-hardly any w
orse’’vs. ’’sam
e’’ 
and ’’hardly any better’’ and ’’a little 
better’’ and ’’som
ew
hat better’’ and 
’’m
oderately better’’ and ’’a good deal 
better’’ or ’’a great deal better’’ or ’’a very 
great deal better’’
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V
alidation C
ID
: ’’
know
ing w
hat your hip or knee replacem
ent surgery did for you, if you 
could go back in tim
e, w
ould you still have undergone this surgery (?)’’
V
alidation C
ID
Positive C
ID
’’Y
es’’ vs. ’’N
o’’ or ’’U
ncertain’’
N
egative C
ID
’’N
o’’ or ‘‘U
ncertain’’ vs. ’Y
es’’
W
O
M
A
C
 –
W
estern O
ntario and M
cM
aster U
niversities O
steoarthritis Index;PA
SS –
Patient A
cceptable Sym
ptom
 Scale; M
C
ID
 –
M
inim
al C
linically 
Im
portant D
ifference; R
O
C
 –
R
eceiver O
perating C
haracteristics; O
M
ER
A
CT-O
A
R
SI –
O
utcom
e M
easures in R
heum
atology-O
steoarthritis R
esearch 
Society International responder criteria; C
ID
 –
C
linically Im
portant D
ifference
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IX
 B
 -E
stim
ates of appropriate and inappropriate outcom
es as m
easured w
ith the W
O
M
A
C
 follow
ing T
K
A
 and 
T
H
AStudy
T
ype of surgery
T
im
e point after 
intervention
W
O
M
A
C
 
dom
ain
E
stim
ate of outcom
e
Q
uintana et al. 
(2012)
Prim
ary TH
A
6 m
onths
Pain
D
erivation C
ohort
PA
SS
1st quartile
of preoperative total W
O
M
A
C
 scores: 20
2
ndquartile
of preoperative total W
O
M
A
C
 scores: 25
3rd tertile
of preoperative total W
O
M
A
C
 scores: 25
Positive M
C
ID
 
1st quartile
of preoperative total W
O
M
A
C
 scores: 14.66 ± 12.55
2
ndquartile
of preoperative total W
O
M
A
C
 scores: 23.29 ± 16.99
3rd tertitle of preoperative total W
O
M
A
C
 scores: 23.29 ± 16.99
R
O
C
 
1st quartile
of preoperative total W
O
M
A
C
 scores: 19
2
ndquartile
of preoperative total W
O
M
A
C
 scores: 25
3rd tertitle of preoperative total W
O
M
A
C
 scores: 25
V
alidation C
ohort
PA
SS
1st quartile
of preoperative total W
O
M
A
C
 scores: 20
2
ndquartile
of preoperative total W
O
M
A
C
 scores: 25
3rd tertitle of preoperative total W
O
M
A
C
 scores: 25
R
O
C
1st quartile
of preoperative total W
O
M
A
C
 scores: 20
2
ndquartile
of preoperative total W
O
M
A
C
 scores: 25
3rd tertitle of preoperative total W
O
M
A
C
 scores: 25
6
m
onths
Function
D
erivation C
ohort
PA
SS
1st quartile
of preoperative total W
O
M
A
C
 scores: 28
2
ndquartile
of preoperative total W
O
M
A
C
 scores: 35
3rd tertitle of preoperative total W
O
M
A
C
 scores: 42
Positive M
C
ID
 
1st quartile
of preoperative total W
O
M
A
C
 scores: 9
2
ndquartile
of preoperative total W
O
M
A
C
 scores: 22
3rd tertitle of preoperative total W
O
M
A
C
 scores: 1
R
O
C
1st quartile
of preoperative total W
O
M
A
C
 scores: 26.4
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2
ndquartile
of preoperative total W
O
M
A
C
 scores: 39
3rd tertitle of preoperative total W
O
M
A
C
 scores: 40
V
alidation C
ohort
PA
SS
1st quartile
of preoperative total W
O
M
A
C
 scores: 32
2
ndquartile
of preoperative total W
O
M
A
C
 scores: 32
3rd tertitle of preoperative total W
O
M
A
C
 scores: 40
R
O
C
1st quartile
of preoperative total W
O
M
A
C
 scores: 25
2
ndquartile
of preoperative total W
O
M
A
C
 scores: 39
3rd tertitle of preoperative total W
O
M
A
C
 scores: 40
Q
uintana et al. 
(2005)
Prim
ary TH
A
6 m
onths
Pain
Positive M
C
ID
: 29.26 (16.90)*
Function
Positive M
C
ID
:26.54 (17.79)*
Stiffness
Positive M
C
ID
: 25.91 (22.94)*
2 years
Pain
Positive M
C
ID
: 33.13 (19.04)*
Function
Positive M
C
ID
: 25.93 (18.04)*
Stiffness
Positive M
C
ID
: 33.20 (18.68)*
Escobar et al. 
(2007)
Prim
ary TK
A
6 m
onths
Pain
Positive M
C
ID
: 22.87 (18.13)*
Function
Positive M
C
ID
: 19.01 (17.48)*
Stiffness
Positive M
C
ID
: 14.53 (26.50)*
2 years
Pain
Positive M
C
ID
: 27.98 (19.44)*
Function
Positive M
C
ID
: 20.84 (18.20)*
Stiffness
Positive M
C
ID
: 21.35 (27.22)*
Escobar et al. 
(2012)
Prim
ary TH
A
1 year
Pain
PA
SS**:
W
orst quartile
of preoperative total W
O
M
A
C
 scores: 25.0 (15.0 –
30.0)***
M
edium
 quartile
of preoperative total W
O
M
A
C
 scores: 20.0 (15.0 –
25.0)***
W
orst quartile
of preoperative total W
O
M
A
C
 scores: 20.0 (15.0 –
25.0)***
Full sam
ple: 20.0 (15.0 –
25.0)***
O
M
E
R
A
C
T
-O
A
R
SI**:
W
orst quartile
of preoperative total W
O
M
A
C
 scores: 25.0 (15.0 –
30.0)***
M
edium
 quartile
of preoperative total W
O
M
A
C
 scores: 20.0 (15.0 –
25.0)***
W
orst quartile
of preoperative total W
O
M
A
C
 scores: 15.0 (15.0 –
25.0)***
Full sam
ple: 20.0 (15.0 –
25.0)***
R
O
C
**: 30.0 (29.4 –
30.6)***
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Function
PA
SS**:
W
orst quartile
of preoperative total W
O
M
A
C
 scores: 39.9 (32.8 –
42.7)***
M
edium
 quartile
of preoperative total W
O
M
A
C
 scores: 27.9 (23.5 –
36.8)***
W
orst quartile
of preoperative total W
O
M
A
C
 scores: 25.0 (20.6 –
29.4)***
Full sam
ple: 30.9 (27.9 –
32.4)***
O
M
E
R
A
C
T
-O
A
R
SI**:
W
orst quartile
of preoperative total W
O
M
A
C
 scores: 41.2 (37.5 –
45.6)***
M
edium
 quartile
of preoperative total W
O
M
A
C
 scores: 28.0 (25.0 –
36.8)***
W
orst quartile
of preoperative total W
O
M
A
C
 scores: 26.5 (23.5 –
30.9)***
Full sam
ple: 32.4 (31.2 –
35.3)***
R
O
C
**: 31.2 (30.7 –
31.6)***
Prim
ary TK
A
1 year
Pain
PA
SS**:
W
orst quartile
of preoperative total W
O
M
A
C
 scores: 30.0 (25.0 –
35.0)***
M
edium
 quartile
of preoperative total W
O
M
A
C
 scores: 25.0 (20.0 –
30.0)***
W
orst quartile
of preoperative total W
O
M
A
C
 scores: 20.0 (15.0 –
25.0)***
Full sam
ple: 25.0 (20.0 –
30.0)***
O
M
E
R
A
C
T
-O
A
R
SI**:
W
orst quartile
of preoperative total W
O
M
A
C
 scores: 30.0 (25.0 –
35.0)***
M
edium
 quartile
of preoperative total W
O
M
A
C
 scores: 25.0 (20.0–
30.0)***
W
orst quartile
of preoperative total W
O
M
A
C
 scores: 15.0 (12.5 –
20.0)***
Full sam
ple: 25.0 (20.0 –
30.0)***
R
O
C
**: 28.6 (28.2 –
28.9)***
Function
PA
SS**:
W
orst quartile
of preoperative total W
O
M
A
C
 scores: 39.7 (33.8 –
48.4)***
M
edium
 quartile
of preoperative total W
O
M
A
C
 scores: 32.3 (27.9 –
35.3)***
W
orst quartile
of preoperative total W
O
M
A
C
 scores: 27.2 (25.0 –
30.9)***
Full sam
ple: 32.3 (29.4 –
35.3)***
O
M
E
R
A
C
T
-O
A
R
SI**:
W
orst quartile
of preoperative total W
O
M
A
C
 scores: 41.2 (36.8 –
47.1)***
M
edium
 quartile
of preoperative total W
O
M
A
C
 scores: 33.3 (30.9–
36.8)***
W
orst quartile
of preoperative total W
O
M
A
C
 scores: 25.4 (23.5 –
29.4)***
Full sam
ple: 33.8 (30.9 –
35.3)***
R
O
C
**: 36.7 (36.4 –
37.1)***
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C
hesw
orth et 
al. (2007)
Prim
ary TH
A
1 year
Pain
D
erivation:
Positive C
ID
: 41
N
egative C
ID
: 35
V
alidation
Positive C
ID
: 36
N
egative C
ID
: 20
Function
D
erivation:
Positive C
ID
: 34
N
egative C
ID
: 33
V
alidation
Positive C
ID
: 34
N
egative C
ID
: 33
Prim
ary TK
A
Pain
D
erivation:
Positive C
ID
: 36
N
egative C
ID
: 30
V
alidation
Positive C
ID
: 31
N
egative C
ID
: 25
Function
D
erivation:
Positive C
ID
: 33
N
egative C
ID
: 25
V
alidation
Positive C
ID
: 26
N
egative C
ID
: 20
* R
esults reported as m
ean (standard deviation)
** W
O
M
A
C
 values are transform
ed on a standardized 0-100 scale w
here 0 indicates the best possible status and 100 the w
orst status; original study (Escobar et al, 
2012) reports a score of 0 as the w
orst status and a score of 100 as the best possible status.
** 95 %
 confidence interval
W
O
M
A
C
 –
W
estern O
ntario and M
cM
aster U
niversities O
steoarthritis Index; TH
A
 –
Total H
ip A
rthroplasty; TK
A
 –
Total K
nee A
rthroplasty: PA
SS –
Patient 
A
cceptable Sym
ptom
 Scale; M
C
ID
 –
M
inim
al C
linically Im
portant D
ifference; R
O
C
 –
R
eceiver O
perating Characteristics; O
M
ER
A
C
T-O
A
R
SI –
O
utcom
e 
M
easures in Rheum
atology-O
steoarthritis R
esearch Society International responder criteria; C
ID
 –
C
linically Im
portant D
ifference
APPENDIX C - Pubmed/Medline search strategy for the systematic review on 
determinants of THA outcomes
((((((tha OR hip arthroplast* OR thr OR hip replacement*[Title/Abstract]))) OR ((((hip[MeSH 
Terms]) OR hip joint[MeSH Terms])) AND ((hip prosthesis[MeSH Terms]) OR arthroplasty, 
replacement[MeSH Terms]))) OR arthroplasty, replacement, hip[MeSH Terms])) AND (((predict* OR 
determinant* OR determinat* OR determining* OR contribut* OR impact* OR influenc* OR 
predispos* OR characteristic* OR associat* OR affect*)) AND (((((recovery of function[MeSH 
Terms]) OR ((postoperative period[MeSH Terms]) AND pain[Title/Abstract])) OR ((pain, 
postoperative[MeSH Terms]) OR pain measurement)) OR "clinical outcome") OR (((pain OR 
function*)) AND (postoperati* OR post-operati* OR postsurgical* OR post-surgical* OR outcome* 
OR limitation* OR status OR disabilit* OR recovery))))
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APPENDIX D - Pubmed/Medline search strategy for the systematic review on 
determinants of TKA outcomes
((((((tka OR knee arthroplast* OR tkr OR knee replacement*[Title/Abstract]))) OR ((((knee[MeSH 
Terms]) OR knee joint[MeSH Terms])) AND ((knee prosthesis[MeSH Terms]) OR arthroplasty, 
replacement[MeSH Terms]))) OR arthroplasty, replacement, knee[MeSH Terms])) AND (((predict* 
OR determinant* OR determinat* OR determining* OR contribut* OR impact* OR influenc* OR 
predispos* OR characteristic* OR associat* OR affect*)) AND (((((recovery of function[MeSH 
Terms]) OR ((postoperative period[MeSH Terms]) AND pain[Title/Abstract])) OR ((pain, 
postoperative[MeSH Terms]) OR pain measurement)) OR "clinical outcome") OR (((pain OR 
function*)) AND (postoperati* OR post-operati* OR postsurgical* OR post-surgical* OR outcome* 
OR limitation* OR status OR disabilit* OR recovery))))
191
APPENDIX E - Methodology Checklist for Prognostic Studies
192
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APPENDIX F – WOMAC Questionnaire
197
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APPENDIX G – Hip perception questionnaire
199
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APPENDIX I – Information and consent form
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APPENDIX J – Proof of manuscript acceptance 
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APPENDIX K – STROBE guidelines for the prediction algorithm
Item 
No Recommendation                                                                     Pages
Title and abstract 1 (a) Indicate the study’s design with a commonly used 
term in the title or the abstract
63
(b) Provide in the abstract an informative and balanced 
summary of what was done and what was found
63
Introduction
Background/rationale 2 Explain the scientific background and rationale for the 
investigation being reported
67
Objectives 3 State specific objectives, including any prespecified 
hypotheses
68
Methods
Study design 4 Present key elements of study design early in the paper 68
Setting 5 Describe the setting, locations, and relevant dates, 
including periods of recruitment, exposure, follow-up, 
and data collection
68
Participants 6 (a) Give the eligibility criteria, and the sources and 
methods of selection of participants. Describe methods 
of follow-up
68
(b) For matched studies, give matching criteria and 
number of exposed and unexposed
N/A
Variables 7 Clearly define all outcomes, exposures, predictors, 
potential confounders, and effect modifiers. Give 
diagnostic criteria, if applicable
69-70
Data sources/ 
measurement
8 For each variable of interest, give sources of data and 
details of methods of assessment (measurement). 
Describe comparability of assessment methods if there 
is more than one group
69-70
Bias 9 Describe any efforts to address potential sources of bias 71
Study size 10 Explain how the study size was arrived at 69-70
Quantitative 
variables
11 Explain how quantitative variables were handled in the 
analyses. If applicable, describe which groupings were 
chosen and why
70-71
Statistical methods 12 (a) Describe all statistical methods, including those 
used to control for confounding
70-71
(b) Describe any methods used to examine subgroups 
and interactions
N/A
(c) Explain how missing data were addressed N/A
(d) If applicable, explain how loss to follow-up was 
addressed
N/A
(e) Describe any sensitivity analyses 73 – Internal 
validation
Results
209
Participants 13 (a) Report numbers of individuals at each stage of 
study—eg numbers potentially eligible, examined for 
eligibility, confirmed eligible, included in the study, 
completing follow-up, and analysed
71-72
(b) Give reasons for non-participation at each stage 71
(c) Consider use of a flow diagram N/A
Descriptive data 14 (a) Give characteristics of study participants (eg 
demographic, clinical, social) and information on 
exposures and potential confounders
78
(b) Indicate number of participants with missing data 
for each variable of interest
78
(c) Summarise follow-up time (eg, average and total 
amount)
72
Outcome data 15 Report numbers of outcome events or summary 
measures over time
72-73
Main results 16 (a) Give unadjusted estimates and, if applicable, 
confounder-adjusted estimates and their precision (eg, 
95% confidence interval). Make clear which 
confounders were adjusted for and why they were 
included
73
(b) Report category boundaries when continuous 
variables were categorized
73
(c) If relevant, consider translating estimates of relative 
risk into absolute risk for a meaningful time period
N/A
Other analyses 17 Report other analyses done—eg analyses of subgroups 
and interactions, and sensitivity analyses
N/A
Discussion
Key results 18 Summarise key results with reference to study 
objectives
73-74
Limitations 19 Discuss limitations of the study, taking into account 
sources of potential bias or imprecision. Discuss both 
direction and magnitude of any potential bias
76
Interpretation 20 Give a cautious overall interpretation of results 
considering objectives, limitations, multiplicity of 
analyses, results from similar studies, and other 
relevant evidence
77
Generalisability 21 Discuss the generalisability (external validity) of the 
study results
76
Other information
Funding 22 Give the source of funding and the role of the funders 
for the present study and, if applicable, for the original 
study on which the present article is based
77
210
APPENDIX L – Additional prediction algorithms that were considered
Figure 1 Graphical representation of prediction algorithm (PA) 1
Table 1.1 Two by Two table of predicted versus actual outcomes of the PA1
Table 1.2 Validity measures of the PA1
Measure Estimates in training sample
Sensitivity % (95% CI) 75.0 (59.8-85.8)
Specificity % (95% CI) 72.9 (66.7-78.3)
Positive predictive value % (95% CI) 33.0 (24.2-43.1)
Negative predictive value % (95% CI) 94.3 (89.7-96.8)
Positive likelihood ratio (95% CI) 2.77 (2.09-3.66)
Negative likelihood ratio (95% CI) 0.34 (0.20-0.59)
Actual Outcome
Predicted outcome
AT RISK NOT AT RISK 
Worst postoperative WOMAC quartile
(>11.5/100) & “Artificial with minimal or 
major limitations” joint perception
Postoperative WOMAC ≤ 11.5/100 or 
‘’Artificial with no limitations’’ or 
‘’Natural joint’’ joint perception
AT RISK 30 61
NOT AT RISK 10 164
TOTAL 40 225
211
Figure 2 Graphical representation of PA2
Table 2.1 Two by Two table of predicted versus actual outcomes of the PA2
Actual Outcome
Predicted outcome
AT RISK NOT AT RISK 
Worst postoperative WOMAC quartile
(>11.5/100) & “Artificial with minimal or 
major limitations” joint perception
Postoperative WOMAC ≤ 11.5/100 or 
‘’Artificial with no limitations’’ or 
‘’Natural joint’’ joint perception
AT RISK 30 59
NOT AT RISK 10 166
TOTAL 40 225
Table 1.2 Validity measures of the PA2
Measure Estimates in training sample
Sensitivity % (95% CI) 75.0 (59.8-85.8)
Specificity % (95% CI) 73.8 (67.7-79.1)
Positive predictive value % (95% CI) 33.7 (24.7-44.0)
Negative predictive value % (95% CI) 94.3 (89.9-96.9)
Positive likelihood ratio (95% CI) 2.86 (2.16-3.80)
Negative likelihood ratio (95% CI) 0.34 (0.20-0.58)
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Figure 3 Graphical representation of PA3
Table 3.1 Two by Two table of predicted versus actual outcomes of the PA3
Table 3.2 Validity measures of the PA3
Measure Estimates in training sample
Sensitivity % (95% CI) 82.5 (68.1-91.3)
Specificity % (95% CI) 72.9 (66.7-78.3)
Positive predictive value % (95% CI) 35.1 (26.2-45.2)
Negative predictive value % (95% CI) 95.9 (91.8-98.0)
Positive likelihood ratio (95% CI) 3.04 (2.35-3.94)
Negative likelihood ratio (95% CI) 0.24 (0.12-0.47)
Actual Outcome
Predicted outcome
AT RISK NOT AT RISK 
Worst postoperative WOMAC quartile
(>11.5/100) & “Artificial with minimal or 
major limitations” joint perception
Postoperative WOMAC ≤ 11.5/100 or 
‘’Artificial with no limitations’’ or 
‘’Natural joint’’ joint perception
AT RISK 33 61
NOT AT RISK 7 164
TOTAL 40 225
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Figure 4 Graphical representation of PA4
Table 4.1 Two by Two table of predicted versus actual outcomes of the PA4
Actual Outcome
Predicted outcome
AT RISK NOT AT RISK 
Worst postoperative WOMAC quartile
(>11.5/100) & “Artificial with minimal or 
major limitations” joint perception
Postoperative WOMAC ≤ 11.5/100 or 
‘’Artificial with no limitations’’ or 
‘’Natural joint’’ joint perception
AT RISK 29 46
NOT AT RISK 11 179
TOTAL 40 225
Table 4.2 Validity measures of the PA4
Measure Estimates in training sample
Sensitivity % (95% CI) 72.5 (57.2-83.9)
Specificity % (95% CI) 79.6 (73.8-84.3)
Positive predictive value % (95% CI) 38.7 (28.5-50.0)
Negative predictive value % (95% CI) 94.2 (89.9-96.7)
Positive likelihood ratio (95% CI) 3.55 (2.57-4.89)
Negative likelihood ratio (95% CI) 0.35 (0.21-0.57)
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Figure 5 Graphical representation of PA5
Table 5.1 Two by Two table of predicted versus actual outcomes of the PA5
Actual Outcome
Predicted outcome
AT RISK NOT AT RISK 
Worst postoperative WOMAC tertile
(>9.4/100) & “Artificial with minimal or 
major limitations” joint perception
Postoperative WOMAC ≤ 9.4/100 or 
‘’Artificial with no limitations’’ or 
‘’Natural joint’’ joint perception
AT RISK 32 53
NOT AT RISK 12 168
TOTAL 44 221
Table 5.2 Validity measures of the PA5
Measure Estimates in training sample
Sensitivity % (95% CI) 72.7 (58.2-83.7)
Specificity % (95% CI) 76.0 (70.0-81.2)
Positive predictive value % (95% CI) 37.6 (28.1-48.3)
Negative predictive value % (95% CI) 93.3 (88.7-96.1)
Positive likelihood ratio (95% CI) 3.03 (2.26-4.08)
Negative likelihood ratio (95% CI) 0.36 (0.22-0.59)
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Figure 6 Graphical representation of PA6
Table 6.1 Two by Two table of predicted versus actual outcomes of the PA6
Table 6.2 Validity measures of the PA6
Measure Estimates in training sample
Sensitivity % (95% CI) 72.7 (58.2-83.7)
Specificity % (95% CI) 78.7 (72.9-83.6)
Positive predictive value % (95% CI) 40.5 (30.4-51.5)
Negative predictive value % (95% CI) 93.5 (89.1-96.3)
Positive likelihood ratio (95% CI) 3.42 (2.50-4.67)
Negative likelihood ratio (95% CI) 0.35 (0.21-0.56)
Actual Outcome
Predicted outcome
AT RISK NOT AT RISK 
Worst postoperative WOMAC tertile
(>9.4) & “Artificial with minimal or 
major limitations” joint perception
Postoperative WOMAC ≤ 9.4/100 or 
‘’Artificial with no limitations’’ or 
‘’Natural joint’’ joint perception
AT RISK 32 47
NOT AT RISK 12 174
TOTAL 44 221
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APPENDIX M – STROBE guidelines for the clinical prediction rule
Item 
No Recommendation                                                    Pages 
Title and abstract 1 (a) Indicate the study’s design with a commonly used 
term in the title or the abstract
125
(b) Provide in the abstract an informative and balanced 
summary of what was done and what was found
125
Introduction
Background/rationale 2 Explain the scientific background and rationale for the 
investigation being reported
129
Objectives 3 State specific objectives, including any prespecified 
hypotheses
130
Methods
Study design 4 Present key elements of study design early in the paper 130
Setting 5 Describe the setting, locations, and relevant dates, 
including periods of recruitment, exposure, follow-up, 
and data collection
130
Participants 6 (a) Give the eligibility criteria, and the sources and 
methods of selection of participants. Describe methods 
of follow-up
131
(b) For matched studies, give matching criteria and 
number of exposed and unexposed
N/A
Variables 7 Clearly define all outcomes, exposures, predictors, 
potential confounders, and effect modifiers. Give 
diagnostic criteria, if applicable
131-132
Data sources/ 
measurement
8 For each variable of interest, give sources of data and 
details of methods of assessment (measurement). 
Describe comparability of assessment methods if there 
is more than one group
132
Bias 9 Describe any efforts to address potential sources of bias 133
Study size 10 Explain how the study size was arrived at Reference 
[121]
Quantitative 
variables
11 Explain how quantitative variables were handled in the 
analyses. If applicable, describe which groupings were 
chosen and why
133
Statistical methods 12 (a) Describe all statistical methods, including those 
used to control for confounding
133
(b) Describe any methods used to examine subgroups 
and interactions
N/A
(c) Explain how missing data were addressed 133
(d) If applicable, explain how loss to follow-up was 
addressed
140
(e) Describe any sensitivity analyses 136 – Internal 
validation
Results
217
Participants 13 (a) Report numbers of individuals at each stage of 
study—eg numbers potentially eligible, examined for 
eligibility, confirmed eligible, included in the study, 
completing follow-up, and analysed
134-135
(b) Give reasons for non-participation at each stage 134-135
(c) Consider use of a flow diagram 143
Descriptive data 14 (a) Give characteristics of study participants (eg 
demographic, clinical, social) and information on 
exposures and potential confounders
146
(b) Indicate number of participants with missing data 
for each variable of interest
146
(c) Summarise follow-up time (eg, average and total 
amount)
135
Outcome data 15 Report numbers of outcome events or summary 
measures over time
136
Main results 16 (a) Give unadjusted estimates and, if applicable, 
confounder-adjusted estimates and their precision (eg, 
95% confidence interval). Make clear which 
confounders were adjusted for and why they were 
included
147
(b) Report category boundaries when continuous 
variables were categorized
147
(c) If relevant, consider translating estimates of relative 
risk into absolute risk for a meaningful time period
N/A
Other analyses 17 Report other analyses done—eg analyses of subgroups 
and interactions, and sensitivity analyses
N/A
Discussion
Key results 18 Summarise key results with reference to study 
objectives
136-137
Limitations 19 Discuss limitations of the study, taking into account 
sources of potential bias or imprecision. Discuss both 
direction and magnitude of any potential bias
139-140
Interpretation 20 Give a cautious overall interpretation of results 
considering objectives, limitations, multiplicity of 
analyses, results from similar studies, and other 
relevant evidence
140
Generalisability 21 Discuss the generalisability (external validity) of the 
study results
140
Other information
Funding 22 Give the source of funding and the role of the funders 
for the present study and, if applicable, for the original 
study on which the present article is based
142
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APPENDIX N – Additional clinical prediction rules that were considered
Figure 1 Graphical representation of Prediction Rule (PR) 1
Table 1.1 Two by Two table of predicted versus actual outcomes of the PR1
Table 1.2 Validity measures of the PR1
Actual Outcome
Predicted 
outcome
AT RISK
(Postoperative WOMAC > 40.4)
NOT AT RISK 
(Postoperative WOMAC ≤ 40.4)
AT RISK 23 42
NOT AT RISK 5 71
TOTAL 28 113
Measure Estimates in training sample
Sensitivity % (95% CI) 82.1 (64.4-92.1)
Specificity % (95% CI) 62.8 (53.6-71.2)
Positive predictive value % (95% CI) 35.4 (24.9-47.5)
Negative predictive value % (95% CI) 93.4 (85.5-97.2)
Positive likelihood ratio (95% CI) 2.21 (1.65-2.97)
Negative likelihood ratio (95% CI) 0.28 (0.13-0.63)
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Figure 2 Graphical representation of PR2
Table 2.1 Two by Two table of predicted versus actual outcomes of the PR2
Table 2.2 Validity measures of the PR2
Actual Outcome
Predicted 
outcome
AT RISK
(Postoperative WOMAC > 40.4)
NOT AT RISK 
(Postoperative WOMAC ≤ 40.4)
AT RISK 22 51
NOT AT RISK 6 62
TOTAL 28 113
Measure Estimates in training sample
Sensitivity % (95% CI) 78.6 (60.5-89.8)
Specificity % (95% CI) 54.9 (45.7-63.7)
Positive predictive value % (95% CI) 30.1 (20.8-41.4)
Negative predictive value % (95% CI) 91.2 (82.1-95.9)
Positive likelihood ratio (95% CI) 1.74 (1.32-2.31)
Negative likelihood ratio (95% CI) 0.39 (0.19-0.81)
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Figure 3 Graphical representation of PR3
Table 3.1 Two by Two table of predicted versus actual outcomes of the PR3
Table 3.2 Validity measures of the PR3
Actual Outcome
Predicted 
outcome
AT RISK
(Postoperative WOMAC > 40.4)
NOT AT RISK 
(Postoperative WOMAC ≤ 40.4)
AT RISK 18 23
NOT AT RISK 10 90
TOTAL 28 113
Measure Estimates in training sample
Sensitivity % (95% CI) 64.3 (45.8-79.3)
Specificity % (95% CI) 79.6 (71.3-86.0)
Positive predictive value % (95% CI) 43.9 (29.9-59.0)
Negative predictive value % (95% CI) 90.0 (82.6-94.5)
Positive likelihood ratio (95% CI) 3.16 (2.00-4.99)
Negative likelihood ratio (95% CI) 0.39 (0.19-0.81)
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Figure 4 Graphical representation of PR4
Table 4.1 Two by Two table of predicted versus actual outcomes of the PR4
Table 4.2 Validity measures of the PR4
Actual Outcome
Predicted 
outcome
AT RISK
(Postoperative WOMAC > 40.4)
NOT AT RISK 
(Postoperative WOMAC ≤ 40.4)
AT RISK 24 30
NOT AT RISK 4 83
TOTAL 28 113
Measure Estimates in training sample
Sensitivity % (95% CI) 85.7 (68.5-94.3)
Specificity % (95% CI) 73.5 (64.6-80.7)
Positive predictive value % (95% CI) 44.4 (32.0-57.6)
Negative predictive value % (95% CI) 95.4 (88.8-98.2)
Positive likelihood ratio (95% CI) 3.23 (2.29-4.55)
Negative likelihood ratio (95% CI) 0.19 (0.08-0.49)
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Figure 5 Graphical representation of PR5
Table 5.1 Two by Two table of predicted versus actual outcomes of the PR5
Table 5.2 Validity measures of the PR5
Actual Outcome
Predicted 
outcome
AT RISK
(Postoperative WOMAC > 40.4)
NOT AT RISK 
(Postoperative WOMAC ≤ 40.4)
AT RISK 21 33
NOT AT RISK 7 80
TOTAL 28 113
Measure Estimates in training sample
Sensitivity % (95% CI) 75.0 (56.6-87.3)
Specificity % (95% CI) 70.8 (61.8-78.4)
Positive predictive value % (95% CI) 38.9 (27.0-52.2)
Negative predictive value % (95% CI) 92.0 (84.3-96.0)
Positive likelihood ratio (95% CI) 2.57 (1.80-3.67)
Negative likelihood ratio (95% CI) 0.35 (0.18-0.68)
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Figure 6 Graphical representation of PR6
Table 6.1 Two by Two table of predicted versus actual outcomes of the PR6
Table 6.2 Validity measures of the PR6
Actual Outcome
Predicted 
outcome
AT RISK
(Postoperative WOMAC > 40.4)
NOT AT RISK 
(Postoperative WOMAC ≤ 40.4)
AT RISK 25 40
NOT AT RISK 3 73
TOTAL 28 113
Measure Estimates in training sample
Sensitivity % (95% CI) 89.3 (72.8-96.3)
Specificity % (95% CI) 64.6 (55.4-72.8)
Positive predictive value % (95% CI) 38.5 (27.6-50.6)
Negative predictive value % (95% CI) 96.1 (89.0-98.6)
Positive likelihood ratio (95% CI) 2.52 (1.91-3.34)
Negative likelihood ratio (95% CI) 0.17 (0.06-0.49)
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Figure 7 Graphical representation of PR7
Table 7.1 Two by Two table of predicted versus actual outcomes of the PR7
Table 7.2 Validity measures of the PR7
Actual Outcome
Predicted 
outcome
AT RISK
(Postoperative WOMAC > 40.4)
NOT AT RISK 
(Postoperative WOMAC ≤ 40.4)
AT RISK 21 31
NOT AT RISK 7 82
TOTAL 28 113
Measure Estimates in training sample
Sensitivity % (95% CI) 89.3 (72.8-96.3)
Specificity % (95% CI) 64.6 (55.4-72.8)
Positive predictive value % (95% CI) 38.5 (27.6-50.6)
Negative predictive value % (95% CI) 96.1 (89.0-98.6)
Positive likelihood ratio (95% CI) 2.52 (1.91-3.34)
Negative likelihood ratio (95% CI) 0.17 (0.06-0.49)
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Figure 8 Graphical representation of PR8
Table 8.1 Two by Two table of predicted versus actual outcomes of the PR8
Table 8.2 Validity measures of the PR8
Actual Outcome
Predicted 
outcome
AT RISK
(Postoperative WOMAC > 40.4)
NOT AT RISK 
(Postoperative WOMAC ≤ 40.4)
AT RISK 26 40
NOT AT RISK 2 73
TOTAL 28 113
Measure Estimates in training sample
Sensitivity % (95% CI) 92.9 (77.4-98.0)
Specificity % (95% CI) 64.6 (55.4-72.8)
Positive predictive value % (95% CI) 39.4 (28.5-51.5)
Negative predictive value % (95% CI) 97.3 (90.8-99.3)
Positive likelihood ratio (95% CI) 2.62 (2.00-3.43)
Negative likelihood ratio (95% CI) 0.11 (0.03-0.42)
